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ABSTRACT
This thesis develops two lines of investigation that focus on HMGBl protein from 
different points of view. In Section 3, acétylation of lysine is identified as the molecular 
switch that controls movement of HMGBl from the nucleus to the cytoplasm and 
Section 4 investigates its role in chromatin remodelling. High Mobility Group protein 
HMGBl is a chromatin component that, when leaked out by necrotic cells, triggers 
inflammation. HMGBl can also be secreted by activated monocytes and macrophages 
and fimctions as a late mediator of inflammation. Secretion of a nuclear protein must 
require a tightly controlled relocation programme. It was found that in all cells HMGBl 
shuttles actively between nucleus and cytoplasm due to two nuclear localisation signals 
(NLSs) and two nuclear export signals (NESs) within its sequence. Analysis of HMGBl 
samples, extracted under specific conditions, using iso-electric focussing/SDS 2- 
dimensional gels, followed by mass spectrometry, demonstrated that HMGBl is 
extensively acetylated (up to 10 modification sites per molecule) and that acétylation of 
the two NLSs inhibits nuclear import, causing cytoplasmic accumulation of the protein. 
This provides the first step in directing the protein to the secretion pathway, since 
cytosolic HMGBl is then concentrated by default into secretory lysosomes and finally 
secreted when monocytic cells receive an appropriate second signal. Multiple acétylation 
of lysine sidechains was thereby defined as the molecular switch redirecting the nuclear 
protein HMGBl to the cytoplasm and subsequently to secretion.
The second project investigated the potential role of HMGBl in nucleosome 
sliding. Nucleosome remodelling complexes containing the ATP-ase ISWl, such as ACF, 
contribute to chromatin remodelling by converting chemical energy into the sliding of 
nucleosomes on DNA. ISWl interacts with DNA at the sites of its entry into the 
nucleosome, where it alters histone/DNA interactions that may lead to the relocation of 
DNA relative to the associated histone octamer. This work elaborated on this concept: if 
the rate-limiting step in nucleosome sliding is the distortion of linker DNA, a protein that 
can generate and/or stabilise such distortions might facilitate sliding. HMGBl is able to 
transiently bend DNA, so is a good candidate to help “lubricate” nucleosome sliding. 
Using gel-shift assays, it was found that transient interaction of HMGBl with 
nucleosomal DNA, at sites overlapping with ISWl binding sites, enhanced ACF-induced 
sliding. The ACFl subunit of ACF was required to render the remodelling process
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sensitive to HMGBl action since no enhancement was detected when the sliding assay 
was performed using ISWl alone. In contrast, an HMGBl derivative lacking the acidic 
tail that interacts with chromatin in a more dynamic way, had a strong inhibitory effect on 
sliding. These data suggest that HMGBl is able to increase chromatin ‘fluidity’ by 
generating strategic DNA bends, or ‘bulges’, which are profitably used by ACF to induce 
nucleosome sliding. Moreover they support a “local loop” model of sliding and identify 
HMGBl as a potential regulator of ATP-dependent nucleosome remodelling processes. 
This work was published in the EMBO Journal on 16th December 2002.
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CHAPTER 1. INTRODUCTION
1.1 Literature review: HMGBl and HMG-box family
1.1.1 HMGB proteins (High Mobility Group Box)
The HMGB family comprises in mammals the three proteins HMGBl 
(previously, HMGl), HMGB2 (previously, HMG2) and HMGB3 (previously, HMG4 or 
HMG2b) (Bustin, 2001). HMGB proteins are very abundant, non-histone chromatin 
proteins present in the nucleus of all eukaryotic cells. They are small proteins (~ 25 
KDa), characterised by high mobility in denaturing SDS polyacrylamide gels, hence the 
acronym High Mobility Group (Bustin et ah, 1990), .
HMGBl is the archetypal member of the group and gives the name to the family. 
It is ubiquitous and only 10 times less abundant than core histones, counting about one 
million molecules per typical mammalian cell. The expression of the other two family 
members is more restricted: HMGB3 is only expressed in a significant amount during 
embryogenesis (Vaccari et al., 1998); HMGB2 is widely expressed during embryonic 
development, but restricted mainly to lymphoid organs and testis in the adult mouse 
(Ronfani et al., 2001).
The structure of these three proteins is highly conserved (Fig. 1) (more than 80% 
amino acid identity), and their biochemical properties are so far indistinguishable. 
HMGBs are composed of three different domains. The two homologous DNA binding 
domains, HMG box A and B, are each around 75 amino acids in length. The C-terminal 
domain is highly negatively charged, consisting of a continuous stretch of glutamate or 
aspartate residues, and is longest in HMGBl and shortest in HMGB3 (reviewed in 
(Bianchi and Beltrame, 2000); (Bustin, 1999)).
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HMGBl N
HMGB2 N
HMGBS N
box A box B acidic tail
Fig. 1 Structure of HMGB proteins
All HMGBs possess two DNA binding domains, HMG box A and B (black boxes), and an 
unstructured acidic tail of variable length at the C-terminus (grey box).
Putative counterparts of HMGBs are present in Saccharomyces cerevisiae (non­
histone proteins 6A and 6B, NHP6A and NHP6B) (Kolodrubetz and Burgum, 1990) 
and Drosophila melanogaster (HMG-D and HMG-Z) (Wagner et ah, 1992), as well as 
in plants (Fig. 2A). Single HMG-box domains, with no acidic tail, characterize also an 
increasing number of mammalian sequence-specific transcription factors, such as the 
sex determining factor SRY (sex-determining region Y) (Goodfellow and Lovell- 
Badge, 1993) and the lymphocyte enhancer factor 1 (LEF-1).
1.1.2 The H M G -box dom ain
All the known biochemical and functional properties of HMGBs are specified by their 
HMG-boxes. The HMG-box motif is a stretch of about 75 residues, with a net positive 
charge and rich in aromatic residues and prolines (Bianchi et al., 1992). No amino acid 
is absolutely conserved in all known HMG-boxes, and only three residues have 
conservative substitutions.
The three-dimensional structures of several HMG-boxes have been resolved by 
means of either NMR or crystallography, showing that the global fold of the domain is 
well conserved (Read et al., 1993); (Hardman et al., 1995); (Weir et al., 1993); (Jones et
16
al., 1994); (Werner et al., 1995)). The HMG-box of HMGBl consists of three a-helical 
segments forming an L-shaped structure stabilised by a hydrophobic core. The shorter 
arm of the "L" consists of helices I and II and the longer arm is composed of the 
extended N-terminal section packed against the C-terminal region, helix III (Fig. 2B, 
C).
Despite having a broadly similar fold, the structures of the A and B domains of 
HMGBl differ significantly in the relative disposition of helices I and II and in the 
trajectory of the helix I-II loop. In box A, helix I is essentially straight whereas in box 
B it is bent, and the loop between helices I and II is longer in box A than in box B.
The HMG boxes of HMGBl are highly similar to the HMG domains of S. cerevisiae 
NHP6A and Drosophila HMG-D and, to a lesser extent, to the sequence-specific (e.g. 
SRY and LEF-1) HMG-boxes.
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1 (X) (Y)
rHMG1 -A  GKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSAKEKGKFEDMAKADKARYEREMKTYIPPKG-
rH M G l-B  -FKDPNAPKRPPSAFFLFCSEYRPKIKGEHP-G-LSIGDVAKKLGEMWNNTAADDKQPYEKKAAKLKEKYEKDIAAYRAKGK-
HMG-D SDKPKRPLSAYf.;LWLNSARESIKRENP-G-IKVTEVAKRGGELWRAMKD--KSEWEAKAAKAKDDYDRAVKEFEANGG-
N h p e a  KKKDPNAPKRALSAY>:FFANENRDIVRSENP- D - ITFGOVGKKLGEKMKALTPEEKQPYEAKAOADKKRYESEKELYNATLA
hSR Y  -------- QDRVKRPMNAFIVWSRDQRRKMALENP-R-MRîJSBISKQLGYQW(WLTEAEKWPFFQEAQKLQAMHREKYPNYKYRPR-
m L E F -1 ................HIKKPLNAFKLYMKEMRANWAECT-L-KESAAINQILGRRWHALSREEQAXYYELARKERQLHMQLYPGWSARDN-
----------
A domain B domain HMG-D domain A domain 6  domain HMG-D domain
Fig. 2 Comparison between aminoacid sequences and folds of different HMG boxes
A) Residues of non-sequence-specific and sequence-specific HMG boxes intercalating into the 
DNA minor groove (marked in red and indicated as X and Y) are localised with respect to the 
a-helices determined by NMR spectroscopy for HMGBl box A (shown in green, above the 
sequence) and the sequence-specific LEF-1 HMG box (shown in blue below the sequence). 
Prefixes r, h and m signify rat, human and mouse, respectively.
B) Location of residues at X and Y in the 3D structures of HMGBl box A, HMGBl box B 
(inferred intercalations) and the HMG-box of HMG-D.
C) Solution structures of the A and B HMG boxes of HMGBl and of the HMG box of HMG-D, 
determined by NMR spectroscopy ((Hardman et al., 1995); (Weir et al., 1993); (Jones et 
al., 1994)). The stmctures are oriented to show the differences in the relative disposition of 
helices I and II between the different domains.
The main feature of the HMG-boxes of HMGB 1 is the ability to both recognise 
and produce distorted structures in DNA. HM G Bl binds rather inefficiently to linear
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DNA, with no preference for any nucleotide sequence. It shows, on the contrary, high 
affinity and selectivity to structured DNA, such as 4-way junctions, cisplatin-DNA 
adducts, and kinked DNA ((Bianchi et ah, 1989), (Bianchi et ah, 1992)). The binding of 
HMGBl to DNA is therefore sequence-independent, but structure-specific. Beyond the 
ability to recognise distorted structures, HMGBl can also introduce them in the double 
helix, thanks to a DNA bending activity. In spite of its low affinity for linear DNA, 
when present at high concentrations, HMGBl is capable of inducing DNA bends upon 
binding, as revealed by ring closure of short DNA firagments (Pil et ah, 1993).
As yet, no structure of a complex between HMGBl and linear DNA has been 
solved. However, the similarity with other HMG-boxes, for which structural data are 
available (Werner et ah, 1995); (Murphy and Churchill, 2000)), is revealing with respect 
to the mechanism underlying HMGBl-mediated DNA bending. The DNA-binding 
surface of the HMG box domain has a hydrophobic surface that conforms to a wide, 
shallow minor groove. In the centre of this surface, a hydrophobic wedge, usually 
consisting of four spatially close residues, inserts deep into the minor groove. This 
partial intercalation introduces a kink into the bound DNA, enhancing the more uniform 
bend associated with the widening of the minor groove (Fig. 3A). The only resolved 
complex between HMGBl and a DNA substrate is the X-ray structure of the rat HMG- 
box A domain complexed to cisplatin-modified DNA (Fig. 3B) (Ohndorf et al., 1999). 
Cisplatin is a drug that damages DNA, creating intrastrand crosslinks between adjacent 
purines (Pil and Lippard, 1992). These crosslinks bend and unwind the duplex, 
generating a structure that HMGBl binds with high affinity, without inducing any 
further distortion. The analysis of the complex revealed which amino acids are mainly 
involved in contacts with DNA: particularly important appeared to be a phenylalanine 
residue in helix II (see Fig. 2A,B), which intercalates into the kinked platinated GpG 
site, and whose substitution dramatically reduces the binding of the domain. 
Nevertheless, the cisplatin-induced intrastrand crosslinks alter the contact surface for 
the HMG box on DNA, compared to a linear molecule, and indeed significant 
differences are observed with respect to LBFl- and SRY-DNA complexes. These 
. proteins induce in DNA a bend similar to the one formed at the kinked platinated site, 
but the bend locus in this case is near the centre of the protein-binding site. In contrast, 
the binding surface of HMGBl box A extends exclusively to the 3’ side of the bend, 
when the platinated strand is used as a reference, and it covers five base-pair steps (Fig. 
3B). Thus, the relationship between the DNA bend and the protein-binding site is
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slightly altered by the cisplatin-induced intrastrand crosslinks. Taking this into account, 
and considering that the general fold of all HMG boxes is well conserved, a complex 
between the HMG box of HMGBl and a linear DNA is likely very similar to those 
formed by the sequence-specific HMG boxes (Fig. 3C).
SRY box-DNA HMGB1 boxA-c/s-Pt DNA HMGB1 box-DNA
Fig. 3 Structures of HMG box-DNA complexes
A) Stmcture of the complex between the HMG box (red) of human SRY and the octanucleotide 
GCACAAAC (blue). The DNA is significantly distorted: the minor groove is widened 
considerably to accommodate the extended stretch of the HMG box; the planes of the bases are 
tilted, and the double helix is unwound and bent. The contact between the HMG box and the 
DNA occurs over a surprisingly large area and with a very tight fit; thus, the energetic cost of 
distorting the DNA is more than compensated by the chemical energy freed by the protein-DNA 
interaction.
B) The complex of the HMGBl box A with cis-platinated DNA (X-ray crystal stmcture) 
(Ohndorf et al., 1999). Remarkably, in this stmcture the orientation of the intercalating Phe 
group differs from that in the solution stmcture of the free domain shown in Fig. 2B.
C) Model of HMGBl box B positioned on 15 bp of DNA. The model is derived from the high 
similarity between sequence-specific HMG boxes and the HMGB boxes of HMGBl. The 
electrostatic surface (blue is positive charge; red is negative charge) is shown with the 
intercalating phenylalanine residue in yellow. DNA strands are shown in magenta and cyan 
(Wolffe, 1999).
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1.1.3 HMGB proteins as architectural regulators
Many studies have been performed over the last few years in the attempt to 
correlate the characteristic DNA-binding properties of the HMG-box domain to the 
biological roles of the abundant HMGB proteins. One proposed general function of 
these proteins is to overcome the barrier imposed by the axial rigidity of DNA and 
thereby promote the formation of complex nucleoprotein assemblies containing tightly 
bent DNA (Kahn and Crothers, 1993). Such a role probably requires the bend be 
precisely placed; a displacement of the binding site by even 1 bp would alter the 
trajectory of the bent DNA by 30-36°. Because DNA-sequence recognition by the 
abundant HMGB proteins lacks selectivity, the precise targeting of these proteins must 
depend on the presence of other sequence-specific DNA-binding proteins in the 
complex. This indeed appears to be the case,
HMGBl and HMGB2 have been implicated, from several in vitro assays, in both 
the activation and repression of transcription. A recurring theme is the enhancement of 
the binding of various transcription factors [e.g. Oct-1 and 2 (Zwilling et al., 1995)), 
HoxD9 (Zappavigna et al., 1996), p53 (Jayaraman et al., 1998), Rel proteins (Jayaraman 
et al., 1998), and steroid hormone receptors (Boonyaaratanakomkit et ah, 1998) to their 
cognate DNA binding sites. In most of these cases, the interaction of the HMGB protein 
with a transcription factor has been detected in vitro even in the absence of DNA, and 
could presumably serve as the mechanism for recruitment of HMGBl, 2 to particular 
DNA sites (Fig. 4). In turn, HMGB proteins bound to their partners increase the protein 
surface contacting DNA, froni both the major and the minor groove, thereby achieving 
high affinity interactions. In some cases, transfection experiments have also proved 
functional interactions in vivo. The demonstrated interactions in vitro are between 
HMGBl and/or 2 and a single transcription factor. However, it is probable that in vivo, 
in a natural regulatory context, the DNA bending by HMGBl or 2 may allow the 
recruitment of a second transcription factor to the complex, generating a complex 
network of interactions (Fig. 4).
In vitro interactions between HMGB proteins and the basal transcription 
machinery have also been reported. Human HMGBl binds to the TATA-box binding 
protein (TBP) and interferes with the normal binding of TFIIB in the pre-initiation 
complex, thereby inhibiting TBP function ((Ge and Roeder, 1994); (Sutrias-Grau et ah, 
1999); both HMGBl and TFIIB independently enhance binding of TBP to TATA-box
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DNA. By contrast, HMGB2 has been reported to stabilize and activate the TBP- 
containing TFIID-TFIIA complex bound to promoter DNA (Shykind et ah, 1995)).
(a)
Fig. 4 A possible chaperone role for HMGBl in facilitation of transcription-factor 
binding
(a) Recruitment of HMGBl (green) to specific DNA sites through interaction with a sequence- 
specific transcription factor (TFl; red). Formation of a ternary complex that is probably 
unstable, but has been detected and/or inferred in some cases. In this ternary complex, HMGB 1 
might bend the DNA, thus providing the potential for the recruitment of additional DNA- 
binding proteins (TF2; purple) to the complex (b). If no additional protein is recruited, HMGBl 
could dissociate from the complex, leaving the transcription factor stably bound (c) [in this 
diagram, the final DNA is shown straight (as in the case of Oct-1 binding), but this is not 
necessarily the case; for example, the progesterone receptor bends its DNA in the binary 
complex]. Only a single HMG box is shown because the separate A and B HMG boxes of 
HMGBl have been shown to facilitate binding of various transcription factors in vitro.
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HMGB proteins exert their architectural function also in other nuclear processes 
involving manipulation of DNA structure. The best example is observed in 
lymphocytes, during V(D)J recombination, a complex process which allows the 
generation of a nearly infinite number of antibodies and T Cell Receptors. In developing 
T and B lymphocytes, antigen receptor genes are somatically assembled from several V 
(variable), D (diversity), and J (joining) DNA segments, in a process mediated by two 
lymphoid-specific enzymes, RAGl and RAG2 (products of Recombination Activating 
Genes 1-2) (Schatz et al., 1989). These proteins bind specifically to the Recombination 
Signal Sequences (RSS), regions flanking each antigen receptor segment, which direct 
the site of rearrangement. Upon binding, the RAG 1/2 complex cleaves the DNA, 
producing a hairpin intermediate with nucleotide overhangs. In the second step of the 
process, while RAGl/2 remain stably bound to the RSS, the free ends generated by the 
cleavage are linked to each other by DNA repair activities. During my work for the 
"Laurea”, I could show that HMGBl and HMGB2 are recruited by RAGI/2 to the RSS, 
and functionally interact with the complex, facilitating V(D)J recombination (Aidinis et 
al., 1999). Also in this case, a physical interaction between HMGB 1,2 and RAG 1/2 
enhances the binding of the enzymes to the RSS. The RAG 1/2 complex possesses an 
intrinsic DNA bending activity, and upon binding, it alters the structure of the RSS site 
even in the absence of HMGB 1,2. However, the DNA bending induced by RAG 1/2 is 
very inefficient unless assisted by HMGB 1,2, suggesting a crucial contribution of 
HMGB proteins in stabilising the complex between RAG 1,2 and the bent RSS (Aidinis 
et al., 1999).
The picture emerging from all these data point to HMGB proteins as important 
and versatile architectural chromatin components, required for the formation and the 
stabilisation of functional nucleoprotein complexes. This function is sustained by their 
peculiar DNA binding properties and their ability to modulate the structure of DNA, 
which guarantee a correct three-dimensional assembly of DNA binding proteins on bent 
DNA
The molecular analysis of the HMGBl- deficient mice further supports the model 
of HMGBl as a co-activator of the steroid hormone receptor in controlling their target 
genes and -  more in general -  provides further insight in the model of HMGBl 
involvement of regulation of gene expression at various level and in different ways.
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1.1.4 Phenotype of HMGBl- and HMGB2- deficient mice
Mice lacking either HMGBl or HMGB2 were produced in our lab, by 
conventional knock-out, in order to study the function of the proteins in vivo (Calogero
et ah, 1999, Ronfani et ah, 2001). The most dramatic phenotype is displayed hy Hmgbl~
mice, which are bom, but die within the first day of life as a result of severe 
hypoglycaemia (Fig. 5A) (Calogero et ah, 1999). While the level of glucose is
decreased in the blood of Hmgbl'^~ animals, abundant glycogen is present in their liver
(Fig. 5B), but is not metabolised. Indeed, intraperitoneal injection of glucose in Hmgbl~
/“ newborns permits the survival of some animals, even though the rescued mice 
remain very sick, with several anatomical abnormalities (Fig. 5C).
At the cellular level, Hmgbl~^~ mice have defects in steroid hormone-dependent 
gene expression. Fibroblasts from knock-out mice transiently transfected with a reporter 
plasmid containing a GR responsive element respond weakly to the glucocorticoid
analogue dexamethasone, compared to wt fibroblasts (Fig. 5D). Moreover, CD4"  ^CD8"^
T cells from Hmgbl~^~ mice are partially resistant to dexamethasone exposure, while wt
CD4"  ^ CD8*^  cells undergo massive apoptosis upon treatment (Calogero et ah, 1999). 
All these findings are consistent with the proposal that HMGBl helps steroid hormone 
receptors in controlling their target genes.
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Fig. 5 Hmgbl'^' mice develop neonatal hypoglycaemia
A) Hmgbl~l~ mice die within the first day of life but can survive if given glucose parenterally. 
Intraperitoneal glucose injections were administered to 10 Hmgbl'^' newborns during the first 
days after birth. Survival is indicated by a blue line. Ten HmgbH~ control mice, injected with 
saline solution, all died within day 1 (red line), similar to untreated HmgbH~ mice.
B) Periodic acid-Schiff (PAS) staining for glycogen (magenta) in livers from Hmgbl~^~ mice
are shown. Despite very low blood glucose concentrations, hepatocytes of HmgbH~ mice do 
not completely mobilize glycogen (arrows, glycogen granules).
C) Phenotype of an Hmgbl'^' spontaneous survivor at day 25. Spontaneous survivors of the 
mixed 129Sv/CDl genetic background are very similar to the most successfully glucose-
rescued Hmgbl'^' mice of 129Sv/BALB-c background: they have a very reduced size, but 
respond positively to basic neurological tests. All spontaneous or glucose-treated surviving 
animals have sealed eyelids, arched backs, long hind paws and abnormal gait.
D) The absence of Hmgbl reduces the activity of GR in transfection assays. The expression of a
GR-controlled reporter is reduced in Hmgbl~^~ fibroblast cell lines exposed to dexamethasone.
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Unexpectedly, however, no defects in V(D)J recombination were found; even 
though the in vitro data implicate HMGBl in the process, the newborn mice have a 
normal serum abundance of immunoglobulins, and normal numbers of mature single­
positive CD4" ,^ and CD8 "^  T cells expressing a complete VB repertoire in the thymus 
(Calogero et ah, 1999). Moreover, in spite of the cooperation between HMGBl and 
HOX proteins and the basal transcription machinery, the gene regulation necessary to 
generate a neonatal animal with fully differentiated tissues is unimpaired in mutant 
mice.
The most plausible explanation for the lack of defects in the V(D)J products and
in the body plan of the Hmgbl~^~ mice is that HMGB2 could compensate for the 
absence of HMGBl in the interaction with RAG 1/2 and HOX proteins. HMGB2 is 
widely expressed during embryonic development, when HOX proteins exert their 
function, and even after birth it is particularly concentrated in the thymus, which is the 
site of V(D)J recombination. Therefore, even in the absence of HMGB 1, HOX proteins 
and RAG 1/2 could find a suitable partner. By contrast HMGB2 is completely absent 
from liver in the adult, and this might explain the defects in the GR-mediated functions
and the hypoglycaemic phenotype of the Hmgbl~^~ mice.
In order to test the possibility that HMGB2 might provide partial redundancy to
HMGBl, Hmgb2~l~ mice were also generated, with the perspective to generate double
Hmgbl'!' Hmgb2'!' mutants. Mice lacking HMGB2 are apparently healthy, and only 
show a reduced fertility in males. Increased apoptosis of germ cells in seminiferous 
tubules and production of defective spermatozoa appeared to underlie this defect (Fig. 
6 ) (Ronfani et al., 2001). This phenotype correlates with the observation that HMGB2 is 
highly abundant in the testis, even more than HMGB 1.
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Fig. 6 Abnormalities in the testis of Hmgb2 ! mice
A) TUNEL staining for apoptotic cells in testis seminiferous tubules of Hmgb2~!~ mice, 
showing the high content of dead cells.
B) Haematoxylin-eosin stained sections of testis from a 163-day Hmgb2~!~ mouse. The regular 
periphery-to-lumen succession of spermatogonia, primary and secondary spermatocytes, 
spermatids and spermatozoa is lost, cells are separated by gaps, and degenerated Sertoli cells 
with large vacuoles are present.
C) Electron micrographs of an elongated spermatid where the acrosome (arrows) is detached 
from the nucleus, impairing its function.
Taken together, the data obtained from H M G Bl- and HMGB2- deficient mice 
suggest that H M GBl and HMGB2 are indeed functionally equivalent, and a minimum 
total amount of HM GBl plus E1MGB2 is required at all times. The lack of HM GBl is 
phenotypically more noticeable because H M GBl is ubiquitous and usually much more 
abundant than HMGB2. In contrast, as HMGB2 has a more restricted pattern of 
expression, and in most cases HM GBl can compensate for the loss of HMGB2, the
defects in Hmgh2~!~ mice are less severe and more localised. In order to definitively 
prove the redundancy of HMGB proteins, we are currently breeding H M G Bl and 2 
knockouts, to generate double mutants. So far, no double knock-out has been found at
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embryonic day 14 (p < 0.05). This result implies that HMGBl and HMGB2 have indeed 
similar functions and a sufficient amount of HMGBs is required for embryonic 
development.
The functional interaction of HMGB 1 and HMGB2 protein during the very first 
stages of embryonic development is still under investigation. Since embryos do not 
survive to do day 14 post coitum, we are searching for double mutant embryos at earlier 
stage: so far, living blastocysts at 3.5 days post- coitum have been found. This result 
means that the time in which absence of both proteins becomes incompatible with life is 
between these two dates. The next step, still in fieri, consists in searching and analysing 
embryos at 7.5 days p.c.
Another line of research in our lab is the development of a conditional knock out 
for HMGBl, in order to be able to excise the Hmgbl gene in a tissue-specific manner 
and, therefore, to study in a more detailed way the specific roles of the protein.
The collection of evidence presented above allows depiction of a scenario in 
which HMGBl acts as a chaperone in a wide set of events involving chromatin 
rearrangements, when chromatin structure has to undergo both rapid variations 
(condensation/ decondensation cycles) and temporary modifications (site-specific 
recombination, transcriptional activation). To find a “fil rouge” in the mechanism of 
involvement of HMGB 1 in all these phenomena, a better description of its relationship 
with chromatin becomes necessary.
In spite of the amount of investigation devoted to the issue, the relative interaction 
between HMGBl and chromatin is still ill- defined and highly controversial.
Part of my PhD work has been dedicated to add some pieces to this puzzle: we set 
up a collaboration with Peter Becker and his team, in Munich, who are leaders in the 
field of gene expression through chromatin remodelling. The results presented in 
Chapter 4 are related to the results that 1 obtained during this collaboration.
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1.2 The debate about the functional relationship between HMGBl and 
chromatin
1.2.1 HMGBl does not have a mere structural role in chromatin organisation
The most surprising finding derived from Hmgbl'!' mice is that HMGBl is not 
essential for the life of cells, in spite of its abundance and evolutionary conservation. 
This observation impacts on the proposed role of HMGB 1 as structural protein involved 
in packaging DNA into chromatin.
For many years, HMGB proteins have been considered to cooperate with histones 
in determining chromosome architecture. Both protein families appeared to serve the 
function of wrapping DNA into arrays of repetitive modules, thereby ensuring the 
formation of organised high-order structures ((Wisniewski and Grossbach, 1996); 
(Zlatanova et al., 1999)). On average, a typical cell nucleus contains one molecule of 
HMGBl every 10-20 nucleosomal particles, and a role for the protein in promoting the 
formation of nucleosomes has been suggested (Travers et al., 1994). In addition, 
HMGBl has been proposed to stabilize nucleosomes by binding at the DNA crossover 
site (Lilley, 1992), with a function similar to that of histone HI. Indeed, HMGBl and 
histone HI share several properties. Xenopus HMGBl (xHMGl) binds to nucleosomes 
in vitro in much the same way as histone HI ((Nightingale et al., 1996); (Ura et al.,
1996)); the Drosophila HMGB 1-like protein HMG-D is a structural component of 
condensed metaphase chromosomes (Ner and Travers, 1994); histone HI also binds to 
four-way junctions (Varga-Weisz et al., 1993). These observations suggested that 
HMGBl and HI could possess similar overall properties but specifically adapted to 
perform subtly different structural functions.
The first data in conflict with this model were the finding that the association of 
HMGBl with chromatin is markedly different from that of histone HI (Falciola et al.,
1997). If cells are treated with NP-40, a non-ionic detergent which permeabilises 
plasma and nuclear membranes, nuclear proteins not tightly bound to DNA leak into the 
extracellular medium, whereas stable components of chromatin remain anchored to the 
nuclear remnants (Fig. 7A). Permeabilised cells, both in mitosis and in interphase.
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release the vast majority of HMGB 1, indicating that the protein is not a structural 
component of either condensed or decondensed chromatin (Fig. 7B). On the contrary, 
histone HI remains firmly associated with DNA, as well as the core histones and other 
chromatin binding proteins. Moreover, immunofluorescence analysis showed that while 
in interphase HMGBl is uniformly distributed in the nucleoplasm, like histone HI, in 
mitosis, contrary to HI, it is displaced from chromosomes (Falciola et al., 1997).
B
SRY box-DNA HMGB1 boxA-c/s-Pt DNA HMGB1 box-DNA
Fig. 7 HMGBl is not stably associated to chromatin
A) The cartoon shows what happens after NP-40 addition; both cellular and nuclear membranes 
are permeabilised and soluble proteins (blue squares and red circles) leak out from nucleus and 
cytoplasm. Thus, nuclear proteins not stably bound to DNA (red circles) are released in the 
extracellular milieu, whereas histones and other stable component of chromatin (green triangles) 
are retained in the nucleus.
B) After permeabilisation, the buffer bathing the cells (lanes 1 and 3; S= supernatant) and the 
cellular remnants, containing chromatin associated proteins (lanes 2 and 4; P= pellet) can be 
analysed by Western blot with different antibodies, to distinguish between stable components of 
chromatin and proteins that interact with DNA only transiently. While histone HI and HMGAl 
are found in the pellet, bound to DNA, HMGB 1 is released outside the cells both in interphase 
and in mitosis.
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The results described above indicated that HMGBl and histone HI do not have 
equivalent functions in differentiated mammalian cells, but did not rule out the 
possibility that HMGBl might substitute for HI when the linker histone is absent. This 
is what happens in Xenopus and Drosophila, where respectively xHMGl and HMG-D 
appear to substitute for histone HI during embryogenesis ((Dimitrov et al., 1993); 
(Dimitrov et al., 1994); (Ner and Travers, 1994)). Later studies addressed this problem, 
investigating the association of HMGBl with chromatin in very early mouse 
development, a period when histone HI is present at very low abundance (Clarke et al., 
1992). Nonetheless, even in preimplantation embryos, the affinity of HMGBl for 
chromatin appeared similar to that observed in somatic cells, and the protein did not 
remain associated with chromosomes during metaphase (Spada et al., 1998). This result 
indicated that HMGBl has non-overlapping roles with the linker histone and does not 
compensate for its absence during mouse early embryogenesis.
In partial contrast with these observations, however, in vitro HMGBl appeared to 
bind to reconstituted nucleosomes with high affinity, like HI, forming complexes 
sufficiently stable to survive band-shift assays (Falciola et al., 1997). I also confirmed 
and extended these preliminary results during my collaboration with P.Becker. (See 
4.2.1).
Furthermore, our group recently showed by means of photobleaching experiments 
that the interaction of HMGB 1 with chromatin is highly dynamic: the protein has a very 
high rate of diffusion in the nucleus, which indicates that the binding to specific sites is 
very transient (Scaffidi et al., 2002).
HMGBl can bind to nucleosomes with high affinity and structure-specificity in 
vitro’, by contrast, in vivo its association with chromatin is quite loose. Taken together, 
these findings disproved a structural role of HMGB 1 in packaging bulk DNA, and 
rather suggested that the protein may establish only transient interactions with 
chromatin.
Thus, HMGBl must posses a specific role in chromatin organisation and 
remodelling that may reconcile the apparently opposite data of the strong affinity for 
nucleosomes in vitro with the high dynamism detected in vivo.
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1.3 A new field of investigation: HMGBl is also an extracellular signal
In accordance with its role as an architectural component of chromatin, the 
localisation of HMGB I is nuclear in most cell types. Surprisingly, recent data have 
established that beyond its intranuclear function, HMGBl also has a pivotal function 
outside of the cell.
1.3.1 HMGBl as a potent mediator of inflammation
Wang et al (Wang et al., 1999) have recently identified HMGB 1 as a late 
mediator of endotoxin lethality in mice. HMGBl was found to be secreted by 
monocytes/macrophages stimulated by bacterial lipopolysaccaride (LPS, endotoxin), 
and to accumulate in the serum of the mice, mediating septic shock.
LPS is a component of all Gram-negative bacteria. It is toxic to mammals because 
it activates the innate immune system (macrophages and neutrophils) to secrete 
proinflammatory cytokines, such asTNF-a, interleukin 1 (IL-I), and macrophage 
migration inhibitory factor (MIF) (Tracey and Cerami, 1993); (Bemhagen et al., 1993). 
These factors drive the acute phase response and mediate the development of shock and 
tissue injuiy. In recent years, therapeutic strategies for sepsis have attempted to 
modulate the excessive inflammatory response by inhibiting cytokines released by 
macrophages with specific antibodies. However, a major difficulty in targeting cytokine 
activities derives from the fact that most pro-inflammatory mediators are released early 
in septic shock, and inhibitors should therefore be administered immediately. In order to 
broaden the therapeutic window for sepsis, Wang et al initiated a search for a putative 
macrophage-derived mediator of lethality that appears relatively late after the onset of 
endotoxemia. This study culminated in the identification of HMGB I as the proposed 
late mediator of LPS lethality. The serum concentration of HMGB I significantly 
increases 16-32 hours after LPS administration in mice. Administration of anti-HMGBl 
antibodies attenuated LPS-induced endotoxemia, and conversely, injection of HMGBl 
caused toxic shock. Moreover, septic patients showed, increased serum levels of 
HMGBl, which correlated with the severity of the infection (Wang et al., 1999).
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The source of extracellular HMGBl is provided by activated 
monocytes/macrophages. Macrophage-like RAW 264.7 cells release the protein 18 
hours after stimulation with LPS; confirmation of the inducible nature of HMGBl 
release was obtained also in murine primary peritoneal macrophages, and in human 
primary peripheral blood mononuclear cells (Wang et al., 1999). Pituicytes, which 
provide an important link between the immune and the neuroendocrine systems, also 
release HMGBl in response to specific stimuli like TNF-a and IL-1, suggesting that 
HMGBl participates in the regulation of neuroendocrine and immune responses to 
inflammatory processes (Wang et al., 1999).
Subsequently, HMGBl was also shown to cause acute lung inflammation when 
administered intratracheally (Abraham et al., 2000). Antibodies against HMGBl 
decreased lung edema and neutrophil migration, whereas they did not reduce the levels 
of the other proinflammatory cytokines, such as TNF-a, IL-ip or macrophage- 
infiammatory-protein-2 (MIP2).
One major issue that remains to be investigated so far is how HMGBl is secreted 
by monocytes and the other competent cell types: it possesses no signal peptide that 
would direct it to the endoplasmic reticulum (ER) through the canonical secretion 
pathway. This lack of a secretion leader peptide is a feature shared with a small number 
of other secreted proteins, like the cytokine IL-ip (Andrei et al., 1999). Studies in 
murine erythroleukemia (MEL) cells have shown that HMGBl export does not involve 
the ER and the Golgi complex, but is promoted by intracellular Ca^  ^ increase and 
possibly by activation of a Ca-dependent PKC isoform (Passalacqua et al., 1997).
Anna Rubartelli and co-workers have just published (Gardella et al., 2002) a 
description of the last steps of HMGB 1 secretion, showing that activation of monocytes 
results in HMGBl accumulation firom nucleus to cytoplasmic organelles that display 
ultrastructural features of endolysosomes; secretion of the protein is induced by stimuli 
triggering lysosome exocytosis (LPC: lysophosphatidyl- choline).
In any event, the first step for HMGB I secretion is re-distribution firom nucleus to 
cytoplasm; the question of how a nuclear protein can be directed to cytoplasm and then 
to the extracellular space upon specific stimuli was the starting point of my 
investigation.
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Once released, HMGBl is able to activate several other cells involved in the 
immune response or inflammatory reactions, and can act as a cytokine itself (Andersson 
et ah, 2000). HMGBl activates monocytes to secrete a specific subset of 
proinflammatory cytokines, including TNF-a and IL-1. Stimulation occurs at the level 
of gene transcription, since cytokine mRNA levels increase after HMGB I stimulation 
(Andersson et ah, 2000). In comparison with the well-known inflammatory stimulus 
LPS, HMGBl causes a delayed and biphasic release of TNF-a, with a first peak at 3 
hours, followed by a second peak at 8-10 hours after HMGB I exposure.
In light of all these data, it is now clear that HMGBl has a crucial role during 
phlogystic processes: it is secreted by macrophages in response to proinflammatory 
stimuli, and also itself provokes a delayed response, thereby prolonging and sustaining 
inflammation.
1.3.2 HMGBl in differentiation processes
Before the discovery of the role of HMGB 1 in inflammation, it had already been 
observed that several cells release the protein into their surroundings as part of their 
differentiation process. Murine.erythroleukemia (MEL) cells, exposed to a chemical 
inducer (hexamethylenebisacetamide, HMBA), release HMGBl (also called DEF for 
differentiation enhancing factor) into the medium. In turn, extracellular HMGB I 
significantly increases the rate of MEL cell differentiation via specific binding to the 
external surface of the cell membrane (Passalacqua et ah, 1997); (Sparatore et al., 
1996).
Likewise, HMGB I is also secreted by neurons and participates in their 
differentiation process ((Pages et ah, 2000), and references therein). Some years ago, an 
extracellular, membrane-bound form of HMGBl was purified from rat brain for its 
capability of mediating neurite outgrowth. The membrane bound form was named 
amphoterin because of its dipolar structure, but at the sequence level it is identical to 
HMGBL Membrane HMGBl has been implicated in enhancing neurite outgrowth in 
cerebral neurons during development, and in regenerating peripheral neurons by 
binding to a cell surface proteoglycan, syndecan. Membrane HMGB I is abundant in 
both neuronal cell bodies and in neurites in neuroblastoma cells, whereas in neurons and
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peripheral glial cells (Schwann cells) it is localised in non-nuclear compartments. 
HMGBl mRNA is developmentally regulated, and reduced significantly after the rapid 
perinatal growth phase of the rat brain. The molecular basis for cellular targeting of 
HMGBl to membranes remains unclear.
HMGBl can also be exported to the extracellular space by groups of cells that 
support the differentiation of other spatially associated cell types. Stimulated astrocytes 
release HMGBl, which then induces LAN5 neuroblastoma cells to differentiate 
(Passalacqua et al., 1998). Human promyelocytic HL60 cells, although not secreting 
HMGBl themselves, show an accelerated differentiation when exposed to extracellular 
HMGB 1 (Sparatore et al., 1996).
In all these cases, the release of HMGBl into the extracellular space is well 
controlled and local: HMGBl is either secreted in an autocrine manner, or in a paracrine 
manner by closely associated cells. Remarkably, this spatially restricted secretion of 
HMGB I does not seem to trigger an inflammatory response.
1.3.3 HMGBl mediates cell migration and metastasis
HMGBl can also promote cell migration. Cells migrate in response to
extracellular stimuli, channelled through specific signal transduction pathways that 
ultimately elicit cytoskeletal remodelling. We showed in our lab that vascular smooth 
muscle cells respond to extracellular HMGBl (Degryse et al., 2001). Cells exposed to 
HMGBl undergo rapid and transient changes of cell shape, and actin cytoskeleton 
reorganization, leading to an elongated polarized morphology typical of motile cells.
Even more strikingly, Taguchi et al. (Taguchi et al., 2000) showed that HMGB I
is also involved in tumour growth and metastasis: administration of anti-HMGBl
antibodies suppressed metastasis formation by Lewis lung tumour cells implanted under 
the skin of recipient mice. In this context, HMGBl promotes both migration and 
proliferation of tumor cells.
In vivo, cell migration depends to a large extent on the capability of a cell to 
invade the surrounding tissue, for which the activation of extracellular proteases is 
required. HMGB I appears to play a role here as well: it binds to several components of 
the plasminogen activation system and enhances the activation of t-PA (Parkkinen and
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Rauvala, 1991). Moreover, Taguchi et al. (Taguchi et al., 2000) showed HMGBl- 
elicited activation of metalloproteases MMP-2 and MMP-9, which are downstream 
targets of the plasmin activation cascade. While it enables the degradation of the 
extracellular matrix, the activation of proteases also leads to degradation of HMGB 1, 
and this might serve as a feedback mechanism.
1.3.4 Signalling mechanisms
The signalling mechanisms by which HMGBl activates cells to respond are 
incompletely understood. HMGBl is rather “sticky”, and binds to many different 
molecules on the cell surface: heparin, proteoglycans, but also sulfoglycolipids and 
phospholipids (Bianchi, 1988); (Degryse et al., 2001); (Rouhiainen et al., 2000). This 
could be a mechanism to restrict the diffusion of extracellular HMGBl, and thereby 
keep the effect of this potentially dangerous molecule local. HMGBl can also be taken 
up by the cell in an as yet unidentified manner, and promote the co-uptake of DNA. 
This property was therefore used to transfect cells (Mistry et al., 1997). It is however 
unclear whether binding to cell surface glycans and cellular uptake are causally related.
However, at least one high-affinity receptor for HMGB I exists: RAGE (receptor 
for advanced glycation endproducts) (Hori et al., 1995). RAGE belongs to the 
immunoglobulin superfamily and binds a variety of ligands: the glycated proteins that 
are present in the serum of diabetic patients (advanced glycation endproducts, AGEs), 
but also calgranulin, a proinflammatory peptide that derives from the proteolytic 
processing of the cytoplasmic protein SI00, and amyloid beta-peptide in Alzheimer 
patients (reviewed by (Schmidt et al., 2000)). It is expressed on a wide set of cells, 
including endothelial cells, smooth muscle cells, macrophages/monocytes and neurons, 
and has been implicated in several pathological processes, such as diabetes, 
amyloidoses and atherosclerosis. HMGBl binding on the cell surface itself induces the 
transcriptional upregulation of RAGE (Li et al., 1998).
The understanding of the signal transduction pathways activated by HMGBl 
binding to RAGE is still fragmentary. Extension of neurites requires the small GTPases 
Cdc42 and Rac, but not the ras-MAP kinase pathway (Huttunen et al., 1999). However, 
in neural cells, HMGBl binding to RAGE also activates the Ras-MAP kinase pathway
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and leads ultimately to the activation of NF-kB, the transcription factor classically 
linked to inflammatory processes (Huttunen et ah, 1999). During tumour invasion the 
MAP kinases p38^"^^, JNK and p42/p44 MAPK have been shown to be activated by 
RAGE-HMGBl (Taguchi et al., 2000). HMGB 1 -mediated migration of smooth muscle 
cells also results in activation of the MAP kinase pathway and translocation of 
phosphorylated ERX 1 and 2 into the nucleus, but also involves a Gj/o protein (Degryse
et al., 2001). How and if these pathways are linked remains an open question; moreover, 
different pathways may be activated in different cell types. One potentially interesting 
observation is that cells that respond to extracellular HMGBl appear to contain very 
little HMGBl themselves, and almost none in the nucleus. In support of this
observation, it has been shown that Hmgbl'!' embryonic fibroblasts respond better to 
extracellular HMGBl in cell migration assays than their wild type counterparts (B. 
Degryse and M.E. Bianchi, unpublished data).
The second role of HMGB I, as an extracellular signal, has been now extensively 
documented, and is well established. Together, all the data indicate that, as in the 
nucleus, also outside the cell HMGBl is a very versatile molecule, involved in several 
processes: many cellular types can read out the HMGB I signal, and depending on the 
target cells very different biological responses are induced (Fig. 8 ).
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Fig. 8 Different biological responses induced by extracellular HM GBl
Many cells are equipped to recognise HMGBl in the extracellular milieu. The protein binds 
with moderate affinity to the proteoglycans covering the surface of every cell (yellow lines). In 
addition, high affinity receptors like RAGE (green structures) mediate cell-specific responses to 
HMGBl, triggering different responses, involved in physiological and pathological processes.
1.4 HMGBl: a single molecule for many functions or different isoforms 
of the same molecule for diverse jobs (and places)?
The discovery of the presence of H M G Bl in the extracellular milieu and of its 
functions as a signalling molecule has opened an entirely new field of investigation and 
raised several important questions concerning the signal transduction pathway that 
regulates its release from the cells, the identity of all its cell surface receptors, and the 
molecular characterisation of the processes induced by H M G Bl stimulation.
Another major question is how the intracellular and the extracellular roles of 
HM GBl are linked to each other. The question of “why” the cell uses a chromatin 
protein for signalling purposes has recently been partially solved by Paola Scaffidi in 
her PhD thesis and in the corresponding publication (Scaffidi et al., 2002).
A large part of my thesis work also tried to address these issues: I concentrated 
primarily on the characterisation of the molecular mechanism employed by the cell to 
re-distribute a nuclear protein to the cytoplasm and, subsequently, to direct it to 
secretion.
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The problem could be approached from different points of view; since my 
background was predominantly biochemical, I chose - as starting goal - to identify the 
biochemical “label” that marks HMGBl’s address to the nucleus, the cytoplasm and 
eventually the extracellular milieu.
The hypothesis that my supervisor and I shaped at the beginning of my work was that 
HMGBl, a small protein lacking either known regulatory domains, or traditional 
sequences directing it to specific compartments, does not consists of a single molecule 
but it is instead composed by a collection of differentially modified isoforms, bearing 
diverse biochemical/ biophysical properties and thus different functions and subcellular 
distributions.
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CHAPTER 2. MATERIALS and METHODS
2.1 Plasmids and Nucleic Acids
HMGB 1/M l-176 is a truncated form of HMGBl lacking the COOH-terminal acidic 
domain of intact HMGBl molecule; in this thesis had been indicated with different 
names: HMGBl-boxA+B, -tailles, or -AC; the plasmid pRNHMGl/Ml-VI76 coding 
for this derivative has been previously described, as well as the plasmid pT7-HMGlbA 
coding for HMGlboxA a truncated form of HMGB 1 containing, amino acids M1/F89 
(Bianchi et ah, 1992).
The plasmid pT7-7-rHMGlcm used for expression of full-length HMGBl in bacteria 
was a kind gift of prof. J.O. Thomas (Cambridge University. Cambridge, UK).
Plasmids pGEX 2TK-P-CBP (1098-1858) and pGEX2TK-P-PCAF (352-695) 
expressing the HAT domains of CBP and pCAF respectively, fused with GST, were a 
kind gift of Dr. J. Bannister (Wellcome/ CRC Institute, Cambrige).
The plasmid pEGFP-N 1 -HMGB 1 contains the open reading frame of HMGB 1 fused at 
the 3' end with the coding region of the Enhanced Green Fluorescent Protein (Enhanced 
GFP). It was generated inserting a 680 bp fragment of rat HMGB I cDNA (35 bp 
upstream the ATG until the stop codon) into the pEGFP-Nl vector (Clontech), using 
EcoRI and SacII restriction sites. Both restriction sites were inserted at the end of the 
cDNA by PCR using appropriate oligonucleotides designed by Paola Scaffidi (Scaffidi 
et ah, 2 0 0 2 ).
All the mutant GFP-HMGBl fusions were generated by PCR according the protocol 
described in paragraph
2.2 Mononucleosomes assembly and purification
Nucleosomes were assembled using purified histones and polyglutamic acid (PGA, 
Sigma P4886) according to (Stein et ah, 1979). Histones and PGA were mixed in a 2:1 
(w:w) ratio in 0.15M NaCl and incubated for Ihr at RT. Precipitates were removed by
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centrifugation at RT for 4 min at 11 krpm, the supernatant (named HP-mix) was stored 
at -20°C. Different ratios of body labelled DNA and HP-mix were incubated for 3 hr at 
37°C and analysed by electromobility shift to reveal optimal conditions for nucleosome 
assembly. Translational positions of the nucleosomes were separated by electrophoresis 
on 5% polyacrylamide gels in 0.5x TBE. The gel slice containing the separated 
nucleosomes was crushed and the nucleosomes were eluted by overnight incubation in 
EXl 10 buffer (llOmM KCl, 20 mM Tris pH 7.6, 3 mM MgC12, 0.5 mM EGTA, 10% 
Glycerol additionated with 600 ng/pl Chicken Egg Albumin (CEA, Sigma) The final 
quantity of radiolabelled mononucleosomes of different species were estimated by 
autoradiography after loading the purified isoforms on a 4.5% polyacrylamide gel in 
0.4x TBE, drying it and exposing to X-ray films (Pharmacia Biotech.)
2.3 E. coli strains
DH5a: Strain with genotype supE44 DlacUl69 (F80 lacZDMlS) hsdRl? recAl 
end A l gyrA96 thi-l relAl. A recombinant-deficient suppressing strain used for plating 
and growth of plasmids.
XL 1-Blue: Strain with genotype supE44 hsdRl? recAl endAl gyrA46 thi relAl
lac~ F ’(proAB'^lacI9lacZDM15TT\.10(tef)). It is a recombination- deficient strain that 
support the growth of vectors carrying some amber mutations. Transfected DNA is 
modified but not restricted. The F' in this strain allows blue/white screening on X-GAL 
and permits bacteriophage M I3 superinfection.
HBIQl: supE44 hsdS20(rB~mp') recAlS ara-14proA2 lacYl galK2 rpsL20 xyl- 
5 mtl-L A  suppressing strain commonly used for large-scale production of plasmids. It 
is an E. coli K12XE.  coli B hybrid that is highly transformable.
BL2K-): Strain with genotype hsdS gal (U clts857ind 1 Sam? ninS lacUV5-T? 
genel). A  strain used to express at high levels genes under the control of T7 promoter. 
It lacks the plasmid pLysE, coding for T7 phage lysozyme, which inhibits the RNA 
polymerase basal activity.
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E. coli bacteria were generally grown in LB (Luria-Bertani) Medium, supplemented 
with ampicillin at a concentration of 100 mg/ml or kanamycin at a concentration of 25 
mg/ml as selective agents.
LB (per liter)
bacto-tryptone 10 g
bacto-yeast extract 5 g 
NaCl 10 g
To express recombinant full length HMGBl, bacteria were grown in M9 minimal 
medium supplemented with Chloramphenicol at 100 pg/ ml as selective agent:
M9 (per liter): 5 X M9 salts (per liter):
5 X M9 salts 
1 M MgS04 
1 M CaClz
2 0 0  ml 
2  ml 
0.1%
Na2HP04 • 7 H2 O 64 g 
KH2PO4 15 g
NaCl 2.5 g
NH4 CI 5 g
2. 4 Preparation of NLSl and NLSl mutants and NLSs -GFP construct
Plasmid pEGFP-HMGBl, generated by Paola Scaffidi in our lab was used as template 
to generate the single mutants in NLSl and NLS2 in two-step PCR mutagenesis. 
Oligonucleotides 5 ’HMG-GFP (5 ’-ATCCTCgAgACATgggCAAAggAg-3 ’) and 
3’HMG-GFP (5’- ACCCCgCggTTCATCATCATCATC-3’) were used as external 
primers and six pairs of internal mutagenic primers (substitutions in bold type): 
NLSlKQdir: 5’- gAggAgCACCAgCAgCAgCACCCggATg-3’ and 
NLSlKQrev: 5’- CATCCgggTgCTgCTgCTggTggTCCTC-3’;
NLSlKRdir: 5’- gAggAgCACAggAggAggCACCCggAT-3’ and 
NLSlKRrev 5’- CATCCgggTgCCTCCTCCTggTggTCCTC-3’;
NLSlKAdir: 5’- gAggAgCACgCggCggCgCACCCggATgC-3’ and
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NLSlKArev: 5’- gCATCCgggTgCgCCgCCgCgTgCTCCTC-3’;
NLS2KQdir: 5’- AgCCAgCAACAgAAggAAgAggAAgACgAC-3’ and 
NLS2KQrev: 5’- CTgTTgCTggGTCTTCTCAgCCTTgAC-3’;
NLS2KRdir: 5’- AgCAggAgAAggAAggAAgAggAAgACgAC-3’ and 
NLS2KRrev: 5’- CCTTCTCCTgCTCTTCTCAgCCTTgAC-3’;
NLS2KAdir: 5’- AgCgCggCAgCgAAggAAgAggAAgACgAC-3’ and 
NLS2KArev: 5’- CgCTgCCgCgCTCTTCTCAgCCTTgAC-3’.
The final PCR products were then cloned into the Xho I/Sac II sites of the pEGFP- 
HMGBl to obtain the mutants plasmids. Sequences were confirmed by double Strand 
sequencing.
Double mutants were generated using the NLS2 internal mutating primers on the 
pEGFP-HMGl mutants in the NLSl as template. The cloning approach was the same as 
for the single mutations.
We generated the constructs containing each single NLSl and NLS2 fused in Jfiame to 
the GFP by cloning into the Xhol/Sacll sites of the vector pEGFP- N1 two cassettes, 
produced by annealing the following pairs of long-primers, coding for NLSl and NLS2 
sequences, respectively:
NLSldir:
5’TCTACTCgAgACATGAAgAAgAAgCACCCggATgCTTCTgTCAACTTCTCAgAg 
TTCTCCAAgAAgCCgCggCTAA-3 ’
NLSl rev:
5’TTAgCCgCggCTTCTTggAgAACTCTgAgAAgTTgACAgAAgCATCCgggTgCTTC 
TTCTTCATgTCTCgAgTAgA-3 ’ ;
NLS2dir:
5’- TCTACTCgAgACATGAAgAgCAAgAAAAAgAAggAACCgCggCTCA-3’ 
NLS2rev:
5’-TgAgCCgCggTTCCTTCTTTTTCTTgCTCTTCTAgTCTCgAgTAgA-3’.
The primers were temperature-annealed; the annealed cassette was digested with 
Xhol/Sacll restriction enzymes to generate cloning sites, then purified on a 12%AAgel 
and cloned in the pGFP-Nl vector. Constructs were checked by double strand 
sequencing.
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2.5 Protocol of plasmid DNA extraction
Plasmid DNA was prepared using two classical techniques of plasmid extraction. The 
first was used to prepare plasmid DNA from 3 ml of many different cultures (1 to 24) of 
plasmid-containing bacteria (Sambrook et al., 1989). The second one was used to 
isolate large quantities of plasmid DNA, using anionic exchange cartridges produced by 
QIAGEN. Bacterial cells were lysed under alkaline conditions and the crude lysates 
were cleared by centrifugation. The cleared lysate was then loaded onto the anion- 
exchange tip where plasmid DNA selectively binds under appropriate low-salt and pH 
conditions. RNA, proteins, metabolites, and other low-molecular-weight impurities 
were removed by a medium-salt wash, and plasmid DNA was then eluted in high-salt 
buffer. The DNA was concentrated and desalted by isopropanol precipitation and 
collected by centrifugation.
2. 6  Proteins: expression and purification
To produce recombinant HMGB 1 AC (boxA+boxB) and HMGBlboxA we followed the 
protocol described in (Bianchi et al., 1992); briefly, we inoculated BL21(-) E.coli strain, 
freshly transformed with appropriate plasmids, in LB medium, supplemented with 0.4% 
Glucose and lOOug/ml ampicillin. The overnight inoculus was then diluted 1:200 in the 
same medium and grown at 37°C shaked at 200 rpm. When OD at A, = 600nm, the 
culture is induced with ImMlPTG for 90-120 min.
We harvested bacteria by centrifugation and we resuspended them in Buffer L2 (50 
mM Tris-HCl pH 8.0, 20 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF), using sonication 
to clarify them. NaCl was added to a final concentration 0.5M and the extract was 
centrifuged to pellet the debris, which is discarded. We then perfomed a fractionated 
precipitation of the supernatant by adding (NH4)2 S0 4  to 60% solubility (corresponding 
to 3.9g of salt per 10 ml of sample), taking advantage of the capability of HMGB 1 to 
remain in solution at 60% saturation of (NH4 )2 S0 4 . After 30 min in ice, we centrifuged 
the extract at 10 kpm for 30 min; The supernatant was collected, filtered and loaded on 
a Phenyl-Sepharose Column (Amersham Pahrmacia), connected to a FPLC System.
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Proteins are eluted in a decreasing gradient of (NH4)2 S0 4  (60-0% saturation) generated 
mixing the following buffers:
buffer A 20 mM HEPES pH 7.9 
0.5 mM DTT 
0.2 mM PMSF 
0.2 mM EDTA pH 8.0 
0% (NH4)2S04
buffer B 20 mM HEPES pH 7.9 
0.5 mM DTT 
0.2 mM PMSF 
0.2 mM EDTA pH 8.0 
60%(NH4)2S04
Positive fractions were evaluated on Acrylamyde Gels stained with Coomassie and pooled. 
At this step, the protocol for purification of the single boxes (boxA and boxB) can be 
considered completed, while for HMGB 1 AC (boxA+boxB) an additional step of 
chromatography was required so the positive fractions were dialysed overnight in buffer 
A’(see later) and loaded on a Hi-Trap -  SP column (Amersham Pharmacia) connected to a 
FPLC System (Amerhsam Pharmacia).
HMGB 1 AC was eluted in an increasing gradient of NaCl, mixing the two buffers:
buffer A’ 50 mM Hepes pH 7.9 
0.5 mM DTT 
0.2 mM PMSF 
20 mM NaCl
buffer B' 50 mM HEPES pH 7.9 
0.5 mM DTT 
0.2 mM PMSF 
1 MNaCl
Positive fractions -  evaluated by Coomassie stain in 10-12% SDS PAGE - were collected, 
pooled, concentrated using a Centricon Cartridge (Millipore); the protein was then desalted 
using PD-10 columns (Amersham Parmacia) and equilibrated in
Buffer G:
lO mMNaP pH 7.5 
lOOmMNaCl 
0.5 mM DTT 
0.1 mM PMSF.
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Full-length HMGBl was produced in BL21(-) E. coli strain, following the protocol of 
Studier and Moffatt (Studier and Moffatt, 1986), but with some modifications: briefly, 
instead of LB medium used for HMGB 1 derivatives, we used M9 medium (see before), 
completed with:
Cas-aminoacids 20 g/L
Glycerol 0.5%
Yeast Extract 5 g/L
Glucose 0.4%
Chloramphenicol (instead of Ampicillin) 100 pg/ ml
After an overnight growth, 300 ml of BL21 (-) E. Coli strain were inoculated in 3 liters 
of medium and let grow at 37°C, with a shaking of about 400rpm. When the O.D. was 
0.7, IPTG was added to the culture to a final concentration of 0.5mM/lmM; shaking
was slowed down to 150/200 rpm and temperature shifted down to 23°C. Bacteria were
let grow for other 16 hours, then they were collected by centrifugation.
In principle the protocol is very similar to the one for HMGl derivatives, until the step 
of loading on the Phenyl-Sepharose Columns. At this point we didn't elute the protein 
with a continuous decreasing gradient as described before, but with a stepwise 
decreasing gradient of 60%- 50%- 40%- 30% of saturation of (NH4)2 S0 4 . For each salt- 
step we waited until the elution-peak was completed and then we went down to the step 
of lower concentration. Positive fractions were eluted approximatively at the 50% 
(NH4 )2 S0 4  step. Positive fractions were then passed through a Hi-trap MonoQ (5ml 
column volume) with an increasing gradient from 20 mM to IM NaCl. Positive 
fractions were collected, and concentrated in Centricon Cartridges (Millipore). The 
protein was desalted in final Buffer G and the final concentration was evaluated both by 
Bradford Method and by Coomassie Staining on 12% SDS-PAGE.
Mammalian HMGBl was purified from calf thymus according to the protocol kindly 
provided by Jordi Bemués (CSIC, Barcelona); briefly: the organ is minced in Bufferl 
(0.14 M NaCl, 0.5 mM EDTA, 0.1 mM PMSF) after removal of the fat arid the 
connective tissue.
The homogenate was subjected to three subsequent 5% PCA extractions; supernatants 
collected after centrifugation were pooled and clarified with TCA (18% final 
concentration) Fractionated precipitations with Acetone-HCl (400:1 v/v) and acetone
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alone were performed to get rid of histone HI from the sample. The sediment was then 
dissolved in buffer borate pH 9.0 and passed once or twice (according to the purity of 
the sample) on a CM-Sephadex C25 column (Amersham Pharmacia), positive fractions 
were eluted with a NaCl gradient from 0.1 IM to 0.2M. Typically, different pools were 
generated according to the purity of the protein, going from very high to mid to low 
purity of HMGBL The purified protein was then equilibrated in maintenance Buffer 
(Buffer G or an analogous neutral Phosphate Buffer) with or without addition of 15% 
glycerol according to the following applications. Aliquots were frozen at Liquid N% and 
kept at -80°C. Alternatively the protein was lyophilised.
GST-fused HATs (GST- CBP and GST- pCAF) were expressed in DH5a E.coli 
bacterial strain and purified using Glutathione Sepahrose 4B (Amersham -Pharmacia), 
according to manifacturer’s protocol: briefly, bacteria freshly transformed with 
pGEX2TK-PCAF and pGEX2TK-CBP plasmids, were inoculated in LB- ampicillin 100 
pg/ml. After an overnight growth, bacteria were diluted 1:100 in 500 ml of fresh 
medium and grown until the O.D.goonm was about 0.7-0.8, then the expression of the 
protein was induced with IPTG ImM. Induction was carried on for 2 hours at 37°C. The 
cells were harvested and resuspended in about about 12 ml of PBS IX, DTT ImM, and 
protease inhibitors cocktail tablets (Boehringer Mannheim). Cells were disrupted by 
cycles of sonication; Triton 1% was added to the extract, that was then centrifuged after 
10 min of ice-incubation. We then added the supernatant to Glutathione Sepharose 4B, 
previously equilibrated in PBS with an approximate ratio of 2.5 mg of GST-protein per 
ml of slurry. We incubated the protein with the slurry for about 60 -  90 min at 4°C, then 
we sedimented by centrifugation the beads and we washed them 3- 4 times with 10 bed 
volumes PBS . The quantity and the purity of the GST-fusions bound to the beads were 
estimated by loading aliquots of the slurries in 10-12% SDS-PAGE.
Since we needed the GST- fused acetyltransferases for in vitro acétylation assays, we 
did not need to elute the proteins form the slurry, provided that binding to the slurry was 
not compromising their enzymatic activity (this was appropriately tested).
Histones used to assembly mononucleosomes in vitro were extracted from Drosophila 
embryos and purified by chromatography on a hydroxylapatite column by Ralph
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S trôner (Becker’s lab, Butenandt Institute, Munich) as described (Simon and Felsenfeld, 
1979).
The baculovirus stocks for the expression of Acfl and C-terminally Flag-tagged Acfl 
were kindly provided by Dr. J. Kadonaga. Flag-tagged Acfl was expressed and purified 
as previously described (Brehm et al., 2000): SF9 cells were tranfected and recombinant 
baculovirus was produced using the MaxBac system according to manufacturer’s 
instructions. Exponentially growing SF9 cells were infected with recombinant virus and 
harvested 48 hours post-infection by centrifugation.
We then resuspended cells in about 20 ml of HEMG500 Buffer:
25 mM Hepes pH 7.6 
500 mM KCl
12.5 mM MgCl2 
0.5 mM EDTA 
0.5 mM EGTA 
ImM DTT 
0.2 mM PMSF 
1 0 % glycerol 
0.1%NP-40
and submitted to two cycles of freeze-thaw in liquid nitrogen followed by to three 
cycles, of sonication (amplitude 50%, 15 sec/ burst). Total cell lysates were clarified by 
centrifugation and filtration. The supematant was collected and incubated with Anti- 
Flag M2 affinity Gel (Sigma). After incubation on a rotating wheel for 4-6 hours at 4°C, 
the gel was recovered and washed three times with HEMGIOOO (IM KCl) and then 2 
times in HMEGIOO (100 mM KCl). Bound flagged-Acfl was eluted with 0.25 mg/ml 
flag peptide (Sigma) in HEMGIOO 70.5% NP-40 incubated 3hours up to 0/N at 4°C on 
a rotating wheel. A second elution is possible (with lower yield) using the same 
condition.
The ISWI expressing baculovirus was a gift from Dr. C. Wu: recISWI was expressed 
and purified by Gemot Langst according to the protocol described in (Corona et ah, 
1999).
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2. 7 In vitro traslation of recombinant proteins and pull down assays
CRMl protein was in vitro transcribed-translated with the TnT ® Coupled Reticulocyte 
Lysate System (Promega) following the manifacturer’s protocol, using pSGCRMl a 
templatge plasmid kindly gifted by Charlotte Kirlstrup in our institute, as the protocol to 
test the protein -  protein interaction.
Seven pi of Met -[^^S] labelled CRMl (freshly made) were incubated with 
approximatively 1-4 pM of recombinant HMGBIAC protein and derivatives (boxA and 
boxB), previously cross-linked to Activated Sepharose -  CH (Amersham).
Protein GST-NS2 coupled to Gluthatione Sepharose (Amersham) beads was used as 
positive control of interaction with CRMl (Askjaer et al., 1998) and BSA-cross linked 
to Sepharose -CH was used as negative control to test unspecific binding.
The reaction mix for each sample was composed as follows: about 10-20 pi of beads, 7 
pi of CRMl, 15 pi of RAN Buffer (50 mM Tris/HCl pH 7.5, 200 mM NaCl, 2 mM 
MgC12, 10% glycerol), 5pi of 6 x CRMl buffer (20mM Hepes/KOH pH 7.5, 80 mM 
CH3 COOK, 4mM (CH3 COO)2 Mg, 250 mM sucrose, 2.5 mM DTT), 1 mg/ml BSA, +/- 
Leptomycin B 400 nM.
The reaction is performed at 4°C for one hour mixing the slurry on a rotating wheel.
The beads are pelleted by centrifugation and supematant are collected and dried in the 
Savant. Beads are then washed 5 times with 50 volumes of PBS additionated with 9% 
Glycerol, 5 mM MgCL and 1% NP-40. Washes are performed at 4°C, incubating the 
beads 1 0  minutes /wash on the rotating wheel and pelletting the beads by centrifugation. 
Washed beads are loaded on a 8 % SDS PAGE together with dried output, the fourth 
wash and one aliquot of the input as a reference. The gel is then blotted onto nylon filter 
and exposed to X-ray film to detect labelled CRMl.
2. 8  Generation of Sepharose CH-coupled proteins for pull down assays
Sepharose-CH beads (Amersham) conjugated to purified proteins were prepared 
according to manufacturer’s protocol: briefly purified protein are dialysed against 
Coupling Buffer (0.1 M NaHCOS pH 8.0, 0.5 N NaCl), while the freeze-dried slurry is 
reswelled in HCl ImM ice-cold and washed in this chloride buffer 5 times.
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Coupling reaction is carried on in the bicarbonate buffer for 2 hours at room 
temperature or 4 hours at 4°C. After coupling reaction excess ligand is washed away 
and any remaining active groups are blocked by treatment with ethanolamine IM, pH 9 
for one hour.
The slurry thus generated is washed alternatively with high pH (Tris-HCl O.IM pH 8 , 
0.5 N NaCl) and low pH (acetate O.IM pH 4, 0.5N NaCl) buffers solution four of five 
times. The slurry is then conserved in different storage buffer depending on the 
properties of the ligand: we used PBS Ix (with a suitable bateriostaticd agent like 
NaAzide or Thimerosal 0.01% added) at 4°C.
2. 9 Heterokaryon assay and cooling assay (by Paola Scaffidi)
HeLa cells were plated on glass coverslips in a 6 -well dish (100 000 cells/dish). After 16 
hours, 200 Hmgbl -/- mouse fibroblasts were plated on the same coverslips. 
Following a 3-hour incubation in the presence of 100 pg/ml cycloheximide, the cells 
were washed with PBS and treated with 100 pi of prewarmed 50% PEG-6000 in PBS 
for 1 min. After 3 washes with PBS, the cells were incubated with DMEM containing 
100 pg/ml cycloheximide for 4 hours, and then fixed with 4% paraformaldehyde. 
Immunofluorescence was performed using anti-human cytokeratin and anti-HMGBl 
antibodies, and chromatin was visualized by DAPI staining. When indicated, 150 nM 
leptomycin B (Sigma) was added to the medium together with cycloheximide.
For testing passive diffusion of HMGBl, HeLa cells were pretreated with 100 
pg/ml cycloheximide at 37°C for 30 min, incubated at 4°C for 4 hours, fixed with 4% 
paraformaldehyde, and stained with anti-HMGBl antibodies.
2.10 Cell cultures and transfections
HeLa cells, 3T3 and 3139 mouse fibroblasts were cultured in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS from
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GIBCO), 100 lU/ml of penicillin and 100 pg/ml streptomycin, in 5% CO2  humidified 
atmosphere.
HeLa cells were transfected with pEGFP-Nl- HMGBl vector and mutant derivatives by 
calcium phosphate co-precipitation (Sambrook et ah, 1989): To express HMGBl-GFP, 
2 x 1 0  ^ cells were plated in 6  cm dishes and were transiently transfected with 8  pg of 
pEGFP-HMGBl and derivatives. Cells were observed around 36 hours after 
transfection. The average amount of HMGBl-GFP in the cell population was between 1 
and 3% of HMGBl (as measured by immunoblotting with anti-HMGBl antibodies).
Three clones of U937 pro-myelocytic cells (#10, #12, and #34, kindly provided by M. 
Alfano and G. Poli (HSR, Milano), were grown in RPMI medium (Gibco) supplemented 
with 10% FCS, L-glutamine, 100 U/ml penicillin 100 pg/ml streptomycin.
To generate a sensitisation to LPS treatment, the cells were first treated for about 3 days 
with 10'^ M Vitamin D3 that induces expression of CD 14 receptor and its exposure on 
the cell membrane; subsequently they were stimulated with 200 ng/ml LPS (Sigma 
catalogue #L4391) for about 20 hours.
The treatment with 10 ng/ml TSA was instead performed for a time -lag of 3- 6  hours. 
Primary human monocytes, purified, from peripheral blood (a kind gift from M. 
lannacone, Dibit-HSR), were grown in RPMI medium supplemented as described 
above, and were activated by overnight incubation in RPMI medium supplemented with 
200 ng/ml LPS.
SF9 cells, used for baculovirus infection, were cultured in SF900 II Complete Medium 
with added 1% Pluronic ® F- 6 8  (Life Technologies), 1% L-Glutamine, 1% Penicillin- 
Streptomycin, 10% Foetal Bovine Serum.
2.11 Preparation of extracts from cultured cells and organs
Total extracts from cultured cells (Hela, 3T3, U937 and primary monocytes) were 
prepared using the Freeze-and-Thawn protocol: cells were trypsined if required and 
pelleted by centrifugation. Pellets were resuspended in F/T buffer:
50 mM PIPES pH 7.0 
50 mM KCl 
5mM EGTA
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2mMMgCl2 
ImM DTT
proteases inhibitors (one pastille of complete'^^ Proteinase Inhibitors Cocktail from 
Boehringer Manheim GmbH was dissolved in 50 ml of buffer)
Four cycles of fast freezing in liquid N2  followed by thawing at 37°C were performed 
before centrifuging the lysates at maximum speed for 15 min at 4°C. Pellets containing 
membrane debries were discarded and supematant quantified and analysed by SDS- 
PAGE.
To prepare a lysate from a mouse embryonic thymus, the N2  frozen organ was 
powdered by mechanical pressure and then was lysed in an adequate volume of lysis 
buffer containing 10 mM Hepes, pH 7.3, 0.1 mM DTT, 1 mM EDTA, 100 mM NaCl, 
0.1% Triton X-100, 0.2 mM PMSF and a mix of protease inhibitors. The total extract 
was then mixed with Equilibration Buffer for 2D -PAGE and loaded on strips for the 
2D analysis.
2.12 Detection of proteins by SDS-PAGE: Western blots and Coomassie staining
Samples in SDS-PAGE loading buffer were heated for 5 minutes at 100°C, and applied 
to SDS polyacrylamide protein gels.
The separating gel consisted of:
9% -12% of Acrylamide-bis stock sol (30% acrylamide, 1% bis)
375 mM Tris pH 8 . 8  
0.1% SDS.
The concentration of the acrylamide-bisacrylamide was variated from 9% to 12%, 
depending on the size of the proteins to visualise.
The stacking gel consisted of:
4% acrylamide-bisacrylamide 
125 mM Tris pH 6 . 8  
0.1% SDS.
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The running buffer contained:
14.4 g/1 glycine 
3.0 gd Tris 
0.5% SDS.
Gels were run at 5-15 Volt/cm.
In some situations we made use of Tricine -  SDS PAGE system, that is useful for 
separation of proteins in the 5 kD to 20 kD range, where normal PAGE-SDS gels have 
low resolution. The vertical mini-apparatus was used. In this system not only the 
stacking and running gels are characterised by different AA percentages and different 
pH values, but also the buffers at the two electrodes have a different composition and 
chemical properties. This allows gaining a higher resolution in the range of low 
molecular weighs. The composition of the buffers and of the gel -  follows:
Anode bf: Cathode bf: Gel bf:
0.2 M Tris pH 8.9 O.IM Tris 3M Tris pH 8.45
0.1 M Tricine (Sigma #T0377) 0.3 % SDS
0.1 % SDS
pH is automatically 8.25 
Acrylamide-bis stock sol: 30% acrylamide, 1% bis
Stacking gel Separating gel
6  ml stock acryl-bis 1 0  ml stock acryl-bis
12.4 ml gel bf 10 ml gel bf
water to 50 ml 3.4 ml glycerol 80 %
water to 30 ml
Loading buffer 3X (10 ml)
3 ml Tris 0.5 M pH 6 . 8  
0 . 6  ml mercaptoethanol pure
1.2 g SDS solid
4.5 ml glycerol 80 % 
bromophenol blue, some 
water to 1 0  ml
53
The procedure to mount the apparatus and to pour the gel was the usual one. The gels 
were run at about 25 V/cm.
For. Western blots, the proteins separated by SDS-PAGE (with either methods) were 
transferred onto nylon Immobilon P membranes (Millipore) using a tankblot system 
(Hoefer) in 25 mM Tris pH 7.5, 0.192 M glycine, 20 % methanol. Blots were blocked 
for 1 hour at room temperature in 5% skim milk in TEST:
20 mM Tris pH 7.5 
137 mM NaCl 
0.1% Tween 20.
Washing was performed in TBST and filters were then incubated for 1 hour at room 
temperature with anti-HMGBl antibody (working dilution: 1:4000 in TBST/0.01% 
BSA). After three additional washes in TBST, filters were further incubated for 1 hour 
with an anti-rabbit antibody conjugated to HRP (Amersham) (1:5000 in TBST/0.01% 
BSA). The polyclonal antibody RIO, a kind gift from B.M. Turner (University of 
Birmingham Medical School), was used to detect specifically the acetylated form of 
histone H4. After incubation with secondary antibodies, blots were washed with TBST 
and developed using the ECL system (Amersham).
Coomassie staining was used to detect proteins and to evaluate their purity and 
concentration: after electrophoresis, gels were incubated for 45 minutes in staining 
solution, containing 45% EtOH, 8 % acetic acid, 5 g/1 Coomassie blue, and then in 
destain solution, containing 23% EtOH, 8 % acetic acid, until proteins were clearly 
visible. Gels were finally dried on 3 MM paper with a gel drier.
Silver Staining, used to detect proteins in 2D gels, is described in the next session.
2.13 2D - gel Electrophoresis separation and detection of protein by Silver Staining
The system used for lEF run is provided by Amersham Pharmacia Biotech. About 50 
pg of purified HMGBl or about 250- 400 pg of total protein of total extracts (generated 
by about 10 million cultured cells with freezing-thawing method) were added to 350 pi
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of rehydration buffer (RB), containing 8  M urea, 2% CHAPS, 20 mM dithioerythritol 
(DTE), 0.8% IPG buffer (carrier ampholytes, pH 3-10 Non Linear or pH 4-7 
Linear).Samples were applied onto ceramic strip holders (Pharmacia Biotech), 
connecting two electrodes, in contact with 18 cm polyacrylamide gel strips (pH range: 
3-10 NL, or pH 4-7 L). Isoelectrofbcusing (lEF) was performed on iPGphor (Pharmacia 
Biotech) with 2 different protocols according to the length of the strips used:
18 cm strips protocol:
-rehydration: 30 min at 20°C 
-lEF: 18°C
-SI: step-n-hold 30 V, 10.0 hours 
-S2: step-n-hold 200 V, 1.5 hours 
-S3: gradient 3500 V, 2.5 hours 
-S4: step-n-hold 3500 V, 2.0 hours 
-S5: gradient 8000 V, 1.5 hours 
-S6 : step-n-hold 8000 V, 8.0 hours
7cm strips protocol:
-rehydration: 30 min at 20°C 
-lEF 18°C
-SI: step-n-hold 30 V, 10.0 hours 
-S2: step-n-hold 200 V, 1.5 hours 
-S3: gradient 3500 V, 2.5 hours 
-S4: step-n-hold 3500 V, 2.0 hours 
-S5: gradient 5000 V, 1.5 hours 
-S6 : step-n-hold 5000 V, 8.0 hours
The lEF was stopped after 75000- 90000 Vx hr s.
The second dimension electrophoresis was performed using a Protean II apparatus (Bio- 
Rad). Strips were then soaked first in Equilibration buffer (EB: 6  M urea, 3% SDS, 375 
mM Tris pH 8 .6 , 30% glycerol, 2% DTE), then in EB containing 3% iodoacetamide 
(lAA) and traces of bromophenol blue (BBP). Subsequently, strips were applied onto 
10%-12% polyacrylamide gels. Gels were run at 90 V for about 16 hours and either 
Silver or Coomassie stained or transferred onto nitrocellulose membranes (Hybond 
ECL, Amersham Pharmacia Biotech.) as described before.
Silver Stain of the 2D gels was performed following a protocol developed in our lab 
that gives a high sensitivity but avoids the long times of other methods.
Briefly, after the second dimension the gel was equilibrated (>/=)3 hours with gentle 
shaking in 5 gel volumes of 30% Ethanol, 10% Acetic Acid. Two washes of 30 min in 5 
gel volumes of 30% Ethanol were then performed, followed by three washes of 10 min 
in deionised water.
We incubated the gel in 5 gel volumes of 0.1% AgNOg for 30 min; then we removed the 
AgNO] and washed for 20 seconds. The developing step consisted of incubating the 
gels in 5-10 gel volumes of 2.5% Na2 C0 3 , 0.02% Formaldheyde at room temperature
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with shaking. Incubation was carried on until spots appeared: this can have a variable 
duration according to the quality of the extract and of the gel. The staining development 
was stopped by washing in 1% Acetic acid, then washing several times in deionised 
water.
After scanning the gels, they were dried at the gel-dryer; to avoid breaking of the gels, 
we equilibrated them in Ethanol 30%, Glycerol 2% for 30 min with shaking before 
drying on pre-wetted 3MM paper.
2.14 Mass Spectrometry Analysis
I performed Mass Spectrometry analysis of calf-thymus purified HMGBl with the help 
of Fabio Talamo and under the supervision of Angela Bachi in the Mass- Spectrometry 
facility of our Institute.
Isolated protein spots were excised from 2D gels stained with colloidal Coomassie, and 
reduced and alkylated as described (Shevchenko et al., 1996; Wilm et al., 1996). We 
then performed sequential digestions using different sequence specific pro teases and/or 
chemical cleavage. In particular. Trypsin, Asp-N, Glu-C digestions were performed in 
50 mM NH4HCO3 buffer pH 8.0 at 37°C, with shaking. Time of digestion varied from 3 
hours Xo ovemi^t according to the efficiency of cleavage. Chemical cleavage with 
formic acid (Asp-C) was achieved by incubating spots overnight at 56°C in 2% formic 
acid. Spots blotted on PVDF membranes were incubated in the presence of cyanogen 
bromide (CNBr) in 70% trifluoroacetic acid for 1 hour at RT in the dark. One pi of 
digestion products was loaded onto the MALDI target using the dried droplet technique 
and a-cyano-4-hydroxycinnamic acid (HCCA) or sinapinic acid used as matrix.
MALDI-TOF mass measurements were performed on a Voyager-DE STR time 
of flight (TOF) mass spectrometer (Applied Biosystems, Framingham, MA, USA) 
operated in the delayed extraction and reflector mode. Spectra, internally calibrated, 
were processed via the Data Explorer software.
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2.15 In vitro and in vivo Acétylation Assays
Assays were performed in HAT buffer:
50mM Tris-HCl pH 8.0 
1 0 % glycerol (v/v)
ImM DTT 
0.1 mM EDTA 
0.1 mM PMSF 
10 mM N aButyrate
The protein substrate concentration was approximatively of 0.1- 0.2 pg/pl. The 
concentration of [^ "^ C] acetyl-CoA (55 mCi/mmol, Amersham Pharmacia Biotech) was 
18 pM, while the concentration of the enzymatic activity (both GST-pCAF and GST- 
pCBP) conjugated with Glutatione Sepharose was approximatively of 10/ 20 ng/pl. The 
reaction was performed at 37°C for 20 min and at 4°C for 10 min, stopped by 
centrifugation 5 min at lOOOg that allowed separation of the GST-fiised HAT activités 
from substrates. Supernatants were directly mixed with SDS-gel sample Buffer, boiled 
and loaded on 10% Tricine-PAGE.
Gels were stained with Coomassie Stain then dried and exposed first to Densitometers 
Screens (Molecular Dynamics) then to autoradiography films from Amerhsam 
Phamrmacia Biotech. Films were scanned with a Personal Densitometer IS (Molecular 
Dynamics) and bands were quantified with ImageQuant software.
In vivo acétylation of HMGBl in cultured cells (Hela, 3T3, Phonenix, ) was performed 
incubating 70% confluent cells in DMEM medium with different HD AC inhibitors 
added under the following conditions: TSA 5ng/ml, HC toxin 10 ng/ml, 5mM Butyrate; 
cells were harvested at different time points by trypsinisation and total cells extracts 
prepared subjecting the cells to 3 cycles of Freezing-Thawing in Lysis buffer (50 mM 
Pipes pH 7.0, 50 mM KCl, 5 mM EGTA, 2 mM MgC12, ImM DTT, Protease Inhibitor 
Cocktail from Boehringer Manheim GmbH, 60 pg/ml)
We evaluated the level of acétylation of the extracts by monitoring the acétylation of 
Histone H4 by Western Blot using anti-H4 acetyl-Lys kindly gifted by Prof. Bryan 
Turner (Birmingham), produced as previously described (White et ah, 1999).
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2.16 Immunoprécipitation of pCAF and p300/ CBP from Hela nuclear extracts 
and in vitro acétylation assay
Rabbit anti-pCAF and rabbit anti-CBP (cross-reacting also with p300) (Santa Cruz 
Biotechnology) were used to specifically immunoprecipitate the diverse HATs from 
HeLa total extracts.
About 2 mg of total protein from 3T3 extracts were first precleared by 3 hours of 
incubation with Protein A-Sepharose, then were incubated overnight at 4°C with 
antibodies (1:10 dilution, corresponding to approximately 15 pg Ig) in 300 pi RIPA 
buffer:
10 mM Tris-HCl pH 8.0 
1% Triton 
0.1% SDS,
0.1% Dehoxicolate 
140 mM NaCl 
ImM DTT 
ImM PMSF 
ImM EDTA
Protease Inhibitors Cocktail (as before).
Fifty pi of 50% Protein A-Sepharose were washed twice in RIPA Buffer and added to 
every immunoprécipitation reaction. The mixtures were incubated at 4°C for 3 hours on 
a rotating wheel, then the beads were pelleted by centrifugation and washed 5 times in 
RIPA Buffer, while the supernatants were acetone precipitated. Aliquots of the Beads 
(IP- samples) were loaded on a 10% SDS-PAGE, together with the Supernatants (non 
IP-samples) and the Inputs, to check the efficiency of Immunoprécipitation.
To test the enzymatic activity of the immuno -precipitated proteins, the HATs linked to 
the Protein A Sepharose were incubated with about 0.5 pg of protein substrate and [^ "^ C] 
acetyl-CoA to a final concentration of 80 pi in a total volume of 40 pi of buffer HAT. 
Reaction was carried on at 37°C for 30 min, plus 10 min at 4°C, then the reaction was 
stopped by adding SDS-gel sample buffer and boiling for 5 min. The level of 
acétylation was quantified by running the products on 10% Tricine SDS-PAGE and 
exposing the dried gel to Autoradiography films. The intensities of radioactive bands 
were quantified as described in the previous paragraph.
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2.17 Immunofluorescence and Imaging on living cells
Cell cultured in LabTek II chambers (Nalgene) or grown in 6 -wells plates with a 
microscopy-glass were directly fixed in 3.7% paraformaldehyde (PFA) in PHEM 
buffer:
36.8 g/1 PIPES
13 g/1 HEPES
7.6 g/1 EGTA
1.99 g/1 MgS04
titrated to pH 7.0 with KOH
Fixation lasted 10 minutes, at room temperature. After fixation, cells were washed with 
PBS and incubated for 3 minutes at 4°C with HEPES-based permeabilization buffer 
containing 300 mM sucrose and 0.2% Triton X-100. One hour of incubation in blocking 
solution (3% Bovine Serum Albumin, 0.05% Tween-20 in PBS) followed. Primary 
antibodies were then diluted in PBS+BSA 2% to the suitable final concentration and 
incubation was prolonged for 1 hour at room temperature. After three rinses with PBS 
containing 0.05% Tween-20 (PB-Tween), cells were incubated with secondary 
antibodies in PBS+BSA 0.2% for one hour, washed three times with PB-Tween, and 
then incubated with PBS containing 1.5 pg/ml Hoechst 33342. The polyclonal rabbit 
anti-HMGBl was purchased from BD PharMingen (Torrey Pines, CA), and used at 
1:1600 dilution in blocking solution. Goat polyclonal antibodies against rabbit IgG 
(H+L) conjugated to Alexa Fluor 594 (working dilution 1:1000) were purchased by 
Molecular Probes (Eugene, Oregon, USA).
Living cells expressing HMGBl-GFP, its derivatives and the NLSs-GFP fusions 
were PFA-fixed as described above, then incubated in PBS containing Hoechst 33342 
to stain the nuclei and finally imaged.
Fixed and living cells were imaged using an Olympus 60x/1.4NA Plan Apo oil 
immersion objective lens on a DeltaVision Restoration Microscopy System (Applied 
Precision, Issaquah, WA, USA) built around an Olympus 1X70 microscope equipped 
with mercury-arc illumination. Filters were from Chroma Technology Corp. 
(Brattleboro, VT, USA): Hoechst 33342 excitation 360/40, emission 457/50; GFP 
excitation 490/20, emission 528/38. Twenty optical sections spaced by 0.5 pm were 
collected with a Coolsnap_Hq/ICX285 CCD camera (Photometrix, Tucson, AZ, USA)
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and deconvolved by the constrained iterative algorithm available in the SoftWoRx 2.50 
package (Applied Precision) using 10 iterations and standard parameters. Each image 
measured 512x512 pixels, and effective pixel size was 0.106 pm.
Due to the spherical morphology of monocytic cells, a quantitative analysis of HMGBl- 
fluorescence in different subcellular compartments was not feasable, since it would 
require the normalisation of the fluorescence against the volume of the cell 
compartment. We tried to bypass this problem with a strict statistical analysis of the 
redistribution of HMGBl upon different stimuli: we therefore counted positive cells and 
normalised this value againsts the total cell number.
In case of both fibroblasts and monocytic cells, when we describe a specific localisation 
of HMGBl inside or outside the nucleus, it means that at least 75-80% of the cels 
observed showed the expected distribution of HMGBl.
2.18 Bioinformatics
HMGBl was inspected for potential NLSs using the PredictNLS database, 
maintained at CUBIC (http://cubic.bioc.columbia.edu/predictNLS) (Cokol et al., 2001). 
PredictNLS is an automated tool for the analysis and determination of Nuclear 
Localization Signals (NLS). By submitting a protein sequence or a potential NLS, 
PredictNLS predicts if the protein is nuclear, or finds out whether the potential NLS 
corresponds to a known one in the database. The program also compiles statistics on the 
number of nuclear/non-nuclear proteins in which the potential NLS is found or has a 
match. Finally, proteins with similar NLS motifs are reported, and the references to the 
experimental papers describing the particular NLS are given.
2.19 Nucleosome mobility assay
60 finoles of nucleosomes with defined translational positions were incubated with 
ISWI, ACF, HMGBl and HMGBIAC for 0 to 90 min at 16°C. Reaction mixes 
contained EX70 buffer:
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70 mM KCl 
10 mM Tris 
1 mM EDTA
1.4 mMMgCl2  
1 0 % glycerol
supplemented with 1 mM ATP, 200 ng /pi CEA and 1 mM DTT.
Reactions were stopped by the addition of 300 ng of competitor cold DNA and 
differentially positioned mononucleosomes were separated exploiting their different 
electrophoretic mobility on 4.5% polyacrylamide gels in 0.4x TBE.
Gels were extensively pre-run at lOOmV and after loading samples were run for about
2.5 hours at lOOmV. Shifts were detected by exposure of dried gels to Hyperfilm 
autoradiography films or to the phosporimager. Gels were scanned with a 
Phospholmager (Fuji) and the individual bands were quantitated with Aida software.
2.20 Electrophoretic mobility shift assays
Sixty finoles of purified nucleosomes were incubated with increasing amounts of ISWI, 
ACF, HMGBl and HMGBIAC in EX80 buffer containing 200 ng/pl CEA and 1 mM 
DTT. Reactions were incubated for 10 min at RT and then separated on 5% 
polyacrylamide gels containing 0.4x TBE. The composition of the shifting 
nucleosome/protein complexes was investigated by using a super-shift approach: after 
10 min of binding reaction, the specific antibodies, rabbit anti-HMGBl (BD 
Pharmingen) and monoclonal mouse anti-Flag M2 (Sigma) were added to the mix (1:50 
and 1:25 working dilution, respectively) and incubated 5-10 min prior loading the 
sample on an AA gel.
2. 21 Nucleosome footprinting
Footprinting of HMGBl bound to the nucleosomes was performed by Gemot Langst; 
briefly, nucleosomes localized between -185 to -  40 relative to the centre of the DNA
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at position +16, relative to transcription start site (+1 ), were purified as described before 
and used for footprinting assays. Briefly, DNA was 5’ end labelled with PNKinase and 
end-digested with the specific restriction enzime. Optimal HMGBl-nucleosome ratios 
were estimated in electromobility shift assays. The electromobility shift reactions were 
scaled up 50-fold and treated with increasing amounts of DNase I. Reactions were 
stopped by the addition of EDTA to a final concentration of 5 mM and directly loaded 
on preparative electromobility shift gels. DNase I-treated nucleosomes and HMGBl- 
nucleosome complexes were isolated from the gel, treated with proteinase K, and 
analyzed on 6 % sequencing gels.
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CHAPTER 3: Acétylation of HMGBl regulates its sub-cellular 
localisation, switching its function from a chromatin protein to a 
cytokine. 
3.1 INTRODUCTION
3.1.1 First studies on HMGBl secretion in monocytes
It has recently been shown that activation of monocytes results in the redistribution 
of HMGBl from the nucleus to cytoplasmic organelles, which display ultrastructural 
features of endolysosomes (Andrei et ah, 1999). HMGBl does not traverse the 
endoplasmic reticulum and the Golgi apparatus, consistent with the absence of a leader 
peptide in the protein. The early mediator of inflammation interleukin (IL)-lp is also 
secreted by monocytes through a non-classical pathway involving exocytosis of 
secretory lysosomes (Andrei et ah, 1999). However, in keeping with the roles of IL-ip 
and HMGBl as early and late inflammatory factors, the discharge of the secretory 
vesicles that contain these 2 proteins responds at different times to different stimuli: IL- 
ip secretion is induced earlier by ATP, autocrinally released by monocytes soon after 
activation; HMGBl secretion is triggered by lysophosphatidylcholine (LPC), a lipid 
generated later in the inflammation site (Andrei et ah, 1999).
3.1.2 HMGBl is variably modified
In activated monocyte secretion of HMGBl does not involve protein newly made in 
the cytoplasm, but proceeds through the depletion of nuclear stores. Therefore we 
reasoned that a change on unknown nature had to occur to the protein already existing; 
this modification would be able to alter its biochemical properties and causes its 
redistribution into the cell. The nature of this “alteration ” was the first object of my 
investigation.
Very little is known about functional modulation of HMGBl: structural 
investigations suggest that regions flanking the HMGbox and in particular the C terminal
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acidic tail could modulate the DNA-binding affinity. The indentification in the nucleus of 
a specific protease that cleaves the C-terminal portion of the protein strengthen this 
hypothesis and suggests a means for in vivo regulation of HMGBl function (Dyson and 
Walker, 1984).
Another possibility to regulate HMGBl resides in post-synthetic modifications of 
the protein: alternative functions or alternative localizations of proteins often involve 
post-translational modifications; we therefore imagined that post-translational 
modifications could be the way to generate different functional isoforms from a single 
protein and/or to distribute them in different cellular compartments.
HMGBl is subjected to acétylation and ADP-ribosylation and phosphorylation 
(Sterner et al., 1979); (Wisniewski et al., 1999).
ADP-ribosylation of HMGB proteins and -  among them- of HMGBl was 
described long ago, but its significance has still to be clarified, even if several old works 
relate this modification to cell aging and suggest a role for cell recovery from DNA 
damage (Prasad and Thakur, 1990; Thakur and Prasad, 1990) and (Tanuma et ah, 1985).
Using metabolic labelling with [^H]- acetate and sequential Edman degradation of 
purified HMGBl Allfrey and collaborators identified a moderate level of acétylation of 
lysines 2 and 11 (Sterner et al., 1981).
At the beginning of my PhD, we extended his evidence and hypothesized that PT - 
modifications could be the means employed by the cell to distribute HMGBl from 
nucleus to the cytoplasmic compartments.
Among the panel of modifications described, reversible acétylation was the most 
plausible, mainly because acétylation is emerging as a very widespread modification 
that occurs on an increasing number of nuclear factors in addition to the histone-tails: 
viral proteins, transcription factors, chromatin components (Chan and La Thangue, 
2001) (Kouzarides, 2000) are known to be functionally modulated by acétylation.
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3.1.3 HATs and HDAC regulate gene expression and modulate the function of 
several nuclear factors
Acétylation has been discovered, first, to occur on the histone- octamer tails that 
protrude from the nucleosome moiety, with the primary effect of loosening the histone- 
DNA interaction, rendering the chromatin more accessible to transcription factors and 
therefore more transcriptional active.
Together with the other PT-modifications, acétylation of histone tails is now 
considered a key control level to the accessibility of chromatin, and therefore of its 
activation state. As a matter of fact, the transcriptional activity of specific loci in the 
genome can be strongly correlated to their level of acétylation, which is the result of the 
balanced and regulated activity of two families of enzymes: acetyltransferases (HAT) and 
deacetylatses (HDAC) on the tail of the histones.
Acetyltransferase activity consists in the transfer of an acetyl-group to the e -amino group 
of a lysine residue and, with the neutralization of its positive charge that results in the 
decrease of the pi of the protein substrate. HDACs work in the opposite direction, 
cleaving the acetyl-group from the modified protein.
+ HAT
NH3 i  H N
I HDAC
(C H 2 > 4  ( C H 2 ) 4
lysine acetyi-iysine
Both HATs and HDAC consists typically of large, multisubunit enzyme complexes, 
whose identification was challenging and elusive for many years.
HATs activities were grouped in two general classes, based on their presumptive cellular 
origin and function: cytoplasmic B-type HATs and A-type HATs, the latter group being 
involved in transcription- related events and comprising the best studied enzymes GCN5, 
pCAF, CRBB-binding protein (CBP), p300, and TAF250.
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The HATs were also organized into four families, differing in their biochemcal 
properties, summarized in Table 1:
Table 1 Characteristics of HAT families
HM* group
HAT (and complexes 
associated with it)
Interactions with 
other HATs
GNAT Gcn5 (SAGA, ADA, A2) p300; CBP
PCAF (PCAF) 
Hatl (HatB) 
Elp3 (elongator) 
Hpa2
p300; CBP
MYST Esal (NuA4) 
MOF(MSL) 
Sas2
Sas3(NuA3)
MORF
Tip60
Hbol (ORC)
p300/CBP p300 PCAF; GCN5
CBP PCAF; GCN5
Basal TAFII250 (TFIID)
transcription TFfflC^
factors Nutl (mediator)
Nuclear ACTR(: p300; CBP; PCAF
receptor
cofactors
SRCl pBOO; CBP; PCAF
MrpHIC may contain up to three polypeptides with HAT activity (70,71).
"Also known as RAC3, AIBl, POP, and TRAM (162).
For an extensive and detailed review on HATs, see (Roth et al., 2001).
HDACs were first described almost 30 years ago and since then have been 
reported in almost all biological systems, from mammals to yeast (Carmen et ah, 1996). 
In all organisms, the HDACs form a highly conserved protein family, which encode 
isoforms of the enzyme that may differ in substrate specificity, intracellular localization 
and post - translational modification. In mammals at least three proteins HDAC 1-3 have 
been identified, that have correspondents in other organism (see reviews: (Turner, 1993); 
(Grunstein, 1997)).
Both HATs and HDACs are placed at the end of a growing number of signal- 
transduction pathways exerting a tight regulation; the amount of information in this field 
is constantly growing but still limited. For reviews see (Umov and Wolffe, 2001); (Chan 
and La Thangue, 2001).
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An important element of novelty was provided by the discovery that a number of 
nuclear and cytoplasmic proteins are subject to reversible acétylation, other then 
histones: transcription factors, transcriptional co-regulators, retroviral gene products and 
other chromatin components (Kouzarides, 2000) and (Chan and La Thangue, 2001). 
Typically, acétylation appears to modulate diverse functions, like DNA recognition, 
protein-protein interaction, stability and transcriptional potency, working as a rapid and 
reversible regulatory mechanism, much like phosphorylation.
Remarkably, in 2002 two papers were published that referred to the regulation of 
nuclear versus cytoplasmic localization by acétylation for transcription factors HNF4 
and CTIIA (Soutoglou et al., 2000) and (Spilianakis et ah, 2000).
These papers suggest that acétylation posses also a higher- order regulatory effect and 
add other functional meaning to this post-translational modification.
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3.2 RESULTS
In the past, a detailed characterization of post-translational modifications was quite 
challenging because of lack of appropriate technology; when we started to investigate 
this field of research, we decided to take advantage of new tools in protein analysis 
recently developed.
3.2.1 2D electrophoresis as a tool to study protein post-translational
modifications
We chose the bi-dimensional electrophoresis as a first qualitative approach because it 
allows separating proteins according to two independent parameters: the molecular 
weight, that represents the size of the protein (number of amino acids) and the 
isoelectric point (pi) that is an indicator of the total charge of the protein. As a matter of 
fact, a protein consists of a chain of zwitterionic molecules -  the amino acids - and 
therefore can be considered a big zwitterionic molecule per se. That means there is a 
specific pH value at which all the positive charges of the basic residues are balanced by 
the negative charges of the acid ones, resulting in a neutral total charge. This value 
depends on the amino acid composition of the protein, therefore it is a highly specific 
label to mark a polypeptide.
The first step of 2D- electrophoresis consists of an Isolelectrofocusing (lEF) 
step, where proteins are moved, by an electric field, along a gradient of pH, 
polymerized on a strip of acrylamide. Each protein is moved by the electric field in 
either direction of the gradient according to its internal charge until it reaches the 
position where the external pH equals the pi of the protein. There, the protein is neutral 
and it is not sensitive anymore to the power of the electric field, therefore it stops in that 
specific position. At the end of the lEF we assume that every protein has focused in that 
particular position of the pH gradient corresponding to its pi. The proteins are separated 
-  at this step - only on the base of their charge, so at every pH value we can find 
peptides of different size but equal total charge.
In the second step, the strip with the focused proteins is loaded “horizontally” on 
a classical vertical polyacrylamide gel; the gel is run following the classical ID -
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protocol, so that the proteins focused at the same pH value are separated according to 
their size.
This generates a 2D -matrix where every spot, corresponding to a single protein, is 
defined - like in a Cartesian Plane - by two coordinates: the X axis corresponds to the 
p i and the Y axis gives the molecular weight values (see Fig. 9)
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Fig. 9 Explicative scheme of the m ethod o f 2D-electrophoresis, showing the two steps of 
Isoelectrofocusing and PAGE electrophoresis. The result is a matrix, where proteins are represented by 
spots, characterized by two coordinates (red axis)l likewise points of a Cartesian Plane.
Basing its separating potential onto 2 independent parameters, 2D -PA G E  is much 
more powerful then the classical ID- approach, allowing the discrimination of a higher 
number of protein in a total extract.
Modern 2D lEF-PA GE can discriminate a single -charge difference between proteins of 
average dimension (between 20 and 60 KDa). Therefore it provides a valuable tool to
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separate not only different proteins but also differentially modified isoforms of the same 
one. The addition of small groups, like phosphates or acetyls, to a protein is not 
sufficient to generate detectable changes in the total mass of the protein, but is enough 
to generate a pi variation that can be visualized in the lEF step. A protein that is 
multiply phosphorylated or acetylated can be visualized like a train of spots running at 
the same position along the MW (= Y axis), but regularly distributed along the pH (= X 
axis) gradient. The association of this technique with MALDI-Mass Spectrometry 
analysis, used for high resolution-analysis of polypeptides (see below) provides a 
powerful technique to study complex patterns of post-translational modifications.
3.2.2 2D electrophoresis separates mammalian purified HMGBl into several 
spots, corresponding to differentially modified isoforms
We purified HMGBl from calf thymus following the protocol kindly provided by Dr 
Jordy Bemués. Brielfy, a homogenate is prepared from about IKg of thymus and 
subjected to several extractions with PGA, TCA and acetone- HCl; the sample is then 
passed through a CM-Sephadex C25 column (Amersham Pharmacia); the number of 
chromatographic cycles depends on the purity of the sample; positive fractions are 
collected and pooled; the final concentration is assayed by the Bradford method and the 
purity evaluated by monodimensional SDS-PAGE.
Purified HMGBl separated into two major bands in monodimensional SDS-PAGE 
(Fig. 10, left); a major one with an apparent molecular weight of 29 KDa, and a minor 
band that contains HMGBl modified with ADP-ribosyl moieties (Bemuès, personal 
communications).
Fifty micrograms of this preparation were separated by isoelectrofocusing (lEF) 
in a linear pH gradient from 3 to 10, subjected to electrophoresis in a 15% AA gel, and 
then silver-stained. Eight to ten different spots appeared (Fig. 10, right) at similar 
molecular weight but regularly spaced along the pH gradient.
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Fig. 10 2D electrophoresis of purified HMGBl
HMGB 1 purified from calf thymus gives rise on a monodim ensional gel (SDS-PAGE, Coom assie stain, 
right panel) to two bands (arrows): a m ajor one at about 29 KDa apparent m olecular weight, plus a m inor 
one that contains ADP-ribosylated protein. Fifty pg of the same sample o f H M G B l were subjected to 2D 
gel electrophoresis (silver stain, left panel); 5 pi o f 2D Protein M arker from BioRad were loaded together 
with H M G B l, generating a matrix of spots at the molecular weights listed on the right.
A rabbit anti-HM GBl polyclonal antibody purchased from Pharmingen (BD) 
recognized the spots with similar affinity when the 2D gels were blotted on 
nitrocellulose filter and probed by Western Blot; this confirmed that they corresponded 
to different isoforms of the protein of interest (not shown).
To exclude the possibility that the spots were purification artefacts we prepared 
a total extract of thymus from a mouse embryo of 17 days, powdering the Ni-frozen 
organ by mechanical pressure and then dissolved in a lysis buffer Hepes-based, 
containing 0.1% Triton. The extract thus generated was analysed using the same 
approach.
We chose this organ because the thymus is extremely rich in H M G Bl and extremely 
active as endocrine gland. Thymus reaches its complete development and dimensions
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during post-natal life, then it starts to reduce in size and functionality after weaning and 
is almost totally atrophied at the adult stage.
Twin gels were loaded with approximatively 400 pg of total extract; one gel was 
silver stained while the other transferred on a filter and probed with anti-HM GBl. A 
pattern very similar to that seen with purified HM GBl was seen in the Western Blot, 
confirming not only that the modifications are physiological but also that they are 
conserved among different mammalian species (Fig. 11).
pH 3 10 pH 3 10
mu'», .
Fig. 11 2D electrophoresis of total extract from mouse thymus
Total mouse thymus contains many isoforms o f H M G B l. About 300 pg of protein from  a thymus total 
extract (from a mouse em bryo of 17 days) were loaded on two twin 2-D gels; the gel shown on the left 
was silver stained, while the other one was electroblotted onto a nitrocellulose filter and assayed with a 
specific anti-HM GBl rabbit antibody. Note the similarity o f the pattern to that obtained from purified 
H M G Bl (Fig. 10).
The smaller number of spots detected was probably due to the lower quantity of 
HM GBl loaded.
At this point, we eould conclude that:
1) HM GBl is composed by a pool of isoforms differing in their position along the pi 
gradient of the 2D gel;
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2 ) the modifications do not change significantly its molecular mass: between the first 
spot and the last one we detected a very small shifl; on the vertical axis (MW). PT 
modifications that induce such effects are, for example, phosphorylation and 
acétylation; they consist of the attachment of small groups (phosphate- and acetyl- 
groups) to specific residues, which leads to a change in the total charge of a protein; 
the phosphate brings a negative charge to the protein, while acétylation neutralizes 
the positive charge of Lysines and Arginines. The overall effect is a change in the 
pi of the protein while the effect on the total mass of the protein is limited since all 
these groups are quite small;
3) the regular positioning of the spots is suggestive of a single type of modification 
generating the same Apl and the same slight increment in molecular weight;
4) the modification is present to a high extent, since the spots detected are at least 8 - 
10. Every spot corresponds to isoforms of HMGBl that are modified once, twice, 
three times, etc;
5) the 2D-PAGE can discriminate only between increasing numbers of modification 
but not among the sites of modification along HMGBl sequence; thus, every spot 
corresponds to a collection of all molecules of HMGBl containing a specific 
number of modifications, no matter what their position.
In light of these observations, we reasoned that HMGBl can be modified by the 
addition of up to 1 0  modifying groups and that the sites of the modifications, varying 
along the sequence, are not discriminated by the 2D gel. This means that, for 10 spots 
there are at least 2  isoforms containing a different number of modifications in 
different positions along the protein. The huge amount of variability thus generated 
represented a challenge for our investigation, since our goal was the characterisation of 
the type and pattern of HMGBl modification. We had to develop a specific strategy to 
solve this point.
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3.2.3 Principles of Mass Spectrometry to analyse proteins
We chose the Mass Spectrometry approach to investigate the nature of the modification 
in H M G Bl.
MS analysis allows the measurement of the exact mass of a molecule, in this case a 
protein fragment. A Mass Spectrometer is composed of four elements, represented by 
the following scheme:
Mass Spectrometer
Source —► Analyzer —► Detector —► Recorder
Ions counting Data processingSeparation of 
th e  ions 
depending on 
their m /z
As schematised, the separation principle of mass spectrometry is based on the capability 
of separating ionised molecules depending on their m/z (mass /  charge) ratio.
In a spectrometer, each molecule of a mixture is charged by ionisation, accelerated by a 
strong Electric Field and then allowed to cover a specific distance represented by the 
analsyer, by drifting.
In such condition, a specific parameter is associated with every molecule in a sample, 
the Time Of Flight (TOP), defined as follows: “if ions are accelerated with the same 
potential at fixed point and a fixed initial time and are allowed to drift, the ions will 
separate according to their mass-to-charge ratios”. In a mathematical form, this is 
expressed by the following formula:
m 2 t ^ K
t
L
Drift time 
Drift length
z 1} m = Mass
K Kinetic energy of ion
z - Number of charges on ion
The mass/charge ratio of a molecule is proportional to the square of its drift.
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In the past, a problem in the application of this technique to big molecules resided in the 
fact that either they were not ionised enough to he accelerated or that they were broken 
into pieces by the laser beam used in the ionisation step.
These problem were partially solved by the development of MALDI (Matrix- Assisted 
Laser Desorption- Ionisation) Mass Spec, where a protein of interest or a mixture of 
proteins is crystallized on a matrix of variable composition that fulfils different tasks. A 
typical MALDI matrix compound displays a number of desirable properties:
1 ) an ability to absorb energy at the laser wavelength whereas the analyte generally 
does not;
2 ) an ability to isolate the analyte molecules within some form of solid solution;
3) sufficient volatility to be rapidily vaporized by the laser in the forms of a jet in 
which intact analyte molecules (and ions) can be entrained;
4) the appropriate chemistry so that matrix molecules excited by the laser can 
ionise analyte molecules, usually by proton transfer.
The development of more adapted matrixes allowed the analysis of larger molecules, 
like peptides and even entire proteins. Commonly used matrixes are alpha-cyano-4- 
hydroxycinnamic acid and sinapinic acid; they are better suited for the analysis of small 
and large peptides, respectively.
Using this technique, ionised proteins with molecular masses in excess of 200KDa are 
readily observed -this is considerably more then anything previously achieved. 
MALDI, in fact, is applicable to a wide range of biopolymer types: not only proteins, 
but also glycoproteins, oligonucleotides and oligosaccharides, of course with the correct 
choice of the appropriate matix.
Typically, an average-size protein is cut into pieces by use of an enzymatic or chemical 
digestion and the pool of peptides are subjected to MS analysis. Therefore, every 
protein is characterised by a specific “fragmentation- fingerprint” that is visualised by 
the computer connected to the machine as a pattern of spectra, correlating the mass of 
each peptide with its relative intensity/ abundace.
The peptide fingerprint is launched in a specific Database (MASCOT or ProteinSearch 
or others) of experimental and theoretical spectra and the output provided is the match 
with known protein. In this way it is possible to identify a specific protein.
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A different application of Mass Spectrometry, the Electron Spray Ionization (ESI), is 
based on a more mild principle of ionisation. This technique is less easy-to-handle but 
prone to a wider range of applications; for example in the very last years it it has been 
implemented for the micro-sequencing of analyte proteins through their ordered and 
regulated fragmentation: in this way it is also possible to identify new protein sequences 
and enlarge the existing databases. ESI technique is also under development in order to 
gain a straightforward analysis of protein post-translational modifications.
For a general introduction to the concepts and applications of Mass Spectrometry see 
Methods in Molecular Biology, Vol 61: “Protein and peptide analysis by 
MassSpectometry”, Edited by J.R. Chapman, Humana Press Inc.
For a review ahout the application of Mass Spec approach to the identification of gel- 
separated proteins see (Patterson, 1995).
At present, the sensitivity reached by these instruments is high enough to perform the 
analysis of a protein eluted from a band in a ID gel or even from a spot in a 2D gel; the 
combination of the separating potential of 2D - PAGE approach with the analytical 
power of Mass Spec Analysis led to the rise of the Proteomics, a wide-range analysis of 
the protein-world.
Moreover, MALDI analysis can also be applied to characterize the 
modifications of a protein by evaluating, with high precision, the difference-value 
between the experimental masses and the theoretical ones of its fragments: given the 
sequence of a protein, a specifically designed software predicts the theoretical 
fragmentation patterns of different proteases; by comparing this prediction with the real 
mass of the peptides obtained by digestion and ionisation of the protein of interest it is 
possible to derive difference in masses that correspond exactly to the molecular weight 
of the modifying groups (acetyls, methyls, phosphate, etc..) or multiple of these values 
if the protein is multiply modified.
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3.2.4 Mass Spectrometry shows that HMGBl is acetylated
We made use of this second application to study the modifications in H M G Bl.
The four most abundant spots from a 4 -7N L  pi 2D gel stained in Coomassie were cut 
from the gel and in-gel digested 0 /N  with Trypsin, a mammalian protease that cleaves 
the peptidic bond at the C-terminus of Lysines and Arginines. Peptides derived were 
eluted from the gel, desalted and analysed by MALDI: the mass corresponding to each 
digestion product was compared with the theoretical mass, obtained by digesting the 
protein in silico. Fig. 12 shows the steps of the analytical protocol employed, which 
associates 2D-PAGE technique for the separation of proteins to M ALDI analysis to 
identify and characterise each of them.
Cut spot from gel
Enzymatic/chemical
Digestion N - o
Digestion products
MALDIA ANALYSIS
Spectra Deconvolution 
^  Mass Attribution - 
Identification of PT modifications 
Positioning of modifictions
3 - CN-C
Fig. 12 Strategy for 2D /M ALDI-M S analysis o f m ultiply m odified H M G B l
Spots were excised from 2D gels and proteolyzed; the com plex mixture o f oligopeptides was analyzed by 
M ALDI-TOF. A mass was attributed to each peptide in the mixture; the masses corresponding to peptides 
predicted in silico were selected as “anchors” , and we searched the com plex spectra for further mass peaks 
corresponding to anchor masses plus multiples o f 42 (the mw of an acetyl group); the procedure was 
iterated for all peptides. We also mined the spectra for evidence o f phosphorylation, m éthylation and 
glycosylation, without finding any. This information was used to infer the modification pattern on 
H M G B l.
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We found that the mass difference among the peptides detected by MALDI and the 
corresponding predicted ones corresponded to 42 Da, or multiples of 42 Da: the 
modification that generates this type of difference is acétylation.
Acétylation consists of the cross-linking of an acetyl group (-COCH3) to the s-amino 
group of Lysine (R- (CH2 ) 4  -NHS"^ ); this leads to the neutralization of the basic charge 
of Lysine, and therefore decreases the pi of the entire protein moving it towards more 
acidic values (lower pi).
Acétylation was first discovered for histones; in nucleosomes, acétylation has the 
immediate effect of loosening the interactions between the octamer particle and the 
DNA wrapped around it. Acétylation has been found recently in other nuclear proteins, 
especially transcription factor like p53, GATA-1, E2F, where it seems to fulfil a 
regulatory function (Chan and La Thangue, 2001).
HMGBl, as nuclear, DNA-binding protein, is likely to be acetylated, and, in fact, 
Allfiey and his collaborators, more than 20 years ago, published that HMGBl is 
acetylated at Lys2 and Lys 11 (Sterner et al., 1979) and (Sterner et al., 1981).
Our Mass Spec results were in accordance the pattern of spots in the 2D gel, suggestive 
of a modification altering the pi of the protein but not its MW; the number of spots were 
indicated that the number of modification sites was higher than two, as found by Sterner 
et al.
Given all this, the hypothesis that acétylation could play a role in generating isoforms of 
HMGBl with different biological functions looked sound.
3.2.5 A multi-step digestion approach assigns acétylation to specific sites
To further characterise HMGBl acétylation, we started searching for the sites of 
modification.
Even today, the analysis of protein mixtures with 10 or more acétylation sites is 
challenging. Furthermore, HMGBl contains 43 lysines over a length of just 214 amino 
acids, and many are clustered within a single proteolytic fragment.
We devised a niultiple-digestion strategy: we used different site-specific 
proteolytic agents (Asp-N, CNBr, trypsin, Glu-C, Asp-C), both singly and in
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combination, and analyzed the peptides by MALDI. Thus, one or more acétylations 
were assigned to large fragments of the protein (but not to specific lysines), and their 
positions were then progressively restricted inside smaller fragments. This approach is 
similar to mapping DNA sequences with Restriction Endonucleases.
In the example provided in Fig.l3, HMGBl was first digested with Asp-N, and the non- 
acetylated fragments expected from the digestion were identified in the complex pattern 
of MS data. Peaks corresponding to the masses of the non-acetylated peptides plus 42 or 
n-multiples of 42 were presumptively assigned as 1-to-n acétylations of that specific 
peptide. Then, aliquots of the same peptides were further cleaved with CNBr, and 
smaller fragments were obtained. The assignment procedure was iterated, until the 
acétylations could be attributed to specific lysines.
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Asp-N digestion:
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Fig. 13 Example o f the m ulti-digestion strategy adopted to assign specifically acétylation sites 
along H M G B l sequence.
H M G B l was first digested with Asp-N, and acétylations were approxim ately positioned inside big 
fragments; then, peptides were chemically cleaved by CNBr, and the sm aller fragm ents produced were 
analysed further. In this way, the modifications were attributed with higher confidence to residues inside 
smaller fragments. In the optimal condition o f digestion, all the Lysines inside a specific fragm ent can be 
characterized unequivocally.
By analysis of a large set of digestion products (not shown), we were able to assign 17 
acetylated lysines and to exclude modification of 20 lysines; only 6 lysines out of 43 
remained uneharacterized. We could not find evidence of other types of modification; in
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particular, we sought for méthylation, phosphorylation and glycosylation. MS is not a 
quantitative technique, but it was very clear from the data that no lysine was acetylated 
in all HMGBl molecules in the sample. In principle, if each of the lysines we assigned
17
can be acetylated independently, there can exist 2 molecular species of HMGBl; 
however, it appeared that several lysines tend to be acetylated as a cluster
Diqestion 1 Site speciflcitv 1 Diqestion II Site specificity II
Trypsin
Lys- C 
Arg-C; - -
Asp -N Asp -N
— —
CNBr Met-C
— —
VS Glu-C
— —
CNBr Met-C Asp -N Asp-N
Asp -N Asp -N CNBr Met- C ,
CNBr Met-C FA Asp- C
CNBr Met-C VS Glu-C
Table 2 Summary o f  all the combinations o f  proteases used for our analysis.
Collecting and comparing all products obtained form the digestion performed, 
summarized in Table 2, we were able to assign 17 modifications to specific positions 
and to exclude 20 Lysines from modification; only 6 Lysines out of 43 were 
uncharacterised due to no sequence coverage.
Among the acetylated Lysines, we were able to distinguish between those that were 
always found modified and the others, that are modified less frequently: the sites 
acetylated with a frequency of 100% were only 7 and accumulated in two main clusters, 
one inside the boxA and the second in the stretch of aminoacids linking the boxB with 
the acidic tail at the C-terminus of the protein. Eight Lysines were also found acetylated 
but with a lower frequency; they also show clustering.
Remarkably, 20 Lysines were excluded from modification; this provides an important 
result per se, suggesting that acétylation is not really spread homogeneously all over
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HMGBl sequence. Six Lysines remained uncharacterised because the corresponding 
fragments were not found in the MALDI spectra, probably because they are not 
properly ionised and thus they do not fly well. As a confirmation, the unidentified 
residues are grouped in the same areas of the protein.
The number of characterised residues (37/43) was sufficient to gain a good confidence 
in the results of our analysis. They are summarised in F ig . 14.
1 MGKkOPKKPR GKMSSYAFFV QTCREEHKKK HPDASVNFfiE FSKKfSERWK TMSAKEKGKF EDMAKADKARI 70
71 YEREMKTYIP PKKETKKKFK DPN/UPKRPPS AEFLFCSEYR PKIKGEHPGL SIGDVAKKLG EMWNNTAADD
141
211
KOPYEKKAAK LKEKYEKDIA AYRAKGK^DA AKKGWKAEK SKKKMEEEDD EEDEEDEEEE EEEEDEDEEE
DDDDE
140
210
216
Fig. 14 Distribution o f acétylation sites along the sequence o f H M G B l
Lysines (K) are marked with different colours: blue Lys are never acetylated; violet Lys are the 
uncharacterised residues because because o f lack o f sequence coverage; red Lys and green  Lys are the 
acetylated ones, with the difference that red ones were found acetylated in all the analysis performed, 
while green were found to be acetylated less frequently.
The sites attribution is correlated to the domain organisation o f the protein (blue box = H M G Bl box A  and 
boxB, respectively; red box = acidic tail).
The immediate observation was that HMGB1 seems to be acetylated to a higher degree 
than other proteins studied so far.
Typically, proteins are modified only two or three times along the entire sequence; in 
the case of HMGBl, the most abundant spots correspond to the isoforms modified in 
4/5 sites, while both the isoform that is acetylated 9-10 times and the unmodified one 
are quite rare.
Remarkably, acetyl-groups are not uniformly spread along the protein, but they 
tend to generate clusters and to leave some regions completely untouched; for example 
the internal regions of the two HMG-boxes are rarely modified.
We cannot exclude that the clustering is a mere consequence of the fact that 
some regions of the protein are more exposed to the acetyltransferases while others are
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hidden in the protein core. Alternatively, the peculiar concentration of acétylation in 
two main clusters could have a functional meaning.
3.2.6 In vitro acétylation of HMGBl by recombinant and cellular acetyl­
transferases
After discovering acétylation as a major PT modification of HMGBl, we tried to 
modify experimentally the acétylation level of the protein both in vitro and in vivo.
In eukaryotes, a class of enzymes called acetyl-transferases catalyses transfer of an 
acetyl group from Acetyl- Co A to the side chains of Lysines. The first members of this 
family were discovered by a genetic approach in yeast as general transcription co­
activators capable of stimulating the expression of some genes and to compensate 
mutations in other factors involved in transcription, like GCN5 (Georgakopoulos et ah, 
1995).
Further investigation revealed that their function is based on their 
acetyltransferases activity on histone tails, which causes the decondensation of regions 
of chromatin with concomitant increase in the expression of the genes. Therefore, these 
histone-tails modifying enzymes were called Histone-Acetyl-Transferases, or HATs.
In the following years, this class of enzymes increased in numerosity, with the addition 
of several other members with high homology between different organisms. In parallel 
with this, other substrates were found, as described in the introdcuction.
In search of the enzymes that acetylate HMGBl, we set up in vitro acétylation 
experiments using recombinant GST-fusions of known HATs: pCAF and p300 /GBP 
(CREB-Binding Protein). The constructs were kindly provided by A. J. Bannister 
(CRC, Cambridge).
We expressed in bacteria the recombinant GST-fusions and purified them on 
Glutathione-Sepharose beads. We decided to keep the proteins bound to the beads and -  
without eluting them -  we incubated the slurry with bacterially purified HMGBl in 
presence of Acetyl-CoA. In this way, we could easily separate by centrifugation 
the enzymatic activity from the reaction product that was loaded AA gels. Gels were 
Coomassie Stained, dried and exposed to X-ray films.
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The yield of the reaction was measured by autoradiography and quantified by 
densitometry: the intensity of radioactivity was normalised over the total quantity of 
protein estimated by Coomassie staining.
We found that HMGBl was efficiently acetylated in vitro by recombinant pCAF; the 
reaction efficiency was evaluated as 50% of the efficiency of the same enzyme when it 
modifies recombinant histones H3 and H4, its natural substrates and that were used as 
positive controls, Fig. 15.
MK M K " " * "  + - + - +  [^'^CJAcetylcoA
---------------------------------------------------    + pCAF
-  %
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Fig. 15 In vitro acétylation of H M G B l
A set o f soluble purified proteins were incubated with gluthatione-Sepharose-bound GST-pCAF (+) or
14
control gluthatione-Sepharose (-) and [ C]-acetyl-CoA. After incubation, the reaction products in the 
supernatant were separated by centrifugation from the beads and electrophoresed. The gel was Coom assie 
stained (left side), dried and autoradiographed (right). Both bacterially produced full-length HM GB 1 and 
the isolated boxA were efficiently acetylated (lanes 14 and 18, respectively), like histones H3 and H4 
(lane 16); the negative control, lysozyme, was not acetylated (lane 12).
Also the single boxes, boxA and boxB were tested and showed similar modification 
efficiency (see Fig. 15, lanes 8 , 9 and 17, 18 for boxA, while the acétylation yield for 
boxB is not shown). We used lysozyme as negative control to detect unspecific 
reaction, but no radioactive bands were found on the autoradiographic film 
corresponding to its position.
Analogous results were obtained when recombinant CBP/p300 were tested as 
modifying activity even if with lower efficiency (data not shown).
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Since the pCAF and CBP/p300 are the most common and the best-known acetyl­
transferases, we did not extended our investigation to other HATs that were less 
characterised.
We then tried to confirm this result by using native acetylatransferases immuno-purified 
firom total cell Lysates with specific antibodies. pCAF (about 90 KDa) could be 
efficiently immuno-precipitated firom HeLa or 3T3 cell extracts (Fig. 16, left), and its 
enzymatic activity was tested using recombinant histones H3 and H4 as substrates. 
Protein p300/CBP was immunoprecipitated as well, even if with less efficiency, due to 
its high molecular weight (about 240 KDa) that renders the purification and 
characterisation procedures much more challenging.
Once we were sure that the enzyme was bound to the beads, HMGBl was incubated 
with it in presence of radioactive Acetyl-CoA, (see Methods, section 2): this reaction 
produced a less efficient, but specific, labelling of HMGBl (Fig.l6, right).
This result confirms that native HATs, purified by total extracts, can recognise our 
protein as specific substrate. In this type of experiments the amount of purified enzymes 
used in every assay is much lower then in the previous assay performed with 
recombinant HATs, therefore the idea that HMGBl acétylation was due to a specific 
recognition of a “real “ substrate (and not only due to the proximity of two unrelated 
reagents at high concentration) gained further support.
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Fig. 16 Acétylation of H M G B l by im m unopurified pCAF
Native pCAF was im m unoprecipitated from mouse 3T3 fibroblasts with specific anti-pCAF polyclonal 
antibodies and Protein-A  Sepharose. The efficiency of im m unoprécipitation was tested by western 
blotting: the immunoprecipitated protein (IP-pellet, lane 4) was com pared to aliquots o f pre-incubation 
extract (Input) and o f flow-through (Output) (lanes 2 and 3, respectively). Im m unoprecipitated pCA F was 
incubated with recom binant histones H3 and H4, recom binant full length H M G B l and its AC derivative
14
(lanes 5, 7, 9, respectively). As negative control, no [ C]-acetyl-coA was added to the reaction mix in 
lanes 6, 8 and 10.
3.2.7 In vivo A cétylation of H M G B l
Based on the results of the in vitro acétylation assays, we speculated that H M G B l, like 
histones, undergoes in the cell cycles of acétylation/ deacetylation due to the activity of 
acetyltransferases and deacetylates.
Enzymatic activities classified as “HDAC (Histone- DeACetylases)” cleave acetyl- 
groups from Lysines residues. Specific drugs are known that inhibit this reaction; the 
effect of these drugs is, therefore, the hyperacetylation of histone tails and of other 
nuclear factors (Johnson and Turner, 1999).
Commonly used inhibitors are Sodium Butyrate, Trichostatin A and, more recently, also 
HCtoxin. They were first studied as anti-cancer drugs and then employed also in basic 
research; they differ for their specificity and toxicity: Sodium Butyrate, for example, 
has a general cell toxicity and therefore is the less used in studies in vivo, while the last
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discovered -  HCtoxin -  is much less dangerous for the cells. Usage of these inhibitors 
allowed to define the existence of a dynamic cycle of acétylation /deacetylation, whose 
steady state correspond, for every single protein, to a specific level of modification.
The kinetics of both acétylation and deacetylation are quite high: every protein in basal 
conditions constantly undergoes cycles of acétylation /deacetylation with a specific 
steady state where the two reaction are balanced. Upon specific stimuli, proteins get 
hyper- or under- acetylated. By using deacetylase inhibitors, we can unbalance the 
steady stated towards the hyper acétylation of a protein that is a natural substrate of 
native HATs: we treated 3 different cell -  lines (3T3 mouse fibroblast, Hela human 
cells, Phoenix cells) with the three known HDAC inhibitors.
We first performed titration experiments to define the minimal concentration of 
drugs that is effective in inducing hyperacetylation of histone tails without eliciting 
toxic effects. Total extracts firom treated cells were prepared, loaded on SDS-PAGE and 
then transferred on PVDF filters; the abundance in acetylated Lysines in histone H4 was 
determined by western blot using a specific anti- acetyl-H4 kindly provided by my 
external supervisor. Prof. Bryan Turner (Birmingham).
Instead, to determine the level of acétylation of HMGBl we had to use the 2D PAGE, 
since we could not take advantage of a specific anti-acetyl-HMGBl antibody: therefore, 
the extracts were loaded on 2D gels and blotted on nitrocellulose filters. Each extract 
firom different treatments (TSA, NaButyrate, HO toxin) was compared with the extract 
obtained firom untreated cells: Fig. 17 shows that, while untreated cells showed only 
two spots corresponding to two different isoforms of HMGBl, all HDAC treatments 
generated a train of spots, similar to the pattern detected with the purified protein.
The new spots are shifted to the more acidic part of the pH gradient, that is highly 
suggestive of acétylation.
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Fig. 17 HDAC inhibitors trigger hyperacetylation of H M G B l
3T3 cells were incubated for 6 hours in DM EM , or DM EM  supplem ented with 10 ng/ml TSA, then 
collected and lysed. A bout 400 pg of whole cell extracts was loaded in duplicate on two 2D gels and then 
blotted on nitrocellulose; patterns o f H M G B l were revealed with polyclonal anti-H M G B l antibody. 
Upon inhibition of HDACs (right), several H M G B l spots appeared, com pared to only 2 in control 
fibroblasts (left).
Our conclusion from this experiment is that, in basal conditions, the steady state of 
H M GBl acétylation/ deacetylation maintains the protein to a level represented in 2D- 
PAGE by two spot:
HDAC
CD
HATs
Whenever this balance is perturbed by inhibition of deacetylation, H M G Bl gets 
hyperacetyl ated
The time course of inhibition indicated that the maximal level of acétylation is reached 
between 3- 4 hours of treatment, but that already 90 minutes are sufficient to detect a 
train of spots: this confirms the evidence found in literature that referred to a quite 
dynamic process and of a high acetylation/deacetylation rate (Fig. 18).
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Fig. 18 Time course of H M G Bl acétylation upon TSA treatment
3T3 cells were treated with 10 ng/ml TSA and samples were stopped at different time points; total cell 
lysates were prepared by freeze-thawing and acétylation o f HM GBl was detected by 2D electrophoresis 
and Western Blotting using anti-HMGBl antibody. The efficiency o f the reaction is determined by 
evaluationg the intensity o f novel spots produced upon drug treatment normalised against the intensity o f  
basal spots.
3.2.8 Lysines 27-43 define the boundaries of the Nuclear Localisation Signal of 
HMGBl
Mass Spec analysis, performed on a sample of protein purified from calf thymus, 
provided intriguing hints about a preferential clustering of the acétylation sites in 
HMGBl. We reasoned that this clustering could have specific meaning, and decided to 
investigate the functional effect of these modifications on the activity of HMGBl in the 
cell.
Like most nuclear proteins, also HMGBl should contain a sequence, named Nuclear 
Localisation Signal that selectively directs proteins to the nucleus, mediating their 
interaction with the protein of the nuclear pore complex. As a matter of fact, HMGB 1 is 
small enough to pass by simple diffusion through the nuclear pore; however, NLSs 
mediated nuclear import does not simply regulate nuclear import by size, but more
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generally appears as an answer of the cell to the demand of selectivity and specificity 
for nuclear localisation: only the correct cargoes are imported (and exported) at the 
proper time. NLS signals contribute crucially to the fidelity of this system, but they are 
not the only players in the classical nuclear import mechanism: importins a  and p, and 
Ran are also involved (for a review see (Gorlich, 1998)).
The NLSs have been precisely characterised in several nuclear proteins, both by 
introducing mutations that destroy their function and by fusing the regions of interest to 
cytoplasmic proteins with the aim to test their capability to redirect them to the nucleus. 
This approach showed that these signals can be located almost anywhere in the amino 
acid sequence and that they can have different lengths, but that they require at least one 
main feature: abundance of positively charged residues Lysines and Arginines, with the 
presence also of one or two prolines.
Most NLSs can be grouped in two classes: monopartite NLSs that consists in a 
short stretch rich in basic amino acids ( 5 - 8  residues long) and bipartite NLSs, in which 
the positively charged residues are split into two blocks of two to four aminoacids each, 
separated from each other by about 10 - 12 amino acids. Bipartite NLSs were found in 
well known nuclear proteins like p53, hPR, etc.
Luca Falciola in our lab had done preliminary experiments that pointed to region 27 - 
43 in HMGBl as its Nuclear Localization Signal, with the characteristic consensus of 
classical bipartite NLSs: two stretches of 2-3 basic residues (Lys or Arg), separated by 
12 amino acids (Fig 19)
ra t  HMGBl 
Human p53
human Progesterone Receptor 
Xenopus Nucleoplasmin
26 KKKHPDASVNFSEFSKK
KRALPNNTSSSPQPKKK
RKCCQAGMVLGGRKFKK
KRPAATKKAGQAKKKKL
43
Fig. 19 Identification of N L Sl in H M G Bl
Amino acids 27-43 o f HM GBl were compared with previously characterized bipartite NLSs: this 
sequence matches with the NLSs o f human p53, progesterone receptor and Xenopus nucleoplasmin.
90
To prove the fiinctional significance of the presumptive NLS, we chose the classical 
fusion approach: we assembled a DNA- cassette coding for sequence 27 - 43 and we 
cloned it at the 5 end of the GFP gene inside the vector pEGFP-Nl (see paragraph 2.2).
We compared the NLS-GFP construct to the GFP expressed in transiently transfected 
HeLa Cells. Unfused GFP was distributed all over the cell, whereas about 90% of 
fluorescence from the NLS-GFP fusion was concentrated in the nucleus (Fig. 20 A). 
Thus, amino acids 27-43 can provide a functional NLS for HMGBL 
Since lysines 27, 28, 29 are among the most frequently acetylated, we examined the 
possibility that acétylation of the NLS was related to the sub-cellular localization of 
HMGBL We therefore mutated lysines 27-29 of the HMGBl-GFP ftision into 
glutamines to mimic acétylation; we also frilly destroyed the NLS by changing the 3 
lysines into alanines.
Surprisingly, neither mutation affected the nuclear localization of HMGBl-GFP, 
suggesting that an element other then aa 27-43 might contribute to locate HMGBl into 
the nucleus (Fig. 20B).
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NLS GFP
HMGBl HMGBl
KKK->QQQ KKK->AAA
Fig. 20 Experim ental identiHcation o f N L S l and point m utation approach.
(A) The presumptive bipartite NLS o f H M G B l was fused to GFP and expressed in H eLa cells: while the 
N L S-G FP  fusion is predominantly nuclear, GFP alone is broadly diffuse. (B) Lysines (K) 27, 28, and 29 
of H M G B l-G F P  were changed into glutamines (Q) or alanines (A): neither mutation altered the nuclear 
localization of the fluorescent protein.
This hypothesis was further strengthened by the observation that other proteins of the 
HMG-box family make use of two independent NLSs, (Sudbeck and Scherer, 1997).
We then started hunting for other NLSs in H M G Bl.
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3.2.9 HMGBl has a second monopartite NLS (NLS2)
By visual inspection of the HMGBl sequence we could not find any other canonical 
NLS, so we took advantage of the database available at
http://cubic.bioc.columbia.edu/predictNLS, which offers a collection of experimentally 
verified plus in 5 ///co-generated NLSs (Cokol et ah, 2001), to help us predict additional 
NLSs in HMGBL
The region between aa 178-184 appeared as a good candidate for a monopartite 
NLS motif: typically, these are characterized by a cluster of basic residues preceded by 
a helix-breaking residue, but some variations are possible (Boulikas, 1993). When this 
sequence was launched in the database, it was not identified as an already known NLS, 
but it matched at highest similarity with several proteins, 93% of which were nuclear 
(Fig. 21A).
HMGB1 rat 179EKSKKKK185
database
i
NLS2 GFP'
19 hits: 17 nuclear
EKSKKKK HMGBl rat
QKSKKKK ZFY1 mouse
KKSKKKK TF3A bufam
DKSKKKK SSRP1 mouse
SKSKKKK GATA-C Drosophila
B
Fig. 21 Bioinformatic and experimental identification of a second NLS in H M G Bl
Sequence segments o f HM GBl were launched into the PredictNLS database: the 178-184 segment 
matched with 19 proteins in the database, 17 o f them nuclear proteins. This constitutes a good indication 
for a potential NLS, that we named NLS2. The presumptive NLS2 was fused to GFP and expressed in 
HeLa cells, showing a predominantly nuclear distribution.
Based on this, we tested the nuclear-translocation activity of aminoacids 178-184 of 
HMGBL The DNA sequence coding for it was fused in frame at the 5’ of the GFP in
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the pEGFP-Nl vector: the pNLS2-GFP construct was thus generated. We transfected 
HeLa cells with pNLS2-GFP and inspected its localisation: more then 90% of the 
fluorescence was concentrated into the nucleus, proving that also this region works as a 
Nuclear Localisation Signal (Fig. 21B).
Thus, HMGBl is endowed with 2 motifs with NLS activity: we called the bipartite motif 
NLS 1 and the monopartite motif NLS2. Remarkably, also NLS2 corresponds to a cluster 
of hyperactylated lysines.
Point mutation analysis was operated on Lysines 181-183; as before, we switched 
Lysines into Glutamines and Alanines, to test the effect of mutations mimicking 
acétylation and inactivation respectively: the mutants showed no relocalization in the 
cytoplasm but behaved exactly like the wild type fusion (Fig. 22).
1 HM GBl GFP I I HM GBl | GFP
KKK->QQQ KKK->AAA
Fig. 22 Point mutation approach to investigate the role of acétylation on NLS2
Lysines 181, 182 and 183 o f HM GBl-GFP were mutated into glutamines (Q) or alanines (A) and mutants 
transiently transfected in HeLa cells: neither mutation caused the cytoplasmic localization o f H M G B l-  
GFP.
Thus, we concluded that each motif is per se sufficient to drive HMGB 1 to the nucleus, 
but not necessary: destructive mutation of a single NLS at a time is not enough to 
induce HMGBl accumulation in the cytoplasmic compartment.
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3.2.10 Double mutation of NLSl and NLS2 induces redistribution of HMGBl in 
the cytoplasm
Double mutants of H M G B l-G FP, where both lysine clusters in N LSl and NLS2 are 
changed to glutamines or alanines, were then constructed.
W ith both mutants, fluorescence was redistributed to the cytoplasm, with 
comparable efficiency (Figure 23 A, B). The double NLSl/NLS 2 mutant where lysines 
are changed to arginines (K->R), showing a nuclear localisation, confirmed that the 
mutagenesis per se is not perturbing the natural destiny of the protein (Fig. 23 C).
B
2x (KKK->QQQ) 2x (KKK->AAA) 2x (KKK->RRR)
Fig. 23 Inactivation of both NLSs redistributes H M G Bl-G FP to the cytoplasm
In HeLa cells, mutations of the 6 lysines in the 2 NLSs into glutamines (as a mimic of acetyl-lysine. A) or 
alanines (B) produce a clear cytoplasmic fluorescence of com parable intensity. As negative control, a 
m utant in which the 6 lysines are mutated to arginines did not alter the nuclear localization o f H M G B l-  
GFP (C). Bar represents 10 pm in all panels.
On the other side, the cytoplasmic location of double K->Q and K->A suggested to us 
that acétylation on the two NLSs modulates their function and therefore influence the 
nuclear accumulation of HMGB 1.
One important point is that the cytoplsmic accumulation of K->A and K-> Q mutants is 
still not complete and a fraction of the protein is still detectable in the nucleus. The size
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of the protein does not exclude that some molecules manage to cross the nuclear pore 
by simple passive diffusion.
Then, the NLSs are not the sole activities that may direct HM GBl to the nucleus; 
presumably, the interaction of HM G Bl with its partner proteins and with DNA tilts 
somewhat its diffusion equilibrium towards the nucleus.
As a third possibility, H M G Bl may have other NLSs: at least other two regions rich in 
Lys and Arg could fulfil the consensus requirements of a monopartite NLS. Anyway, 
we did not investigate further this aspect that remains to be clarified.
From a biochemical point of view, acétylation neutralises the positive charges of 
Lysines, which are the “label” of all known NLSs. Since NLSs are the target of 
acétylation, acétylation may prevent the nuclear accumulation of H M G Bl. This 
assumes that HMGB 1 also migrates from nucleus to cytoplasm.
A) B)
NUCLEUS
HMGBl
\
\
\
CYTOPLASM NUCLEUS
\
\
\
CYTOPLASM
/
/
/
o
1
1
/
► ■
As represented in the scheme above, under basal conditions the steady state of HMGB 1 
shuttling in and out of the nucleus in unbalanced towards import and the protein 
accumulates into the nucleus (A). W hen HM GBl gets hyperacetylated in its NLSs, the 
import is strongly reduced; this results in accumulation of HM GBl in the cytoplasmic 
compartment (B).
In this case acétylation regulates a protein function by altering its natural distribution in 
cellular compartments. There are very few cases known where a post-translational 
modification exerts a regulatory role via such a mechanism: so far, a similar regulation 
has been reported for HNF4 and CTIIA (Soutoglou et al., 2000); (Spilianakis et al., 
2000) but with the opposite effect (acétylation promotes nuclear accumulation). Very
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recently, acétylation was shown to restrict El A to the cytoplasm (Madison et ah, 2002). 
We will discuss this point further in the next section.
3.2.11 HMGBl has non-classical Nuclear Export Signals
Our model that acétylation reduces the efficiency of HMGBl nuclear import causing its 
accumulation in the cytoplasm is based the hypothesis that HMGBl recycles between 
nucleus and cytoplasm and that nuclear import is somehow balanced by a corresponding 
export. The investigation was carried on in collaboration with Paola Scaffidi in our 
group, who provided preliminary in vivo experiments described in this paragraph; I 
completed her work with the in vitro interaction assays.
To test whether HMGBl (mw 25 kDa) can pass to and firom the nucleus by simple 
diffusion across nuclear pores, Paola incubated HeLa cells at 4°C for 4 hours, a 
condition that impedes active, GTP-driven nuclear import/export. After cold incubation, 
a part of HMGBl diffused back to the cytoplasm; the same was true for HMGBl-GFP 
(not shown).
However, many small proteins that are able to cross the nuclear membranes by 
passive diffusion are also endowed with a Nuclear Export Signal (NES) that promotes 
active nuclear extrusion of the protein. To test for active export, Hmgbl-I- mouse 
embryonic fibroblasts (Falciola et ah, 1997) were fused with HMGBl-positive human 
HeLa cells. Human cytoplasm was identified by staining with anti-human cytokeratin 
antibodies (red. Fig. 24), mouse nuclei by their bright DAPI-positive heterochromatic 
whitish spots over a blue background. Cells with human cytokeratin and a mouse 
nucleus were heterokaryons. HMGBl is 99.5% identical in mouse and human, and its 
nuclear presence was scored with green fluorescent antibodies. Shortly after fusion, 
mouse nuclei in heterokaryons had very little HMGBl (not shown), but 4 hours at 37°C 
(in the presence of cycloheximide to inhibit protein synthesis) were generally sufficient 
to equilibrate evenly HMGBl between the human and the mouse nucleus (Fig. 24 A 
and B).
By itself, this result just indicates that HMGBl can traverse the nuclear membranes
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from the nuclear side to the cytoplasmic side, and does not show that the export is 
active. However, active export that involves the CRMl exportin can be inhibited by 
leptomycin B. We then treated heterokaryons with leptomycin, and noticed that re­
equilibration of HMGB1 between human and mouse nuclei was strongly reduced.
contro
L_l leptomycin
< 5% 5-30% 40-50%
HMGB1 in mouse nucleus
Fig. 24 H M G B l m igrates from  nucleus to cytoplasm  by both passive and active transport (courtesy  
o f P. Scaffidi)
(A) Heterokaryons were formed by fusing HM GBl-expressing HeLa cells (human) and H m gbl-I- mouse 
embryonic fibroblasts. Human cytokeratin and HM GBl were stained red and green, respectively, with 
specific antibodies; nuclei were stained blue with DAPI. Cells with human cytokeratin staining and two 
nuclei, one o f which with bright DAPI-positive heterochromatic spots characteristic o f mouse cells, were 
considered heterokaryons. After incubation at 37°C for 4 hours, HMGB 1 re-equilibrated from human to 
mouse nuclei, indicating that it could pass from the nuclear to the cytoplasmic side o f the nuclear 
membranes, and be taken up by the other nucleus.
(B) Treatment o f (number) heterokaryons (produced and scored as in panel A) at 37°C for 4 hours with 
leptomycin B substantially reduces, but does not abolish, HM GBl transfer between human and mouse 
nuclei. The 50% level o f HM GBl in recipient mouse nuclei is equivalent to complete equilibration.
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By visual inspection, an approximative quantitation of the intensity of green 
fluorescence suggested that in the vast majority of leptomycin-treated heterokaryons 
approximatively less than 5% of HMGBl had migrated to the mouse nucleus after 4 
hours (in the controls, almost 50% of nuclei had equilibrated).
These results indicate that HMGBl has a NES that interacts with the CRMl 
exportin (the target of leptomycin). I then synthesized labeled CRMl in a reticulocyte 
extract, and passed it over columns that contained GST-NS2 (NS2 is strong nuclear 
export signal used as positive control), BSA (a negative control), HMGBl AC 
(BoxA+B), Box A or BoxB. CRMl bound to both HMG boxes, indicating that each 
contains an NES. When 400 nM leptomycin was added to the reticulocyte extract 
containing CRMl, the labeled protein did not bind to the either NS2 or HMGBl AC, that 
contains both NESs (Fig. 25).
GST-NS2 Seph-BSA Seph-BoxA+B Seph-BoxA Seph-BoxB
In B W4 O B W4 O B W4 O B W4 O B W4 O
h"  H
3 4 5 6 7 8 9 10 11 12 13 14 15 16
+ leptomycin -leptom ycin
GST-NS2 Seph-BoxA+B GST-NS2 Seph-BoxA+B
In B W4 O B W4 O B W4 O B W4 O
17 18 19 20 21 22 23 24 25 26 27 28 29
Fig. 25 Pull down assays to test the interaction o f H M G B l and derivatives w ith C R M l
In vitro translated CR M l, labelled with [^^S]-Methionine, was incubated with Sepharose beads 
conjugated with recombinant HM GBl (boxA+boxB), the single boxes (boxA and boxB) and BSA  and 
GST-NS2, respectively. After incubation slurries (B) were washed 5 times (W 4= fourth wash) and then 
loaded on a Laemmli Gel, together with an aliquot o f the input (In) and output (O). The gels were then 
dried and exposed to X-ray film to detect the presence o f labelled CRMl in different fractions.
99
3.2.12 HMGBl secreted by LPS-activated macrophages is hyper-acetylated
Despite its usual nuclear localisation, several cell types under specific circumstances 
also secrete HMGBl. The HMGBl secretion pathway is obviously interesting, and is 
likely to involve the import-export signals that we had identified.
We focused on the secretion of HMGBl in monocytic cells described recently by 
Gardella et al. (Gardella et al., 2002). Resting monocyes firom human peripheral blood 
contain nuclear HMGBl; upon challenge with LPS, monocytes accumulate a major 
portion of HMGBl into cytoplasmic vesicles. Translocation takes about 16 hours and is 
not inhibited by cycloheximide. Secretion of HMGBl does not follow the classical 
pathway via ER and Golgi apparatus since the protein does not possess the leader 
sequence driving it to the ER. Like other leaderless proteins, HMGBl follows an 
alternative pathway, still not thoroughly characterised. Secretion of HMGl, involves a 
specific type of vesicles, called secretory lysosomes (Gardella et al., 2002).
The coincidence between NLSs and acétylation clusters in the HMGBl purified fi*om 
calf thymus suggested that vescicular accumulation might follow firom cytoplasmic 
localisation and would depend on the acétylation of HMGBl.
To confirm our model, we estabilished a collaboration with the group in Genoa to study 
the biochemical properties of secreted HMGBl. Rubartelli’s group has the expertise to 
prepare cultures of monocytes fi*om Buffy Coats, to activate them via pro-inflammatory 
molecules, and to also to purify the endolysosomal vesicles fi*om a total cell extract by 
ultracentrifugation.
We treated with LPS monocytes purified from Buffy Coats and checked HMGBl 
accumulation in cytoplasmic vesicles by imaging (Fig. 26).
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control monocytes LPS treated monocytes
Fig. 26 LPS-activated human monocytes accumulate H M G Bl in cytoplasmic vesicles
Primary monocytes purified from peripheral blood cells were cultured overnight, in the presence or 
absence o f 100 ng/ml LPS. Aliquots o f activated and control monocytes were then fixed and 
immunostained with anti-HMGBl rabbit antibody (red). Note the exclusively nuclear localization o f  
HMGB 1 in unstimulated monocytes, as opposed to nuclear plus vesicular HMGB 1 localization in LPS- 
activated monocytes.
We generated total extracts from resting and activated monocytes and analysed them by 
2D electrophoresis and western blotting.
Remarkably, while resting monocytes show only two isoforms of HMGBl, likewise all 
the other cell lines tested so far; in LPS -activated monocytes the redistribution of 
HMGBl in to cytoplsmic vesicles parallels the appearance of a major additional spot 
(Fig. 27).
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#
control monocytes LPS treated monocytes
Fig. 27 2D electrophoresis of control and activated monocytes reveals HM GBl hyperacetylation
Aliquots o f untreated and LPS-activated monocytes were lysed by freeze-thawing, and about 400 ^ig of 
total protein extract were loaded on 2D gels, blotted onto nitrocellulose filters, and im m unodetected with 
anti-H M G B l. Note the major additional H M G B l spot in activated monocytes (right).
The spot is approximatively at the same molecular weight of the two “baseline” ones, 
but at a lower pi. The software ImageMaster 2D, specifically designed to calculate the 
pi of a spot form its position in a gel and to estimate the number of specific 
modifications corresponding to a defined Apl, predicts that the novel spot corresponds 
to HMGB 1 acetylated 4 or 5 times more than the rightmost baseline spot. The absence 
of intermediate spots between “activated” and baseline spots suggests that in monocytes 
the acétylation of HMGB 1 is not gradual but highly concomitant.
All this evidence establishes for the first time a correlation between H M G Bl 
distribution in the two major compartments of the cell and its level of acétylation: 
macrophages, and in a similar way others cells, may make use of acétylation to exclude 
HMGB 1 from the nucleus and accumulate it in the cytoplasm, to subsequently direct it 
to the secretory pathway.
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3.2.13 Acétylation of HMGBl determines its relocation to the cytoplasm in 
fibroblast and to vesicles in moncytic cells
The results showed above provided a first correlation between acétylation of HMGBl 
and its sub-cellular localization in primary monocytes.
To further confirm the role of acétylation, we performed experiments with fibroblasts, 
that do not contain secretory lysosomes, and with U937 monocytic cells, that do contain 
them.
TSA treatment for 3 hours of 3134 mouse fibroblasts transiently expressing GFP- 
HMGBl was sufficient to relocate a significant amount of HMGBl to the cytoplasm 
(Fig. 28), suggesting that hyperacetylation can force HMGBl to relocate to the 
cytoplasm in most cells.
fibroblasts Hoechst HMGB1-GFP
control TSA
Fig. 28 GFF-HM GBl relocation upon TSA treatment in 3134 mouse fibroblasts
3134 fibroblasts were left untreated (left) or exposed to 10 ng/ml TSA for 3 hours (right); cells then were 
fixed with PFA and directly imaged by fluorescence microscopy (green): a significant relocation o f  
HM GBl-GFP to the cytoplasm could be detected; no vesicles are recognizable, due either to lack o f these 
structures in fibroblast cells or to inability o f the GFP fusion to be loaded inside vescicles.
The same experiment was then performed with U937 cells; we chose U937 as they are a 
promyelocytic cell line that can be activated to a monocytic-like stage upon treatment 
with differentiating factors. Therefore, they provide a good model to study response of 
monocytes to stimuli, with the advantage that, being a cell line, they have a more 
consistent and more homogenious behaviour than primary monocytes, whose high
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variability in different donors had complicated our work.
Different subelones of U937 cells perform differently in cytokine seeretion; for this 
reason, we chose a defined subclone, 12[-], with a well-established profile of plasma 
membrane moleeular markers and functional responses (Biswas et al., 2001); (Bovolenta 
et al., 1999).
U937.12 cells paralleled elosely the behavior of primary monocytes: resting cells 
contained HMGBl in the nucleus, whereas LPS-activated ones redistributed a 
significant fraction of the protein into cytoplasmie vesicles (Fig. 29, lower panels). 
However, the reloeation was mueh faster than in monoeytes, and was clearly visible 
starting 1 hour after stimulation.
To test whether HMGBl loealization was directly determined by its acétylation 
status, we treated U937.12 cells with 10 ng/ml TSA for 3 hours: a fraction of HMGBl 
started to shift to cytoplasmic vesicles (Fig. 29, arrows). Remarkably, this occurred in 
the absence of the cytoplasmie expansion, nuclear reshaping (form circular to 
horseshoe) and substrate adherence that accompanies activation by LPS.
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H oechst anti-HM GBl m erge
control U937
TSA trea ted  U937
LPS trea ted  U937
Fig. 29 H M G B l relocalisation after LPS and TSA treatm ent in U937 pro m onocytic cells
U937.12 cells were cultured without stimulation or in the presence of 10 ng/ml TSA  for 3 hours or 100 
ng/ml LPS for 20 hours. Stimulated and control cells were fixed and im m unostained with anti-H M G B l 
antibody (red). Note the nuclear localisation o f H M G Bl in resting monocytes, and the nuclear plus 
vesicular localisation of H M G Bl in LPS-activated monocytes, that display a much larger cytoplasm and 
horseshoe-shaped nuclei. TSA treated monocytes do not show cytoplasmic expansion or nuclear 
reshaping, but a fraction of HMGB 1 is relocalized to cytoplasmic vesicles.
In parallel, A. Agresti, in our group, also tested whether hypoacetylated HM GBl could 
be taken up by secretory lysosomes: she incubated U937.12 cells for several hours at 
4°C, causing the passive diffusion of a significant fraction of HMGB 1 to the cytoplasm, 
and then raised back the temperature to 37°C. Within 5 minutes, H M G Bl was 
accumulated in secretory lysosomes. Likewise, HM GBl liberated into the cytoplasm by
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the breakdown of the nuclear membrane during mitosis (Falciola et ah, 1997) was also 
accumulated into secretory lysosomes (not shown).
The results of these two experiments provided a further confirmation of what we had 
already derived from the experiments performed by P.Scaffidi: nuclear import is an 
active process that requires energy and therefore the right temperature to take place, 
while nuclear export consists of two processes, one active and the other passive.
The cytoplasmic accumulation of HMGBl in vesicles provides an important piece of 
information: acétylation is not absolutely required for a specific translocation of 
HMGBl into the endolysosomes, contrary to our expectations.
The model emerging would rather suggest that acétylation only plays a role in switching 
HMGBl from nucleus to cytoplasm; once HMGBl is accumulated into the cytoplasm, 
by default - or at least without any other known signals- it is loaded into the vesicles. So, 
the two events are temporarily connected, but only the former process so far seems to be 
regulatable.
This aspect and its implications will be debated in the discussion (3.3)
We also tried to express -  either transiently or stably -  the construct HMGBl-GFP, and 
the NLSs mutants in the U937.12 clone.
GFP-HMGBl expressed in U937.12 was shuttled from nucleus to cytoplasm in response 
to LPS and TSA, but was unable to proceed further into secretory lysosomes, and much 
less to be secreted (not shown). Also the constructs coding for the double NLS1/NLS2 
mutants (double K->A and double K->Q) fused with GFP were both transiently and 
stably expressed in U937: their localisation is mainly cytoplasmic in resting U937 cells, 
confirming their phenotype in fibroblast cells (not shown). The double substitution from 
lysines to arginines was lethal to U938.12 cells, and could not be tested.
We did not go further in this analysis: the inability of the GFP-fusion to be translocated 
into secretory lysosomes could be due to the size of the protein or to a specific problem 
of folding. We judged that it did not provide a good model to study vesicular 
accumulation.
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3.2.14 Acétylation of HMGBl is controlled via the ERK MAP Kinase pathway (in 
collaboration with A. Agresti)
The experiments reported above indicate that U937.12 cells acetylate and accumulate 
HMGBl in vesicles in response to activation. Therefore, acétylation or deacetylation 
activities (at least on HMGBl) must be controlled by signal transduction pathways that 
start with the engagement of receptors for TNF-a, IL-ip, LPS, HMGBl itself and/or 
other pro-inflammatory ligands. The secretion of TNF-a, IL-1, IL-8, and PGEi by LPS- 
stimulated monocytes can be blocked by inhibiting ERK phosphorylation (Scherle et 
al., 1998). A. Agresti therefore tested whether the same was true for HMGBl 
acétylation and vesicular accumulation. U937.12 cells were exposed to 200 ng/ml LPS 
in the presence of 10 pM U0126 (a specific inhibitor of ERK phosphorylation) or 1 pM 
SB203580 (a specific inhibitor of the p38 kinases). Control cultures were not exposed to 
LPS, or exposed to LPS but no inhibitors. HMGBl translocation was substantial in cells 
exposed to LPS alone, or LPS plus SB203580, but was almost completely blocked in 
cells exposed to LPS plus U0126 (Fig. 30; more than 95% of the cells had the 
morphology shown). Both kinase inhibitors had no effect on U937.12 cell viability, nor 
on cytoplasm expansion and nuclear reshaping that follow activation.
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no LPS, no inhibitors LPS, no inhibitors
LPS, SB203580 LPS,U0126
Fig. 30 LPS-induced relocalisation of H M G Bl is regulated through the MAPkiuase pathway 
(courtesy of A. Agresti)
U937.12 clone cells were stim ulated with 200 ng/ml LPS in the presence o f  1 pM  SB203580 (lower left 
panel) or 10 pM  U 0126 (lower right panel). Control cultures were not exposed to LPS, or exposed to LPS 
but no inhibitors (upper left and right, respectively). H M G B l translocation was substantial in cells 
exposed to LPS alone, or LPS plus SB203580, but was alm ost com pletely blocked in cells exposed to 
LPS plus U0126 (1cm = 8 pm ). Blue= DAPI, red= a -H M G B l.
These results indicate that ERK kinases (but not p38 kinases) are involved in the control 
of HMGBl acétylation and translocation. ERKl and 2 migrate to the nucleus when 
phosphorylated by the kinase MEKl (the step that is inihibited by U0126), and, in turn, 
phosphorylate several transcription factors that promote the expression of a number of 
genes. For example, secretion of TNF-a involves transcriptional upregulation of the 
TNF gene, which depends on the expression of the EGRl transcription factor, which in 
turn depends on the ERK-mediated phosphorylation of the transcription factor ELKl 
(Guha and Mackman, 2002).
In contrast, HMGB 1 relocation does not depend on LPS-activated expression of 
specific genes: U937.12 cells stimulated with 200 ng/ml LPS for 3 hours in the presence
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of 10 fig/ml cycloheximide still translocate HMGBl to cytoplasmic vesicles (Fig. 31, 
left). The same was true for human monocytes (although on a time scale of 16-20 
hours).
These results indicate that ERK kinases have a direct control over HMGBl acetylases 
or deacetylases.
Preliminary results indicate that LPS treatment does not affect the amounts of HATS, 
either pCAF or CBP: we analysed by western Blot the amounts of the two proteins in 
total extracts taken from resting and activated U937: no difference was detected in the 
quantity prior to and after treatment, suggesting that the kinase affect the activities of 
these enzymes rather then their quantity (not shown).
HMGBl destiny was also followed when U937.12 cells were LPS-activated in presence 
of Leptomicin B, that blocks HMGBl export form the nucleus, as previously shown by 
P. Scaffidi: no cytoplsmic vésiculation was detected (Fig. 31, right). This completes 
our investigation and strongly indicates that acétylation is necessary for HMGBl to 
accumulate in the cytoplasm and then to be loaded into the vescicles.
;
LPS, cycloheximide LPS, leptomycin B
Fig. 31 Regulation of HM GBl translocation by cyclohexymide and LMB (courtesy of A. Agresti)
U937.12 cells were incubated with 200 ng/ml LPS in presence o f 10 pg/m l cyclohexim ide: the protein 
still translocates in the vescicles also when translation is blocked (left). LPS stimulation was also carried 
out in the presence of 150 nM leptomycin B that blocks active export (right): H M G B l is not translocated 
into vesicles but remains into the nucleus. Treatm ents were carried on for 3 hours then cells were PFA- 
fixed and imm unostained with rabbit anti-H M G B l as prim ary antibody and A lexa Fluor 594 anti-rabbit 
as secondary antibody. Blue= DAPI, red= a -H M G B l.
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Previous work indicated that CBP phosphorylated by ERK kinase increases its HAT 
activity on histones (Ait-Si-Ali et ah, 1999): it is very likely that this activity can be 
extended also to other protein substrates like HMGBl even if we are still unable to 
verify this hypothesis.
The general model derived form this work will be presented and thoroughly described 
in the discussion.
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3.3 DISCUSSION
HMGBl is unique among nuclear proteins in that it can be secreted, both by cells of 
myeloid origin (which use it as a proinflammatory cytokine) and by developing neural 
cells (where its role is much less understood) [reviewed by (Muller et ah, 2001)].
During my PhD, most of my time was dedicated to investigate how HMGBl is 
distributed in alternative subcellular locations: in the nucleus, where it serves its 
primary function as an architectural factor, and in the cytoplasm or in cytoplasmic 
vesicles, which serve as intermediate stations towards its eventual secretion.
I collected evidence that the final location of HMGBl depends from the acétylation 
status of its nuclear localization sequences (NLSs). Details about this model will be 
widely discussed in the next paragraphs.
3.3.1 HMGBl can be acetylated at multiple sites
We first established that HMGBl is multiply acetylated. In fact, the pioneering work of 
Allfrey and coworkers indicated that lysines 2 and 11 of HMGBl are subject to 
acétylation (Sterner et al., 1979). This certainly holds true for most tissues and cell 
lines, but in thymus, in monocytes and probably in all cells of myeloid origin at least 17 
different lysines within HMGBl can be acetylated, and a single HMGBl molecule can 
be acetylated up to 10 times. Although acetylated species are the vast majority in 
HMGBl from thymus, and a significant fraction in HMGBl from cultured cells, no 
single lysine appears to be acetylated in all HMGBl molecules We did not detect any 
other post-translational modification (other than poly-ADP-ribosylation), but in 
principle this level of acétylation allows for more than 100 000 different HMGBl 
molecular species if all lysines were acetylated independently. In practice, several 
lysines appear to be acetylated concomitantly and, remarkably, the two areas of 
concordant lysine acétylation correspond to sequences with NLS function.
The fact that acétylation is not spread all along HMGBl’s sequence but, on the 
contrary, shows some clustering is suggestive that the actetyltransferases involved are 
processive once they have recognised HMGB 1 as a substrate.
An attempt to characterise presumptive consensus sequences for acétylation has been
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tried, like for tyrosine-phosphorylation, but with little success; the more the number of 
acetylated proteins increases, the clearer it is that a strong consensus for acetyl 
transferases does really not exist. And, in the case of HMGBl, we did not find any 
match with presumptive consensus sequences.
3.3.2 Acetyltransferase and Deacetylase activities in the cells
The discovery of a high extent of acétylation in HMGBlpurifed fi*om an organ (3.2.1- 
3.2.3) and the presence of up to eleven different isoforms of the protein in a 2D gel 
suggests that there is a wide spectrum of of acétylation levels for HMGBl that probably 
can be correlated to different functions in the cell; so far, we managed to understand the 
role of one pattern of acétylation in a restricted cell lineage.
In contrast to the variability detected in organs and tisyuuu32ewwwwwwwsues, 
anyway, all the cell types analysed by 2D electrophoresis (Hela, 3T3, Phoenix, 3134, 
U937) had a basal level of acétylation represented always by two spots. This suggests 
that hyperacetylation of HMGBl as response to external stimuli, can be only partially 
reproduced in a cell culture.
Using both HD AC inhibitors and LPS (in case of U937 and monocytes) we perturbed 
the basal state of the cells. Acétylation of HMGBl, like any other protein, is the result 
of the balanced activity of HATs and HDACs, which are regulated in the cells in order 
to respond to the stimuli firom the environment.
In U937 cells we saw that this response is quick (one hour is enough to trigger 
cytoplasmic accumulation of HMGBl), suggesting that the acetylation-deacetylation 
rates are quite high. This was confirmed when we treated the cells with HDAC- 
inhibitors (paragraph 3.2.6, Fig..20 and 21): 30 minutes are enough to raise significantly 
the acétylation levels of HMGBl and after 60 minutes this level is already saturated.
In light of this, acétylation appears to correlate to rapid responses of the cells to sudden 
variations or stimuli, in a very similar way to how phosphorylation works.
The issue of the identity of the HATs responsible for HMGBl acétylation is still 
debated: the in vitro experiments showed that the most common nuclear HATs -  CBP, 
p300 and pCAF -  can all recognise HMGBl as substrate and acetylate it with a good 
efficiency. However, these experiments may lack specificity and provide no hints about
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the preferential enzyme acting on HMGBl in vivo.
The experiments performed inhibiting LPS-mediated relocalisation of HMGBl with 
different drugs suggest the involvement of the MAP-kinase pathway for the activation 
of the HATs that modify HMGBl. Moreover, works are published that correlate LPS -  
mediated activation of the same cells with an increased activity of CBP (Ait-Si-Ali et 
al., 1999).
This strongly supports the involvement of at least this enzyme in HMGBl acétylation in 
vivo, but a definitive confirmation is still missing.
However, taking into account the lack of any real consensus site for acétylation and the 
high number of acétylation sites in our protein, it is very likely that more the one acetyl­
transferase activity may be responsible of HMGBl acétylation, similarly to what 
happens for histones and other nuclear substrates.
In this perspective, the heterogeneus panel of acétylation sites detected by MassSpec 
might be the result of the activity of different enzymes, with different efficiency and 
site-preference.
According with the clustering of acétylation sites, we imagined that whenever CBP or 
pCAF or p300 or any other still uncharacterized HAT have estabilished a contact with 
HMGBl, they would transfer acetyl- groups to more then one Lysine in more then one 
cycle of acétylation, working in a processive way.
The processivity extensively modifies HMGBl and therefore alters significantly its total 
charge, as we detected by 2D electrophoresis of untreated and LPS-activated 
monocytes. This in the end causes a quick but massive change in the properties (here 
the localization) of the protein.
3.3.3 Functional effect of acétylation of BDMGBl and future fields of investigation
Most frequently, acétylation regulates the function of proteins likewise all the other PT- 
modifications: by affecting their affinity for the DNA-target or for other protein 
partners. This kind of regulation has been proposed also for HMGBl: Pashev and 
collaborators have recently shown that acétylation at Lys 2 and Lysll enhances 
HMGBl binding activity for distorted DNA (Ugrinova et al., 2001).
In our work we did not investigate this aspect; however, given the high number of
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acétylation sites found in HMGBl sequence and considering that some of them are 
outside the two NLSs, it is very likely that acétylation can influences the interaction of 
HMGBl with several of its natural partners in the nucleus, with profound impact on 
several processes, like transcription, V(D)J recombination, etc. Moreover, the 
availability of several functional in vitro assays together with the production of 
recombinant mutants in the acetylated residues, open the possibility to investigate this 
issue quite easily.
For example, acetylated HMGBl might show a different affinity for the nuclesome 
particle, impacting the efficiency of nuclesome sliding itself (see above).
In this case acétylation of HMGBl, together with the modification of the histone tails, 
would provide a supplementary epigenetic mechanism of regulation of gene expression.
Another possibility is that acétylation of NLS2 could modulate the documented 
interaction between the C-terminal tail of HMGBl with the two basic boxes.
Several investigators observed that the C-terminal acidic tail of HMGBl controls the 
DNA binding properties of the HMG boxes (Lee and Thomas, 2000; Muller et al., 
2001; Stros et al., 1994). In past years I also collected several pieces of unpublished 
data suggesting that deletion of the C-terminal domain increases the activity of the 
HMG boxes in protein-protein interaction and transactivation assays.
The peculiar position of the second hyperacetylated cluster of lysines, adjacent to the 
tail, suggests that acétylation in this region might affect the interaction of the tail with 
the boxes; in such a case acétylation would provide a supplementary way to regulate 
HMGBl activity.
With the present work we propose a higher level of regulation accomplished by 
acétylation on the subcellular distribution of a protein.
This type of effect is less commonly documented but not completely novel since there 
are other examples in literature of a similar effect of acétylation of nuclear factors as 
HNF4, CTIIA and El A (Soutoglou et al., 2000); (Spilianakis et al., 2000); (Madison et 
al., 2 0 0 2 ).
The peculiarity of HMGBl acétylation resides in the high extent to which the 
modification is carried, and the effectivness of the events thus triggered. The 
mechanism described is most interesting because it provides an explanation for the
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question about the identity of a molecular switch that redirects a nuclear protein from 
one subcellular location to another.
3.3.4 HMGBl Shuttles Continually between Nucleus and Cytoplasm
HMGBl (mw 25 000) is small enough to diffuse passively through nuclear pores, and 
in fact a significant portion of the protein diffuses to the cytoplasm if cells are incubated 
for a few hours at 4°C, a condition that blocks energy-driven transports. However, 
HMGBl also contains two independent NLSs and two NESs, defined as CRMl- 
interacting surfaces in the protein. One NLS matches perfectly to classical bipartite 
NLSs, the other one is rather loosely related to a monopartite NLS. The 2 NESs may be 
related to each other as they occur in the two HMG boxes, but have no sequence 
similarity to other ones known to date, so it was not possible to identify them using 
bioinformatics tools. The experimental characterisation of these regions should require 
a deletion approach and it is in future plans.
Two NLSs and (at least) one NES are also present in group E Sox proteins (Sox8 , 9 and 
10), and are essential for their transcriptional activity (Sudbeck and Scherer, 1997); 
(Rehberg et al., 2 0 0 2 ).
From an evolutionary point of view the presence of two NLSs in a protein can be 
considered as a way to ensure the proper location of a nuclear protein also in case of 
random mutations inactivating one of them. The evidence from the double mutants 
experiments that, even with the inactivation of both NLSs, the presence of HMGBl into 
the nucleus is not completely abolished, raises the possibility of other regions 
accomplishing this functions: the CUBIC database suggested at least other two 
sequences with presumptive NLS-function, and we already started to generate the GFP- 
fusions constructs to esperimentally test their function. It is also possible that a fraction 
of HMGBl lacking its own NLS function may be transported into the nuclear 
compartment by estabilishing contacts in the cytoplasm with other nuclear partners.
Functionally, the presence of both import and export signals ensures that 
HMGBl shuttles actively between the nuclear and cytoplasmic compartments in all cell
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types, at the basal level the nuclear import exceeds the export, defining a nuclear 
accumulation of the protein.
General deacetylase inhibitors cause the hyperacetylation of HMGBl and the 
relocation of part of the protein to the cytoplasm. This presumably happens in all cell 
types, and is due to the acétylation of lysines within both NLSs. The mutation of the 
lysine clusters within the NLSs to glutamines, which most resemble acetylated lysines, 
is sufficient to abrogate NLS function.
We managed to uncover one of the signals that lead to the perturbation of the 
import/export equilibrium in U937 and monocytes; in other cell types not responsive to 
LPS, acétylation of HMGBl is probably modulated in response to other starting stimuli, 
still to identify.
We propose a scenario (Fig. 32) where HATs and HDACs that are common and 
conserved in mammals have been recruited to control the flow of HMGBl across the 
nuclear envelope: deacetylation or low-level acétylation allows for the default nuclear 
accumulation of HMGBl, whereas hyperacetylation causes the accumulation of 
HMGB 1 in the cytoplasmic compartment.
Nucleus 11 Cytoplasm Nucleus 11 Cytoplasm
11 II
M M , Ac
II
II
II
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Fig. 32 M odel I: acétylation regulates H M G B l distribution between nucleus and cytoplasm
At basal state HMGB 1 is hypoacetylated and nuclear import exceeds export: HMGB 1 accumulates in the 
nucleus; upon stimulation, H M GBl is hyperacetylated by HATs in the NLSs and import is inhibited: 
export exceeds import and HMGB 1 accumulates in the cytoplasm, that serves as temporary location for 
subsequent events (see model in Fig. 33). This model can be applied to all the cell types possessing HATs 
and HDACs that act on HMGB 1.
The regulation of nuclear vs cytoplasmic localization by acétylation has been described 
before for transcription factors HNF4 and CTIIA; however, in these cases lysine 
acétylation promotes nuclear accumulation, in a process that appears to be related to
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NES function and protein export mechanisms. Very recently, acétylation of the NLS of 
viral protein El A has been shown to cause its cytoplasmic accumulation (Madison et 
al., 2002). The process we describe is similar, save for the scale: around a million 
HMGBl molecules per cell must be acetylated in a limited time-span.
3.3.5 HMGBl as a signal for tissue damage
We have recently shown that HMGBl is a very mobile component of chromatin, both 
in interphase and mitotic chromosomes (Scaffidi et al., 2002). The protein constantly 
shuttles between nucleoplasm and chromatin, with a residence time of less than 2  
seconds. This is consistent with the proposed role of HMGBl as an architectural factor, 
or even a “chromatin chaperone” (Travers et al., 1994). As a consequence of its 
dynamie and reversible interaction with chromatin m vivo, HMGBl is passively leaked 
out firom cells (together with all other soluble proteins) when the integrity of 
membranes is lost, either because of the addition of detergents to the medium bathing 
the cells (Falciola et al., 1997), or because of cell necrosis (Scaffidi et al., 2002). The 
release of HMGBl by necrotic cells differs from active secretion, as it is a totally 
passive process and a direct consequence of the transient nature of the association 
HMGBl with chromatin: HMGBl dilutes in the extracellular milieu following the 
concentration gradient. Thus, we expect that all forms of HMGBl, either acetylated or 
not, will be leaked out in a similar fashion. Remarkably, however, HMGBl is 
irreversibly bound to chromatin in cells undergoing apoptosis, a condition that is 
concomitant with a generalized histone deacetylation (Scaffidi et al., 2002). HMGBl 
remains chromatin-bound, and thus indiffusible, even when apoptotic cells lose the 
integrity of their membranes and leak out other soluble cellular components (secondary 
necrosis). This is not a common fate for chromatin proteins: most are either firmly 
bound to chromatin all of the time (like histones), or weakly bound to chromatin all of 
the time (like HMGN proteins or transcription factors) (Scaffidi et al., 2002). A 
“window of opportunity” therefore exists to use HMGBl as a signal for necrosis, as 
opposed to apoptosis or secondary necrosis. The advantage for the organism to 
distinguish between primary and secondary necrosis is obvious: primary necrosis is 
caused by trauma, hypoxia or poisoning, and is associated with damage to the tissues
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that need repair; apoptosis is programmed and is not associated with traumatic tissue 
damage. In this scenario, the evolution of receptors to detect extracellular HMGBl 
endows cells that are not directly hurt by tissue damage with the ability to recognize, at 
a distance, that damage has occurred. Some cells may simply divide to replace dead 
cells, some will migrate to replace them, and some will amplify and relay the tissue 
damage signal(s) to distant districts in the body. At least one receptor for extracellular 
HMGBl has been identified: RAGE (the receptor for advanced glycation endproducts) 
binds several ligands, including HMGBl, with nanomolar affinity (Hori et al., 1995). 
Upon RAGE engagement, smooth muscle cells can both migrate up the HMGBl 
gradient (Degryse et al., 2001), and divide (R. Palumbo and M.E.B., unpublished). 
Neutrophils and other inflammatory cells are recruited to the site of necrosis (Degryse 
et al., 2001), and are activated to secrete TNF-a and other proinflammatory cytokines 
(Andersson et al., 2000).
3.3.6 Myeloid Cells Control HMGBl Acétylation
Monocytes and promyelocytic cells must have developed a specific ability to acetylate 
massively a ehromatin component in order to reroute it to secretion and use it as a 
cytokine. Nuclear export, vesicular accumulation and secretion are separate steps, whose 
occurrenee depends on the completion of the previous step. Thus, it is only natural that 
HMGBl accumulated in seeretory lysosomes should be acetylated, as this is necessary 
for cytoplasmic relocation of the nuclear protein. However, HMGBl acétylation is not 
necessary for vesicular accumulation: secretory lysosomes do capture some of the 
hypoacetylated HMGBl protein that diffuses to the cytoplasm during incubation at 4°C 
of resting U937.12 cells. Most of all, secretory lysosomes also take up hypoacetylated 
HMGBl released into the cytoplasm during mitosis. Thus, it appears that vesicular 
accumulation of cytoplasmic HMGBl is a default process that simply requires the 
presence of secretory lysosomes. This further highlights the physiological importance of 
lysophosphatidylcholine (LPC) as a second signal for HMGBl secretion (Gardella et al..
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2002); if a second signal were not required, some seeretion of HMGBl from newly 
divided cells would be unavoidable. A model for the regulation of HMGBl secretion by 
monocytes is summarised in Fig. 33. This model concentrated on the specific cell type 
that we investigated and at the same time extends the one presented in Fig. 32: the 
scheme is based on the evidence eollected in paragraphs 3.2.10-3.2.12
Monocytes and promyelocytic cells only reroute HMGBl when activated. 
Activation is triggered by binding of inflammatory molecules (IL-ip, TNF-a, LPS, 
HMGBl itself) to their own receptors, and is concomitant with cell differentiation. 
However, also non-activated U937.12 cells can transport HMGBl to vesicles when TSA 
causes hyperacetylation. TSA could potentially also cause the same sort of 
differentiation that is triggered by inflammatory molecules, but this appears unlikely, as 
several morphological markers of activation are absent (cell and nucleus reshaping plus 
other evidence not shown).
Binding of proinflammatory-signals to surface receptors in monoeytes activates a 
number of signaling pathways, including calcium signaling through calmodulin and 
NFAT/calcineurin, NF-kB and all MAP kinases (ERK, Jnk and p38 routes). We have 
shown that inhibition of ERK phosphorylation blocks the LPS-induced translocation of 
HMGBl to secretory lysosomes. ERK kinases must control directly the enzymes 
responsible for HMGBl acétylation, rather than indirectly through the phosphorylation 
of transcription factors that control the expression of specific genes, since 
cycloheximide treatment of either LPS-activated U937.12 cells or monocytes does not 
prevent HMGBl relocation from the nucleus to cytoplasmic vesicles.
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Fig. 33 M odel II: the control o f H M G B l secretion in inflam m atory cells
In all cells, including resting inflam m atory cells (light blue panel), H M G B l partitions between nucleus 
and cytoplasm: nuclear import is mediated by the NLSs, and the protein re-diffuses back to the cytoplasm 
through the nuclear pores via passive diffusion and C R M l-m ediated active export. W hen the NLSs are 
not acetylated, the rate o f nuclear im port exceeds that o f rediffusion or export, and the protein appears 
predominantly or solely nuclear. Upon stimulation o f inflammatory cells (pink panel) through binding of 
IL -ip , T N F-a, LPS or H M G B l itself to their own receptors, the N F-kB (not shown) and M AP kinase 
pathways are activated. Phosphorylated ERKs migrate to the nucleus, where directly or indirectly they 
activate histone acetylases, or inhibit histone deacetylases. This in turn prom otes the acétylation of the 2 
NLSs of H M G B l. Exported acetyl-HM GB 1 cannot return to the nucleus. M yeloid cells are equipped with 
a special variety o f lysosomes that can be secreted upon appropriate stimulation (Jaiswal et al., 2002), and 
that can accumulate IE -1(3 (not shown) or H M G B l, presumably through the action o f specific transporters 
em bedded in the lysosomal membrane (Andrei et al., 1999); (Gardella et al., 2002). Upon the engagem ent 
of LPC (lysophosphatidylcholine, an inflammatory lipid) to its own receptor, the secretory lysosomes 
carrying HM G Bl fuse with the plasma membrane and secrete their cargo.
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3.3.7 Monocytes relay and amplify the tissue damage signal
Remarkably, starting about 16 hours after activation, monocytes and macrophages can 
secrete HMGBl (Wang et ah, 1999). This creates a closed feedback loop with inbuilt 
delay: as inflammatory cells secrete the same protein that can serve as a signal for tissue 
damage, the signal is sustained in time, and HMGBl serves both as an early and a late 
inflammatory signal. This circuit is conceptually simple, economical and elegant, but 
can have complicated outputs in terms of intensity of the inflammatory signal. For 
example, if after 16 hours the sum of passively and actively released HMGBl is larger 
than the amount of HMGBl released as the initial trigger of inflammation, the 
inflammatory response can be self-amplifying and can lead to dramatic outcomes like 
toxic shock. Significantly, one might observe toxic shock-like symptoms even in the 
absence of LPS or bacterial pathogens, provided that the initial tissue damage is 
extensive enough.
In our interpretation, the ability of monocytes and macrophages to provide as 
output the same protein that initially served as input for inflammatory signaling is an 
example of molecular mimicry, and must have evolved after the evolution of HMGBl 
as a tissue damage signal. A clear advantage for using the same protein as early and late 
inflammatory signal is that the organism can re-use the same components aheady 
available, both as ligands and receptors.
3.3.8 Myeloid cells use pre-existing components towards HMGBl secretion
HMGBl is a small protein that could pass easily through nuclear pores. In all cells, 
NLSs shift the equilibrium of HMGBl distribution strongly towards a nuclear 
localization.
NLS acétylation might have evolved ad hoc, or simply be a by-product of 
bystander acétylation of a chromatin protein. Within the nucleus, HMGBl interacts 
directly with nucleosomes ((Falciola et al., 1997); (Nightingale et al., 1996), and will 
come in close contact with the HAT and HD AC activities that reversibly (de)acetylate 
histone tails. The exact specificity of these activities towards their substrates is not 
known, but are likely to be somewhat relaxed, as the same enzymes can acetylate and
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deacetylate transcription factors and co activators in addition to histones (Kouzarides, 
2000). In all likelihood, most HATs and HDACs can accept HMGBl as a substrate, and 
align its acétylation status with that of the histones.
In any event, acétylation of both NLSs would free HMGBl from the Ran-driven 
cycle of nuclear accumulation. This event must be rare spontaneously, as HMGBl is 
tightly confined to the nucleus in cultured cells, even promyelocytic ones like U937. 
We also note that the irreversible deposition of HMGBl onto chromatin during 
apoptosis is concomitant with histone deacetylation (Scaffidi et ah, 2002) thus, HMGBl 
deacetylation (whether controlled or bystander) would clear the cytoplasmic pool of 
HMGBl, and prevent leakage from that pool. HMGBl deposition onto underacetylated 
chromatin and depletion of its cytoplasmic pool are thus aligned, whether by chance or 
design.
The existence of an HMGBl acétylation cycle offers the “window of opportunity” 
to use such a cycle, and the cytoplasmic pool of HMGBl, for secretion. Most cells 
cannot secrete HMGBl, whereas cells of the myeloid lineage can. We postulate that the 
vesicles for HMGBl accumulation must pre-exist the evolutionary invention of 
HMGBl secretion. To some extent, this prediction is supported by the fact that myeloid 
cells appear to secrete IL-lp, another proinflammatory cytokine, precisely via the 
leaderless accumulation of IL-1 p into vesicles, and their regulated exocytosis (Andrei et 
ah, 1999). However, myeloid cells must have invented or deployed a mechanism to 
acetylate HMGBl after receiving inflammatory signals. Thus, in myeloid cells 
acétylation or deacetylation activities (at least of HMGBl) must be controlled by signal 
transduction pathways that start with the engagement of receptors for TNF-a, IL-lp, 
LPS and/or other “innate immunity” ligands.
The molecular mimicry of HMGBl passive release by activated monocytes/ 
macrophages is not perfect, however, since inflammatory cells secrete only 
appropriately hyperacetylated HMGBl, whereas necrotic cells would release all species 
of HMGBl, acetylated or otherwise. Appropriate antibodies towards the acetylated 
NLSs of HMGBl might distinguish between passively and actively released HMGBl, 
and would potentially afford the ability to block the late HMGBl response without 
affecting the early response. Just as possibly, the difference between passively and 
actively secreted HMGB 1 could be perceived by alternative receptors in mammals.
In conclusion, we have shown that inflammatory cells can redeploy a nuclear
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component to a cytokine function by controlling its movement from nucleus to 
cytoplasm. In turn, this depends from the acétylation of the 2 NLSs of HMGBl.
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CHAPTER 4. Investigating HMGBl activity within the nucleus: a 
chaperoning role in chromatin remodelling?
(In collaboration with P. Becker and G. Langst -  Adolf Butenandt Institut, Munich)
4.1 INTRODUCTION
4.1.1 Mechanisms of chromatin remodelling
Chromatin is intrinsically involved in the regulation of all nuclear processes, most 
prominently transcription, replication, repair and recombination (de La Serna et al., 
2000); (Flanagan and Peterson, 1999) (Fyodorov and Kadonaga, 2001) (Muchardt and 
Yaniv, 1999) (Kwon et al., 2000). DNA and histones within nucleosomes are held 
together by a large number of weak interactions, which confer a significant stability to 
the nucleoprotein structure, and movement of a nucleosome has to overcome a 
significant activation energy (Luger et al, 1997) (Fig. 34).
Fig. 34 Crystal structure o f the nucleosom e core particle
The fundamental packing unit of chromatin is the nucleosome, which consists of a short length 
DNA wrapped around a core of eight hi stone protein molecules (octamer). The X-ray crystal 
structure allowed analysing in atomic detail how the histone protein octamer is assembled and
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how the 146 base pairs of DNA are organised into a superhelix around it. Both histone/histone 
and histone/DNA interactions depend on the histone fold domains and additional, well -ordered 
structure elements extending from this motif. Histone N-tenninal tails pass over and between 
the gyres of the DNA superhelix to contact neighbouring particles (from (Luger et al., 1997))
In vitro, specific conditions (temperature, ionic strength) can weaken these interactions, 
rendering the nucleosome a more dynamic structure (Beard, 1978) (Guschin and 
Wolffe, 1999) (Pennings et ah, 1991) (Widom, 1999), but the efficiency of these 
spontaneous rearrangements is usually low.
Yet, nucleosomes have to be moved around all the time, for example to allow 
the passage of elongating KNA polymerase. At least two different mechanisms affect 
nucleosome sliding: covalent modification of histones themselves (reviewed extensively 
in (Grunstein, 1997); (Umov and Wolffe, 2001); (Strahl and Allis, 2000); (Jenuwein 
and Allis, 2001); (Turner, 2002), and mobilization by ATP-dependent machines, called 
nucleosome remodelling factors.
The multi-protein complexes that covalently modify nuclesomes can add or 
remove many chemical moieties; acétylation, phosphorylation and méthylation of 
histone N-termini have received the most attention. The chemical and enzymatic 
activities of many of these complexes are well understood, but the major questions still 
to be investigated concern how these covalent modifications impact on the stmcture of 
the template and the ability of other complexes (e.g. those in the transcription 
machinery) to fiinction coordinately.
The so-called nucleosome remodelling factors are multi-subunit complexes 
containing dedicated ATPases, able to convert the energy stored in ATP into 
displacement of nucleosomal DNA relative to the histone octamer (Kingston and 
Narlikar, 1999); (Narlikar et ah, 2002); (Peterson, 2000; Peterson and Logie, 2000) 
(Aalfs and Kingston, 2000); (Workman and Kingston, 1998). They can be grouped in 
three main families -SWI2/SNF2 type, ISWI type and CHD type (reviewed in (Varga- 
Weisz and Becker, 1998); (Vignali et ah, 2000) and summarized in Table 3.
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Table 3. ATP-dependent chrom atin rem odelling com plexes
ATP-dependent remodelling complexes use ATP hydrolysis to increase the accessibility o f nucleosom al 
DNA. These com plexes can be divided into three main classes based on the identity o f their catalytic 
ATPase subunit. These ATPase subunits display homology only within the ATPase dom ain and contain 
different additional domains. Further, each ATPase subunit forms com plexes with different additional 
proteins, whose identity is still not completely defined. Up to now, m ost o f investigation has been 
directed to the central ATPase activity, which can alter chromatin structure in the absence o f the 
remaining subunits (Kingston and Narlikar, 1999); (Langst and Becker, 2001b); (W ang and Zhang, 
2001). The biochemical characterization of the activity or the remaining subunits has begun to provide 
evidence for mechanistic differences among the three classes o f complexes.
All these multiprotein complexes contain an ATP-ase subunit, working as the “engine” 
of the entire machine, but they differ for the composition of other subunits and for the 
specific effect on nucleosome organisation. Anyway they are all able to alter histone- 
DNA interaction such that nucleosomes can move (reviewed in Becker and Horz, 2002; 
(Langst and Becker, 2001b); (Vignali et al., 2000)).
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4.2.2 M echanism s of nucleosom e sliding: the hulge model
In spite of the several assays developed to study the activity of ATP-dependent 
chromatin remodelling complexes (reviewed in (Narlikar et ah, 2002)), the mechanism 
by which remodelling machines relocate DNA over the histone octamer still remains 
elusive. Although rather extensive nucleosome disruption is effected by the family of 
SWI/SNF-related remodelling factors (Lorch et al., 1999), the two most popular 
scenarios assume that not all the weak histone-DNA interactions are broken 
simultaneously, but only a small number at any given time.
Nucleosome sliding presumably involves the detachment of a DNA segment 
from the histone octamer surface, possibly as a local loop or bulge, or as otherwise 
distorted DNA, at sites where the DNA enters its path around the particle (Becker and 
Horz, 2002). Propagation of this detached segment over the surface of the histone 
octamer would lead to displacement of nucleosomal DNA with respect to landmarks of 
the histone octamer surface. (Fig. 35)
Fig. 35 M echanism  of nucleosm e sliding by diffusion of a DNA bulge around the histone particle
A small region of DNA detaches form the histone octamer surface with the breakage o f a small num ber 
of bonds. Some of the bulges abort by a general relaxation of the entire nuclesom e unit; in some cases the 
bulge is maintained and starts to diffuse all around the histone core particle, for the 1.6 turn that 
correspond to the wrapping of the DNA around the histone core; this diffusion results in a relative 
circular movement o f the DNA respect to the histone core that corresponds, in a linear way, to the sliding 
of the two entities one respect to the other.
The “twist diffusion model” argues that a small set of histone-DNA interactions 
is disrupted when the topology of DNA is altered, for example by varying the DNA 
twist. The bond-breakage would be propagated over the surface of the nucleososme, 
creating a translational shift of one base pair of DNA at the time relative to the histone
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core. Support for this model is provided by recent work in Owen-Hughes’ group (Havas 
et al., 2000), showing that ISWI and SWI/SNF complexes introduce superhelicity into 
linear DNA fragments.
In the “bulge model” local loops of DNA are detached from the histone octamer 
surface, starting at the sites where the DNA enters its path around the particle, and are 
displaced progressively along the length of nucleosomal DNA. Such looping could be 
initiated by thermal energy or by specific conditions of high ionic strength, and 
remodelling machines are postulated to catalyse events that proceed quite inefficiently 
when spontaneous.
Models of this kind are attractive because they explain how a nucleosome can be 
mobilized even though at any given time during the process only a limited number of 
histone-DNA contacts are disrupted. Nucleosome remodelling enzymes may catalyse 
the initial detachment of a DNA segment, possibly by some kind of distortion, and may 
endow its ‘propagation’ through the nucleosome surface with directionality.
Recently, Langst and co-workers (Langst and Becker, 2001a) tested the validity of the 
“twist diffusion” model by introducing randomly positioned nicks in the nucleosomal 
DNA substrate: the nicks, although leading to relaxation of any topological stress, did 
not prevent sliding. This argues against involvement of DNA twist in nucleosome 
mobilization. Remarkably, a single nick in the spacer DNA at the entry of the 
nucleosome facilitates sliding, which suggests that the nick in the spacer DNA between 
nucleosomes might increase the flexibility of DNA and might therefore facilitate the 
kind of DNA distortion necessary for initiating the nucleosome sliding process.
Our collaboration with Langst and Becker elaborated on this idea: if the rate-limiting 
step in nucleosome sliding is the distortion of linker DNA, e.g. the formation of a small 
local loop or bulge, proteins that can generate and/or stabilise such distortions might 
facilitate nucleosome sliding. HMGBl is the archetype of proteins that bend and distort 
DNA, and, because it has been shown to interact with linker DNA at sites overlapping 
ISWI binding sites, is a good candidate to help “lubricate” nucleosome sliding.
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4.2 Results
4.2.1 Interaction of HMGBl with mononucleosomes
Several proteins, among them histone HI and HMGBl, that are able to interact with 
bent or otherwise distorted DNA (Lilley, 1992; Varga-Weisz et al., 1994), are also 
known to bind DNA at the entry points into the nucleosome. Several investigators 
already documented the interaction of HMGBl with nucleosomes (An et al., 1998); 
(Nightingale et al., 1996); (Schrôter and Bode, 1982). Recombinant HMGBl also 
interacts efficiently with the mononucleosomes that are used as substrates in 
nucleosome sliding assays (Fig.36). Electrophoretic mobility shift assays (EMSA) 
document the binding of HMGBl to a nucleosome assembled centrally on a 248 bp 
DNA fragment derived from the ribosomal RNA promoter. The titration of HMGBl 
yields a single retarded band, confirming the existence of one preferred binding site 
(Fig 36 A; lanes 4-6). HMGBl also supershifts a nucleosome positioned at the end of 
the same DNA fragment (lanes 10-12). This interaction does not lead to disruption of 
the nucleosome: excess unlabelled DNA added to an EMSA reaction before gel loading, 
effectively competes HMGBl off the labelled nucleosome, which is released intact 
(Fig. 36 B; lanes 6-9).
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Fig. 36 Specific interaction of H M G B l with nucleosom es exhibiting protruding DNA
(A) Increasing amounts o f H M G B 1 full length (as indicated) were incubated with nucleosom es (60 fmol) 
positioned at the centre (left panel) or at the end (right panel) of the 248bp rDNA Fragm ent. The 
eomplexes were resolved by electrophoresis on a native polyacrylam ide gel. An autoradiograph o f the gel 
is shown. The major nucleosom e-HM GBl com plex is marked by an asterisk. N ucleosom es are 
schematized by ellipses with protruding DNA. (B) Nucleosomes (60 fmol) assembled on a 146bp DNA 
fragment were incubated with increasing amounts o f H M G B l as indicated and analysed by 
electromobility shift assay as above (left panel); no specific binding was detected with increasing 
amounts o f H M G B l. H M G Bl binding to the nucleosome does not disrupt the histone octam er (left). 
HM GBl binding was analysed as described above without (lanes 2-5) and with the addition o f com petitor 
DNA (lanes 6-9) prior to gel loading. (C) Picture schematising HM G Bl binding specificity for different 
mononucleosome isoforms.
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In agreement with earlier results (An et ah, 1998); (Nightingale et ah, 1996) and 
(Schrôter and Bode, 1982), stable interaction of HMGBl requires the presence of some 
linker DNA protruding from the nucleosomal core. It is unable to associate with a 
nucleosome core particle consisting of 146 bp DNA wrapped tightly around a histone 
octamer, even at very high concentrations (Fig.36 B, lanes 4-6). The interaction of 
HMGBl with nucleosomes thus is reminiscent of the properties of the remodelling 
ATPase ISWI: ISWI cannot bind to a nucleosome core, but requires linker DNA at least 
on one side of the nucleosome particle (Brehm et ah, 2000); (Langst and Becker, 
2 0 0 1 b).
We attempted to document the preferred interaction of HMGBl by footprinting 
(Fig.37). Centrally positioned nucleosomes were isolated, incubated with HMGBl and 
partially digested with DNase I. HMGBl-nucleosome complexes were identified on 
native polyacrylamide gels, excised and the purified DNA was analysed on sequencing 
gels. While HMGBl protects free DNA non-specifically from DNase I digestion (panel 
3) the protection of nucleosomal DNA was modulated (panel 5). Since the ‘central 
nucleosome’ actually corresponds to a series of nucleosomes with different translation 
positions between position -20 and -190 on the DNA the footprint naturally lacks some 
precision. However, obvious protection of DNase I digestion on the nucleosomal 
fragment is seen in the area corresponding to one end of the nucleosomes (the -190 
position), but not at the other end (the -40 position).
This interaction is reminiscent of earlier studies involving model nucleosomes, which 
described asymmetrical interactions. Enhancements of DNase I cleavage are also seen 
close to the nucleosomal pseudodyad, which suggests a close interaction of HMGBl 
with the nucleosome, rather than a detached interaction with linker DNA.
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Fig. 37 Footprinting H M G B l on the m ononucleosom e
DNA (panels 2 and 3) or purified nucleosom es (panels 4 and 5) were incubated with H M G B l. DNase I- 
treated free DNA, nucleosomes and nucleosom e-HM GBl complexes were resolved by PAGE, the DNA 
was isolated from the corresponding bands and analyzed on sequencing gels. The cluster o f central 
nucleosome positions is indicated by white ellipses and the area of perturbation o f histone-DNA 
interaction upon HM G Bl binding is marked by white (DNase protection) or black triangles (DNase 
hypersensitivity).
The fact that HM GBl and ISWI approach nucleosomes with overlapping 
binding specificity raises questions about the consequences of the presence of HMGB 1 
in ISWI-indueed nucleosome sliding.
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4.2.2 An in vitro tool to study chromatin remodelling at the molecular level
In order to test for an effect of HMGBl on ISWI- and ACF-induced nucleosome 
mobility, we employed an established assay that allows visualization of single 
nucleosome movement catalysed by ATP-dependent nucleosome remodelling factors. 
The system was developed in Becker’s group and is already well documented in several 
works (Brehm et al., 2000; Clapier et al., 2001; Eberharter et al., 2001; Langst et al., 
1999). The starting point to develop the mononucleosome remodelling experiment was 
the observation that wrapping of short DNA fragments around histone octamers 
frequently led to multiple translational positions and that those isoforms could be 
separated electrophoretically on a 5% AA gel. In our case, nucleosomes occupy 
prominent positions on a 248 bp fragment derived from the rDNA promoter: a dominant 
internal position is dictated by the anisotropic flexibility of the DNA sequence, and in 
addition nucleosomes can abut the fragment ends, as depicted in Fig. 38 A:
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Fig. 38A. Assembly o f m ononucleosom es in vitro
M ononucleosom es are assem bled in vitro by incubating a stretch o f DNA, 248 bp long, with increasing 
amounts o f histone-core proteins (A, see M ethods); the incubation products are loaded on a 5%  
acrylamide gel and exposed to X-ray film. (B): two major bands can be detected, representing different 
translational positions o f the histone core with respect to the DNA stretch. D ifferent isoform s run 
diffently and can be separated in an acrylamide gel: the centrally positioned nucleosom e is slower then 
the pheripherally positioned one.
Isolated nucleosomes positioned either at the centre or at the periphery of the DNA 
fragment serve as substrate for remodelling machines (Fig. 38 B).
Becker and collaborators previously showed that the remodelling ATPase ISW I is able 
to move nucleosomes from internal positions to fragment ends (Langst and Becker, 
2001b); (Langst et al., 1999). Association of ACPI with ISWI reconstitutes the 
heteromeric ACF (Ito et al., 1997). A CFl not only increases the efficiency of ISWI- 
depending remodelling by an order of magnitude, it also leads to a qualitative change in 
nucleosome sliding: in contrast to isolated ISWI, ACF can catalyse the movement of 
nucleosomes from fragment ends to more central positions (Eberharter et ah, 2001). 
While these simple model reactions on short linear DNA fragments are unlikely to 
reflect all physiological constraints of nucleosome movements in nuclei, they provide 
an excellent opportunity to study fundamental parameters that affect nucleosome 
mobility.
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Fig. 38 (From  (Langst et al., 1999)) In vitro sliding assay o f m ononucleosom es w ith  chrom atin  
rem odelling machines
D ifferentially positioned m ononuclesom es are used as substrates in in vitro rem odelling assays by 
incubating them with rem odelling m achines (ISW I, CHRAC and ACF) in the presence o f  ATP. The 
energy derived from hydrolysis o f  ATP is used to slide the histone core with respect to the D N A  stretch, 
with a different directionality depending on the type o f  enzym e used: C HRAC and ISW I, for exam ple, 
recognise and remodel different m ononucleosom es. The reaction is stopped by loading the m ix on an A A  
gel; the labelled m ononucleosom es are detected by autoradiography.
4.2.3 HMGBl affects the sliding activity of ACF and CHRAC
The first evidence for an effect of H M GBl on nucleosome sliding was obtained in 
reactions catalyzed by native CHRAC (Fig. 39A). We measured the kinetics of 
nucleosome sliding as a function of fixed amounts of HMGB 1 by stopping the reactions 
at different time points with competitor DNA followed by native gel electrophoresis. 
We found that nucleosomes moved significantly faster in the presence of H M G Bl 
(compare lanes 2, 3 to lanes 6, 7), but the overall level of nucleosome mobilization at 
the end of an extended incubation was not changed (Figure 2A, compare lanes 5 and 9). 
We next explored whether HM GBl would also affect the kinetics of nucleosome sliding 
by recombinant two-subunit ACF (Eberharter et ah, 2001). In the presence o f 2 pmoles 
of HM GBl a clear increase of nucleosome sliding was detectable, particularly at the 
early time points (Fig.39B, lanes 2-4 and 8-10). A similar stimulation was observed if
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H M G Bl concentrations were increased 5-fold, but raising the concentrations of 
remodelling factor abolished the effect (data not shown).
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Fig. 39 H M G B l stim ulates CHRAC and ACF-m ediated nucleosom e remodelling
(A) 60 fmol o f nucleosomes positioned at the end of the DNA fragment (lane 1) were incubated with 5 
fmol of native CHRAC and ATP, in the absence (lanes 2-5) or presence of 2 pmol o f HM GB 1 (lanes 6- 
9). The reactions were incubated at 16°C and stopped at the indicated time points by the addition of 
com petitor DNA. Nucleosome positions were subsequently analysed by electrophoresis. N ucleosom es are 
schematized by ellipses with protruding DNA.
(B) Nucleosome remodelling assay, as described in (A), using 5 fmol of recom binant ACF in the absence 
(lanes 1-6) or presence of 2 pmol of HMGB 1 (lanes 7-12).
In order to document better the kinetic effect of HM GBl on nucleosome sliding we 
quantified the degree of nucleosome sliding throughout the sliding reaction, and 
determined the degree of stimulation by HMGB 1 for each time point. The graph in Fig. 
40 displays the average data derived from 4 independent experiments. It documents a 
kinetic effect of HMGB 1 on nucleosome sliding which is mainly observable at the early 
times.
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Fig. 40 Quantification of the H M G Bl effect on nucleosome remodelling
The ratio o f  nucleosomes moved in the presence o f  H M G Bl versus nucleosomes moved in the absence o f  
HMGB 1 was calculated for 4 independent experiments and displayed in a graph.
In order to establish whether ISWI by itself would also profit from the presence of 
HMGBl we added the factor to reactions in which ISWI mobilised a centrally 
positioned histone octamer to slide to a fragment end (Fig. 41). Surprisingly, two pmol 
and higher amounts (data not shown) of HMGBl did not affect the kinetics of ISWI- 
dependent nucleosome sliding, suggesting a critical contribution of the ACF I moiety 
for the functional synergism with HMGB I .
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Fig. 41 H M G B l does not affect the kinetics o f ISW I -  m ediated nucleosom e sliding
Nucleosomes positioned at the centre o f the DNA fragm ent were incubated with 30 fmol o f ISW I and 
ATP, in the absence (lanes 1-5) or presence of H M G B l (lanes 6-10, 2 pmol) and assayed as described in 
(Fig. 39).
4.2.4 HMGBl promotes ACF binding to the nucleosome
The stimulatory effect could be due to interactions of H M G Bl with ACF, with the 
nucleosomal linker DNA, or both. We have used mouse H M G Bl in the context of a 
nucleosome remodelling machinery from Drosophila to minimize the probability of 
direct interactions and accordingly we were so far unable to detect any significant 
interactions between HMGB 1 and ACF in biochemical pull-down experiments (data not 
shown). Therefore we next analysed the effect of H M G Bl on the interaction of the 
remodelling factors with the nucleosomes. Binding of ACF to the nucleosome can be 
visualised by EMSA as a single, prominent band if no competitor DNA is added prior to 
gel loading (Fig. 42, lanes 4-6). As before, H M G Bl shifts the nucleosome into a 
position close to, but distinct from the ACF-nucleosome complex (Fig. 42, lanes 13, 
14). Importantly, the presence of 0.6 pmol of HM GBl does not shift the nucleosomal 
band significantly (lane 10). However, if this amount of HM GBl was included in a 
nucleosome binding reaetion with ACF, four fold lower eoncentrations of ACF were 
required to shift the nucleosome (compare lanes 1-6 to 15-20).
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Fig. 42 H M G B l prom otes the form ation o f a ACF-nucleosom e com plex
Nucleosom es preferentially positioned at the centre o f the DNA fragment were incubated with increasing 
amounts o f ACF (lanes 1-7; 15, 30, 60, 120, 240, 480, 960 fmol ACF), H M G B l (lanes 9-14; 0.3, 0.6, 1.2, 
2.4, 4.8, 9.6 pmol) and increasing am ounts o f ACF in the presence o f 0.6 pmol H M G B l (lanes 15-21). 
Com plexes were analysed in electrom obility shift assays, as before. N ucleosom e-ACF com plexes are 
marked by a triangle and nucleosom e-HM GBl com plexes are indicated by a circle.
At higher, saturating concentrations of ACF the degree of nucleosome binding was 
unaffected by H M G Bl, in close correspondence with the nucleosome sliding profiles. 
Under these conditions no evidence for the existence of a ternary complex of ACF, 
HM GBl and the nucleosome was found using specific antibodies in ‘supershift’ 
strategies (data not shown). Thus, H M G Bl may function as a DNA chaperone that 
facilitates ACF binding to the nucleosome at suboptimal conditions, without being a 
stable component of the complex.
A similar experiment, in which we assayed for an effect of H M G Bl on the ISWI- 
nucleosome interaction revealed no stimulation (Fig.43).
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Fig. 43 H M G B l does not affect the binding affinity o f ISW I for the nucleosom es
Positioned nucleosomes were incubated with increasing amounts o f ISW I (lanes 1-5; 30, 60, 120, 240, 
480, 960, 1920 fmol), H M G B l (lanes 7-12, 0.3, 0.6, 1.2, 2.4, 4.8, 9.6 pmol) and ISW I with fixed am ounts 
of H M G Bl (lanes 13-17, 0.3 pmol H M G B l; lanes 18-22, 0.6 pmol H M G B l). Nueleosom e-ISW I 
complexes are marked by triangles and the nucleosom e-HM GB l com plex is indicated by a circle.
We concluded that the potential of H M GBl to facilitate nucleosome sliding correlates 
with its ability to lead to enhanced interaction of the remodelling machine with the 
nucleosomal substrate. The data identify the A CFl moiety of ACF as crucial for this 
effect.
4.2.5 A HMGBl mutant that binds nucleosomes with high affinity inhibits 
nucleosome sliding
Previously, several investigators observed that the C-terminal acidic tail of HM GBl 
controls the DNA binding properties of the HMG boxes (Lee and Thomas, 2000); (Stros 
et ah, 1994) (Muller et ah, 2001). In agreement with these studies I observed that 
deletion of the C-terminal domain increased the activity of the HMG boxes in protein- 
protein interaction and transactivation assays (unpublished observations). We, therefore, 
wished to test a C-terminally deleted H M GBl (HMGB1AC= boxA-fboxB) in 
nucleosome sliding assays.
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Considering the absolute amounts of input protein, HM GBl AC interacted about 100 
fold better with free DNA than full length H M G B l; similarly, H M G Bl AC interacted 
two orders of magnitude better than H M GBl with either peripheral or central 
nucleosomes (Figure 44B, compare to Fig. 36A). Higher concentrations of H M G Bl AC 
yielded several bands, which, in light of the pattern obtained by interaction of 
H M GBl AC with free DNA (Fig. 44 A), presumably are due to interaction of several 
molecules with the free DNA next to the nucleosome.
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Fig. 44 HM GBIAC binding to free DNA and to m ononucleosom es
(A) Comparison o f H M G B l and H M G BIA C binding to the 248bp rDNA fragment. The DNA  fragm ent 
was incubated with increasing am ounts o f H M G B l (lanes 2-7; 1.5, 2.3, 3.4, 5, 7.6, 11 pmol) and 
HM GBIAC (lanes 8-13; 50, 75, 112, 169, 253, 380 fmol). HM G-DNA com plexes were separated on 
native polyacrylam ide gels.
(B) H M GBIAC interacts with nucleosom es positioned at the border or the centre o f the rD N A  fragment. 
Positioned nucleosomes were incubated with increasing amounts of HM G BIAC (20, 40, 80, 160, 320 
fmol). Com pare the binding efficiency with that of H M G B l in Fig.36
Surprisingly, when HMGBIAC was titrated into the nucleosome mobility assay, it 
inhibited the nucleosome sliding catalysed by a fixed amount of ACF (Fig. 45), rather 
than facilitating it. Nucleosome movement decreased as a function of HM GBIAC and 
complete inhibition was achieved upon addition of 80-160 fmoles. This amount of 
HMGBIAC is similar to the amount required to yield the first complex with the 
nucleosome in the EMSA, which presumably reflects the interaction of a single 
HMGBIAC molecule with its preferred binding site (lane 4).
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Fig. 45 HM GBIAC inhibits ACF-dependent nucleosom es rem odelling
ACF-m ediated nucleosome rem odelling is inhibited by the addition o f HM GBIAC. Nucleosomes 
positioned at the border o f the DNA fragm ent were incubated with ACF, ATP and increasing am ounts of 
HM G BIAC (lanes 2-11; 5, 10, 20, 40, 80, 160, 320, 640, 1240, 2560 fmol). Rem odelling reactions were 
stopped by the addition of com petitor DNA and nucleosom e positions were analysed on a 4.5% 
polyacrylam ide gel.
This result suggests that the tight binding of HMGBIAC to nucleosomes prevents 
efficient nucleosome mobilisation by ACF. Our interpretation of these results will be 
summarised in the model presented in the next section.
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4.3 Discussion
4.3.1 HMGBl, a hallmark of dynamic chromatin
Nucleosome remodelling complexes containing the ATPase ISWI are likely to 
contribute significantly to the flexibility of chromatin enabling dynamic structural 
transitions throughout the lifetime of a cell. Among the Drosophila ISWI complexes 
only the Nucleosome Remodelling Factor (NURF) seems to be involved in targeted 
transcriptional regulation (Mizuguchi et al., 1997; Mizuguchi et al., 2001); (Xiao et al.,
2001). By contrast, the features of the related ACF and CHRAC complexes suggest 
more global roles in the assembly and maintenance of dynamic chromatin (Langst and 
Becker, 2001b). Whether or not the activity of these abundant factors is restricted to 
particular subnuclear domains, or otherwise regulated is unknown. The experiments 
described above indicate that HMGBl, one of the most abundant non-histone proteins 
in nuclei, is able to increase the efficiency of ACF-dependent nucleosome sliding in a 
defined model system. This observation may point to an important, novel function of 
HMGBl, but at the same time reveals unexpected insight into the mechanism 
underlying catalysed nucleosome sliding.
HMGBl is a hallmark of dynamic chromatin: it diffuses throughout the nucleus with 
highest rates, indicating a rather dynamic association with chromatin (Scaffidi et al.,
2002). Since HMGBl binds nucleosomes at sites overlapping those recognised by the 
linker histone HI, HMGBl and related proteins in Drosophila may compete with 
histone HI for nucleosomal binding sites (Ner et al., 1993); (Nightingale et al., 1996); 
(Varga-Weisz et al., 1994). Association of histone HI prevents spontaneous 
nucleosome sliding at elevated salt and temperature (Pennings et al., 1994) and 
moderately inhibits the remodelling action of the SWI/SNF complex on 
mononucleosome substrates (Hill and Imbalzano, 2000). Whether histone HI affects 
nucleosome sliding or other ATP-dependent functions of ISWI has not been determined 
in a defined system yet (but see (Varga-Weisz et al., 1995; Varga-Weisz and Becker, 
1995)). Given, that the interaction of HI with linker DNA (Widom, 1998) is likely to 
interfere with ISWI binding, some kind of inhibition is expected. Therefore, HMGBl 
may facilitate nucleosome remodelling in two ways: (1 ) by ‘unlocking’ the nucleosome
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through displacing linker histones, and (2) by stimulating the activity of ACF/CHRAC 
as shown here and discussed below.
4.3.2 Catalysed nucleosome sliding: mechanistic considerations
ISWI-induced nucleosome sliding does not involve the disassembly of the histone
octamer (Fiamiche et al., 1999); (Langst et al., 1999). Given the large number of
histone-DNA contacts in the nucleosome, it is likely that nucleosome sliding involves
disruption of a limited number of histone-DNA contacts at any time. Prevalent models
assume that the critical step in nucleosome mobilisation is the tight bending (or bulging,
1 _ 
looping) of a DNA segment at the edge of the nucleosome by the remodelling ATPase,
effectively replacing the histone-DNA contacts within this segment by analogous ones
involving an equivalent linker DNA segment. This would lead to the formation of a
local loop, or bulge, on the surface of the histone octamer (Langst and Becker, 2001a);
(Havas et al., 2000); (Kingston and Narlikar, 1999). We presume that this initial DNA
distortion is rate-limiting the overall reaction: once the bulge is introduced into
nucleosomal DNA its propagation over the nucleosomal surface is presumed to require
relatively little further energy input (Langst and Becker, 2001b); (Becker and Horz,
2002). These types of models are supported by recent observations of Owen-Hughes
and colleagues, who documented the ability of ISWI to deform DNA in a reaction
depending on the presence of nucleosomes and ATP (Havas et al., 2000).
We recently observed that single stranded nicks in DNA close to the entry into the 
nucleosome - the site of ISWI interaction - facilitated ATP-dependent nucleosome 
sliding (Langst and Becker, 2001a). We hypothesised that the presence of these nicks 
might enhance the flexibility of DNA at this site, such that it could be easier bent or 
otherwise distorted. The current finding that HMGBl - the prototype of proteins that 
preferentially bind distorted DNA and which bend DNA upon binding - facilitates ACF- 
dependent nucleosome sliding, leads us to the model depicted in Fig. 46. We presume 
that HMGBl acts as a DNA chaperone, kinking or bending DNA (or stabilising an 
intrinsic bend) at the nucleosomal edge. The presence of this bend might either enhance 
the ability of ACF to interact with this site, or alternatively, enhance its ability to
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introduce the rate-limiting DNA distortion. Although a direct, allosteric effect on ACF 
cannot be excluded in light of the fact that HMGBl is able to interact with several 
regulators of chromatin structure (Dintilhac and Bernues, 2002), this appears not to be 
the basis of our current findings since we have been unable to detect a direct interaction 
of HMGB 1 with ISWI and ACF in the absence of nucleosomal DNA. HMG domains 
may be more generally involved in the recognition and modification of nucleosomal 
substrate of remodelling factors, since the BAF57 subunit of the SWFSNF-like 
complexes contains an HMG domain (Wang et al., 1998). Similarly, the BAPI II 
subunit of the Drosophila BRM complex, which is important for BRM function, 
contains an HMG box (Papoulas et al., 1998).
Accelerated Step
HMGB1
Fig. 46 Model showing the stimulatory effect of HM GBl on ACF-mediated nucleosome 
remodelling
H M G B l may introduce a kink ar an initial bulge at the nucleosom e side this intrinsic hend is recongised  
hy ACF, w hose binding affinity for the nuclesom es is thus increased. The wrapping o f  D N A  (black line) 
around a histone octamer (grey sphere) is shown sideways.
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Interestingly, HMGBl potentiated the sliding competence of ACF, but did not enhance 
the ability of the ATPase, ISWI alone. Previous work highlighted several important 
distinctions between the remodelling reactions catalysed by these two factors. The 
association of ACFl with ISWI to form ACF affects the activity of the ATPase both 
quantitatively and qualitatively (Eberharter et al., 2001). First, ACF mobilises 
nucleosomes by an order of magnitude better than ISWI alone at similar levels of ATP 
hydrolysis. At the same time, ACF and ISWI appear to approach the nucleosomal 
substrate somehow differently since ISWI only triggers the sliding of nucleosomes to 
fragment ends whereas ACF is able to move nucleosomes from ends to more central 
positions on DNA. This phenomenology is likely to reflect profound differences in the 
initiation of nucleosome mobilisation. The current data identify yet another aspect in 
which ISWI and ACF function differs: the ability to profit from the action of HMGBl. 
In the presence of low amounts of HMGBl, ACF, but not ISWI, interacts better with 
the nucleosomal substrate. Since these amounts of HMGBl do not form ternary 
complexes with ACF and the nucleosome, we speculate that ACFl might enable the 
remodelling factor to recognise DNA structure within the nucleosomal linker and hence 
sensitise it for pre-bent DNA. Remarkably, ACFl-like molecules appear to be 
obligatory subunits of ISWI-containing remodelling ATPases and therefore seem to be 
tightly involved in the remodelling process itself.
4.3.3 Facilitated nucleosome sliding involving the DNA chaperone function of 
HMGBl
The observation that catalytic concentrations of HMGBl affect the rate with which 
ACF interacts productively with the nucleosomal substrate points to highly dynamic 
association of HMGBl with nucleosomes. We envision that the transient association of 
HMGBl with its target will introduce a DNA distortion, which will subsequently be 
bound by ACF while HMGBl dissociates (Fig. 46). Such a DNA chaperone function of 
HMGBl is not without precedent. HMGB 1/2 molecules are known to facilitate the 
DNA binding of various regulatory factors, such as HOX proteins, steroid hormone 
receptors, p53 and the site specific recombinase RAGl (Aidinis et al., 1999); for review 
of the older literature, see (Bianchi and Beltrame, 1998)).
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The general idea is strongly supported by the observation that an HMGBl derivative 
lacking the acidic C-terminus and hence able to interact with the substrate 1 0 0 -fold 
better than full length HMGBl does not stimulate sliding, but rather represses it. We 
consider that, due to its higher affinity for the substrate, HMGBIAC might resist 
displacement by ACF, remain bound to the nucleosome and hence continue to ‘lock’ the 
nucleosome, perhaps in analogy to histone HI.
Obviously, and in agreement with previous findings (Lee and Thomas, 2000); (Muller 
et al., 2001), its acidic C-terminus is responsible for the dynamic interaction of HMGBl 
with nucleosomal DNA. Differential calorimetry experiments, both in the presence 
(Muller et al., 2001) or the absence of DNA (Ramstein et al., 1999), indicated that the 
acidic tail binds to one of the HMG boxes of HMGBl (most likely Box A). By dynamic 
competition with DNA this intramolecular binding might render the HMG box-DNA 
interaction reversible and transient, consistent with a chaperone function of HMGBl. 
The DNA bulge released from box A could then be recognised by ACF.
Our model experiments highlight the importance of bulges for nucleosome sliding. 
HMGBl merely served as a paradigm for a class of factors which, due to their distinct 
DNA binding features may function as DNA chaperones (Travers et al., 1994). Other 
HMG-box proteins, including the single-HMG-box protein HMG-D in Drosophila (Ner 
et al., 2 0 0 1 ), might share the ability to present bulges or kinks to nucleosome 
remodelling machines. In fact, TBP binding to the TATA box of the IFN-P gene 
promotes the relocation nucleosome that obstructs the transcription start site 
(Lomvardas and Thanos, 2001), thus suggesting that any protein capable of bending 
DNA might promote nucleosome sliding.
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CHAPTER 5. CONCLUSIONS
During these years I had the opportunity to develop two independent but related fields 
of investigation that allowed deepening my knowledge on HMGBl as a “doubleface” 
protein; a nuclear chaperone and a signalling molecule.
Searching for a definition of the peculiar duplicity of HMGBl, we coined the term 
“molecular moonlighting” that expresses well the concept that this molecule has two 
jobs in the cell, independent one from the other as far as we know 
P. Scaffrdi discovered that a passive release of HMGBl by necrotic cells can work as a 
“danger signal”.
My PhD work provides a step further in the understanding the molecular mechanism 
used by healthy cells to actively release HMGBl using a danger signal as a specific and 
rapid response to an inflammatory condition; the results in Section 3 suggest also that 
the inflammatory cells may have employed a machinery common to all the cell types 
(the HATs and HD AGs activities) to develop this quick response via a cascade of PT 
modifications.
On the other side, my collaboration with Becker’s group in Munich provided some hints 
for the understand of the role of HMGBl in modulating the mechanism of chromatin 
remodelling. As thoroughly discussed in Sections 1.2 and 4, the debate around the 
structural and functional relationship between HMGBl and chromatin is still 
controversial.
Showing that HMGBl is indeed able to enhance the activity of native CHRAC and 
ACF, apparently by increasing the affinity of AGP for its nucleosomal substrate, we 
propose a model in which HMGBl distorts DNA at its entry into the nucleosome and 
interacts with it in a highly dynamic manner thus effectively ‘presenting’ the DNA bend 
to AGP. These results are particularly relevant in light of the recent discussion about 
the mechanisms governing nucleosome sliding and they allowed identifying HMGBl as 
a potential regulator of ATP-dependent nucleosome remodelling processes.
Both lines of investigation require further development, since the results I collected in 
Sections 3 and 4 are preliminary, even if they represent an important progress in the two 
distinct fields.
Still, an organic perspective, capable of decimating the two aspects of my study in a 
coherent model, is difficult to define; likely, this goal will be reachable only when more 
information will be collected about the issue of HMGBl as a signalling molecule.
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As a general consideration, one common message I could derive from the two lines of 
research is the concepts of dynamism and mobility, as main features of the biological 
world at all levels, in my case from the cellular level to the molecular one.
Dynamism that I could detect in the interactions between molecules: the role of 
HMGBl on sliding is mainly based on its capability to estabilish very dynamic contacts 
with the other partners. A proof is given by the fact that, whenever this dynamism is lost 
due to excessive affinity between partners (like with HMGBl AC), the mechanism 
collapses.
Regarding HMGBl acétylation, dynamism could be detected at many different levels: 
HMGBl moves quickly inside the nucleus, estabilishing specific but loose contacts with 
nucleoplasm; HMGBl shuttles continuously in and out of the nucleus, with a final 
location that is always the result of a very dynamic processes.
The acétylation level of HMGBl is itself the result of a dynamic balance between two 
enzymatic activities (HATs and HD AGs) that are highly and quickly regulatable.
Finally, in monocytes, the quick kinetics of HMGBl secretion upon LPS is the result of 
the sum of all these dynamic processes occurring at all levels and in all subcellular 
compartments.
In perspective, HMGBl emerges like a special archetype of highly dynamic molecules, 
being located in several places, where it plays different roles with different partners: in 
many more sense then one it is a High Mobility Protein.
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